Covalently modified surfaces, kits, and methods of preparation and use
Patent Information
- Application Number
- JP2024075278
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2016-10-21
- Filing Date
- 2024-05-07
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2037-05-26
AI Technical Summary
Existing surfaces of apparatuses and materials that come into contact with biological materials are not optimized for improved performance and often exhibit undesirable interactions with biological molecules and micro-objects, leading to inefficiencies in handling and processing.
The development of microfluidic devices with covalently modified surfaces featuring distinct binding groups and moieties on interior surfaces, allowing for regioselective modification and enhanced interaction with biological materials through the use of siloxane reagents and reactive moieties.
The covalently modified surfaces provide improved handling, manipulation, and processing capabilities for biological materials by reducing undesirable interactions and enhancing surface properties, such as cell adhesion and portability, while maintaining biocompatibility and durability.
Smart Images

Figure 00000000_0000_ABST
Abstract
Description
[Technical field]
[0001] This application is a nonprovisional application that claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application No. 62 / 342,131, filed May 26, 2016; U.S. Provisional Patent Application No. 62 / 345,603, filed June 3, 2016; U.S. Provisional Patent Application No. 62 / 353,938, filed June 23, 2016; U.S. Provisional Patent Application No. 62 / 411,191, filed October 21, 2016; and U.S. Provisional Patent Application No. 62 / 410,238, filed October 19, 2016, the disclosures of each of which are incorporated herein by reference in their entirety. [Background technology]
[0002] 2. Background of the Invention In bioscience and related fields, it can be useful to modify the surfaces of apparatus, devices and materials that come into contact with biomaterials, such as biomolecules and biological micro-objects. Certain embodiments of the present invention include siloxane reagents, their preparation and methods for modifying surfaces to provide improved or altered performance with biomaterials. Summary of the Invention [Means for solving the problem]
[0003] Summary of the Invention In a first aspect, a microfluidic device is provided that includes an enclosure including a base, a cover, and a microfluidic circuit material that defines a fluid circuit therein, where at least one inner surface of the base, cover, and microfluidic circuit material has a first covalent surface modification comprising a first binding group and a first portion that is a first surface contacting moiety or a first reactive moiety; and at least one inner surface of the base, cover, and microfluidic circuit material has a second covalent surface modification comprising a second binding group and a second portion that is a second surface contacting moiety or a second reactive moiety, where the first binding group and the second binding group are different from each other and / or the first portion is different from the second portion. In certain embodiments, a common inner surface of the base, cover, and microfluidic circuit material has a first covalent surface modification and a second covalent surface modification.
[0004] In another aspect, a method of forming a covalently modified surface on at least one interior surface of a microfluidic device comprising an enclosure having a base, a cover, and microfluidic circuit material defining a fluid circuit therein, the method comprising: contacting the at least one interior surface with a first modification reagent and a second modification reagent; reacting the first modification reagent with a first nucleophilic moiety on the at least one interior surface; reacting the second modification reagent with a second nucleophilic moiety on the at least one interior surface; forming at least one covalently modified surface comprising a first covalent surface modification comprising a first binding group and a first moiety that is a first surface contacting moiety or a first reactive moiety, and a second covalent surface modification comprising a second binding group and a second moiety that is a second surface contacting moiety or a second reactive moiety, wherein the first binding group is different from the second binding group or the first moiety is different from the second moiety. In certain embodiments, the first covalent surface modification and the second covalent surface modification may be formed on a common inner surface of the base, the cover and the microfluidic circuit material.
[0005] In another aspect, a method is provided for site-selectively forming distinct covalently modified surfaces within a microfluidic device. The microfluidic device includes a base, a cover, and a microfluidic circuit material that define a microfluidic circuit therein. The microfluidic circuit may include an enclosure having a conduit material, the microfluidic circuit including a flow region and an isolation pen, the isolation pen including a separation region and a connection region, the connection region including a proximal opening to the flow region and fluidly connecting the separation region to the flow region. The method may include flowing a first modification reagent through the flow region under conditions such that the first modification reagent does not enter the separation region of the isolation pen; reacting the first modification reagent with a nucleophilic moiety on at least one surface of the flow region, thereby forming a first modified surface in the flow region, the first modified surface not extending into the separation region of the isolation pen; flowing a second modification reagent through the flow region under conditions such that the second modification reagent enters the separation region of the isolation pen; and reacting the second modification reagent with a nucleophilic moiety on at least one surface of the separation region of the isolation pen, thereby forming a second modified surface in the separation region of the isolation pen. Typically, the first modification reagent does not have the same structure as the second modification reagent.
[0006] In another embodiment, a kit is provided that includes the microfluidic device described herein. The kit comprises a microfluidic device having Formula XII: RP-L-Surface contact part Formula XII wherein RP is a reactive pair moiety; and the surface contacting moiety supports cell growth, survival, portability, or any combination thereof. L is a linker, L can be a bond or 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur, and phosphorus atoms, and can further include 0 or 1 linking group CG.
[0007] In another embodiment, the compound of formula XIII: [ka] wherein h is an integer from 1 to 19, and R is independently selected from the group consisting of H and C1-C6 alkyl. In some embodiments, h is 5 to 19.
[0008] In yet another embodiment, the compound of formula XIII: [ka] A method for synthesizing a compound having the structure: [ka] reacting a compound having the structure of the formula: and producing a compound of formula XIII, wherein h is an integer from 1 to 19, and each R is independently H or C1 to C6 alkyl.
[0009] In a further embodiment, the compound of formula IV: [ka] wherein n is an integer from 3 to 21, and R is independently H or C1 to C6 alkyl. In one embodiment, n is 9, 14, or 16.
[0010] In another embodiment, the compound of formula IV: [ka] A method for synthesizing a compound of formula XIII: [ka] (wherein h is 1 to 19). with azide ion, thereby producing a compound of formula IV, where n is 3 to 21, and R is H or C1-C6 alkyl. [Brief description of the drawings]
[0011] BRIEF DESCRIPTION OF THE DRAWINGS [Figure 1A] 1 illustrates an example system for use with a microfluidic device and associated controls according to certain embodiments of the present disclosure. [Figure 1B] 1 illustrates a microfluidic device according to an embodiment of the present disclosure. [Figure 1C] 1 illustrates a microfluidic device according to an embodiment of the present disclosure. [Figure 2A] 1 illustrates a separation pen according to an embodiment of the present disclosure. [Figure 2B] 1 illustrates a separation pen according to an embodiment of the present disclosure. [Figure 2C] 1 illustrates a detailed isolation pen according to an embodiment of the present disclosure. [Figure 2D] 1 illustrates an isolation pen according to another embodiment of the present disclosure. [Figure 2E] 1 illustrates an isolation pen according to another embodiment of the present disclosure. [Figure 2F] 1 illustrates an isolation pen according to another embodiment of the present disclosure. [Figure 2G] 1 illustrates a microfluidic device according to an embodiment of the present disclosure. [Figure 2H] 1 shows a coated surface of a microfluidic device according to an embodiment of the present disclosure. [Figure 3A] 1 illustrates an example system for use with a microfluidic device and associated controls according to certain embodiments of the present disclosure. [Figure 3B] 1 illustrates an imaging device according to an embodiment of the present disclosure. [Figure 4]1 is a graphical representation of an FTIR spectrum for a modified microfluidic circuit material according to an embodiment of the present disclosure. [Figure 5A] 1 is a graphical representation of an overlay FTIR for a modified surface according to an embodiment of the present disclosure. [Figure 5B] 1 is a graphical representation of an overlay FTIR for a modified surface according to an embodiment of the present disclosure. [Figure 6A] 1 is a photographic representation of a cell culture according to one embodiment of the present invention. [Figure 6B] 1 is a photographic representation of cell unpenning according to one embodiment of the present invention. [Figure 7A] 1 is a photographic representation of a cell culture according to another embodiment of the present invention. [Figure 7B] 1 is a photographic representation of a cell harvest according to another embodiment of the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0012] Detailed Description of the Invention This specification describes exemplary embodiments and applications of the present disclosure. However, the present disclosure is not limited to these exemplary embodiments and applications, or the manner in which the exemplary embodiments and applications operate or are described herein. Furthermore, the figures may show simplified or partial views, and the dimensions of the elements in the figures may be exaggerated or not to scale. Furthermore, the terms "on", "mounted", "connected", "coupled" or similar words, as used herein, may mean that one element (e.g., a material, layer, substrate, etc.) can be "on", "mounted", "connected" or "coupled" to another element, regardless of whether the one element is directly on, attached, connected or coupled to the other element, or whether there are one or more intervening elements between the one element and the other element. Also, unless the context dictates otherwise, directions (e.g., above, below, top, bottom, side, over, under, below, upper, upper side, horizontal, vertical, "x", "y", "z", etc.), when provided, are relative and are provided merely as examples and for ease of illustration and description, not as limitations. Furthermore, when reference is made to a list of elements (e.g., elements a, b, c), such reference is intended to include any one of the listed elements per se, any combination of less than all of the listed elements, and / or all combinations of the listed elements. Divisions of paragraphs herein are merely for ease of review and do not limit any combination of the elements described.
[0013] When the dimensions of a microfluidic feature are described as having a certain width or area, the dimensions are typically described relative to the x-axis and / or y-axis dimensions (both in a plane parallel to the substrate and / or cover of the microfluidic device). The height of the microfluidic feature may be described relative to the z-axis direction, which is perpendicular to the plane parallel to the substrate and / or cover of the microfluidic device. In some cases, the cross-sectional area of a microfluidic feature, such as a channel or passage, may be related to an x-axis / z-axis, y-axis / z-axis, or x-axis / y-axis area.
[0014] As used herein, "substantially" means sufficient to function for the intended purpose. Thus, the term "substantially" allows for small slight variations from absolute or perfect conditions, dimensions, measurements, results, etc., that may be predicted by one of ordinary skill in the art, but that do not significantly affect overall performance. When used in reference to a value or parameter or characteristic that can be expressed as a numerical value, "substantially" means within 10 percent. means.
[0015] The term "a" or "an" means two or more. As used herein, the term "multiple" can be 2, 3, 4, 5, 6, 7, 8, 9, 10 or more.
[0016] As used herein, "alkyl" refers to a straight or branched hydrocarbon chain radical consisting solely of carbon and hydrogen atoms, without any unsaturation, having 1 to 6 carbon atoms (e.g., C1-C6 alkyl). Whenever alkyl appears herein, a numerical range such as "1 to 6" refers to each integer within the given range, for example, "1 to 6 carbon atoms" means that the alkyl group can consist of 1 carbon atom, 2 carbon atoms, 3 carbon atoms, etc., up to and including 6 carbon atoms, but this definition also encompasses occurrences of the term "alkyl" where no numerical range is given. In certain embodiments, alkyl is a C1-C3 alkyl group. Exemplary alkyl groups include, but are in no way limited to, methyl, ethyl, propyl, isopropyl, n-butyl, iso-butyl, sec-butyl isobutyl, tertiary butyl, pentyl, isopentyl, neopentyl, hexyl, and the like. The alkyl is attached to the remainder of the molecule by a single bond, such as methyl (Me), ethyl (Et), n-propyl, 1-methylethyl (iso-propyl), n-butyl, n-pentyl, 1,1-dimethylethyl (t-butyl), hexyl, and the like.
[0017] Unless stated otherwise specifically in the specification, alkyl groups are independently selected from aryl, arylalkyl, heteroaryl, heteroarylalkyl, hydroxy, halo, cyano, trifluoromethyl, trifluoromethoxy, nitro, trimethylsilanyl, -OR', -SR', -OC(O)-R', -N(R'), -C(O)R', -C(O)OR', -OC(O)N(R'), -C(O)N(R'), -N(R')C(O)OR', -N(R')C(O)R', -N(R')C(O)N(R'), N(R')C(NR')N(R'), -N(R')S(O) t R' (where t is 1 or 2), -S(O) t OR' (where t is 1 or 2), -S(O) t It may be optionally substituted with one or more substituents that are N(R')2 (wherein t is 1 or 2) or PO3(R')2, where each R' is independently hydrogen, alkyl, fluoroalkyl, aryl, aralkyl, heterocycloalkyl, or heteroaryl.
[0018] As referred to herein, a fluorinated alkyl moiety is an alkyl moiety in which one or more hydrogens on the alkyl moiety have been replaced with a fluoro substituent. A perfluorinated alkyl moiety has all hydrogens attached to the alkyl moiety replaced with fluoro substituents.
[0019] As referred to herein, a "halo" moiety is a bromo, chloro, or fluoro moiety.
[0020] As referred to herein, an "olefinic" compound is an organic molecule that contains an "alkene" moiety. The alkene moiety refers to a group that consists of at least two carbon atoms and at least one carbon-carbon double bond. The non-alkene portion of the molecule can be any type of organic molecule, and in certain embodiments can include alkyl or fluorinated (including but not limited to perfluorinated) alkyl moieties, either of which can be further substituted.
[0021] As used herein, "air" refers to the composition of gases that predominate in the Earth's atmosphere. The four most abundant gases are nitrogen (typically present at a concentration of about 78% by volume, e.g., in the range of about 70-80%), oxygen (typically present at sea level at about 20.95% by volume, e.g., in the range of about 10% to about 25%), argon (typically present at about 1.0% by volume, e.g., about 0.5% by volume), and argon (typically present at sea level at about 1.5% by volume, e.g., about 0.5% by volume). The primary contaminants in the air are nitrogen dioxide (typically present in the range of about 0.1% to about 3%) and carbon dioxide (typically present in the range of about 0.04%, e.g., about 0.01% to about 0.07%). Air may have other trace gases such as methane, nitrous oxide or ozone, trace contaminants such as pollen, diesel particulates, and organic materials. Air may include water vapor (typically present at about 0.25%, or may be present in the range of about 10 ppm to about 5% by volume). Air may be filtered and provided for use in culture experiments as a controlled composition, and may be conditioned as described herein.
[0022] As used herein, the term "plurality" can be 2, 3, 4, 5, 6, 7, 8, 9, 10 or more.
[0023] As used herein, the term "disposed" includes "located" within its meaning.
[0024] As used herein, a "microfluidic device" or "microfluidic apparatus" is a device that includes one or more individual microfluidic circuits configured to hold a fluid, each microfluidic circuit being composed of circuit elements, including but not limited to regions, flow paths, channels, chambers, and / or pens, that are fluidly connected to one another, and at least one port configured to flow fluid (and optionally microscopic objects suspended in the fluid) into and / or out of the microfluidic device. Typically, the microfluidic circuits of a microfluidic device include a flow region that may include a microfluidic channel and at least one chamber, and hold a volume of fluid of less than about 1 mL, e.g., less than about 750, 500, 250, 200, 150, 100, 75, 50, 25, 20, 15, 10, 9, 8, 7, 6, 5, 4, 3, or 2 μL. In certain embodiments, the microfluidic circuit holds about 1-2, 1-3, 1-4, 1-5, 2-5, 2-8, 2-10, 2-12, 2-15, 2-20, 5-20, 5-30, 5-40, 5-50, 10-50, 10-75, 10-100, 20-100, 20-150, 20-200, 50-200, 50-250, or 50-300 μL. The microfluidic circuit may be configured to have a first end in fluid communication with a first port (e.g., an inlet) in the microfluidic device, and a second end in fluid communication with a second port (e.g., an outlet) in the microfluidic device.
[0025] As used herein, a "nanofluidic device" or "nanofluidic apparatus" is a type of microfluidic device having a microfluidic circuit that includes at least one circuit element configured to hold a volume of fluid of less than about 1 μL, for example, less than about 750, 500, 250, 200, 150, 100, 75, 50, 25, 20, 15, 10, 9, 8, 7, 6, 5, 4, 3, 2, 1 nL or less. A nanofluidic device can include a plurality of circuit elements (e.g., at least 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 50, 75, 100, 150, 200, 250, 300, 400, 500, 600, 700, 800, 900, 1000, 1500, 2000, 2500, 3000, 3500, 4000, 4500, 5000, 6000, 7000, 8000, 9000, 10,000 or more). In certain embodiments, one or more (e.g., all) of the at least one circuit element are configured to hold a volume of fluid of about 100 pL to 1 nL, 100 pL to 2 nL, 100 pL to 5 nL, 250 pL to 2 nL, 250 pL to 5 nL, 250 pL to 10 nL, 500 pL to 5 nL, 500 pL to 10 nL, 500 pL to 15 nL, 750 pL to 10 nL, 750 pL to 15 nL, 750 pL to 20 nL, 1 to 10 nL, 1 to 15 nL, 1 to 20 nL, 1 to 25 nL, or 1 to 50 nL. In other embodiments, one or more (e.g., all) of the at least one circuit element is about 20 nL to 200 nL, 100 to 200 nL, 100 to 300 nL, 100 to 400 nL, 100 to 500 nL, 200 to 300 nL, 200 to 400 nL, 200 to 500 nL, 200 to 600 nL, 200 to The nozzle may be configured to hold a volume of fluid from 250 to 700 nL, 250 to 400 nL, 250 to 500 nL, 250 to 600 nL, or 250 to 750 nL.
[0026] A microfluidic or nanofluidic device may be referred to herein as a "microfluidic chip" or "chip" or a "nanofluidic chip" or "chip."
[0027] A "microfluidic channel" or "flow channel" as used herein refers to a flow region of a microfluidic device that has a length significantly longer than both the horizontal and vertical dimensions. For example, a flow channel can be at least 5 times longer, e.g., at least 10 times longer, at least 25 times longer, at least 100 times longer, at least 200 times longer, at least 500 times longer, at least 1,000 times longer, at least 5,000 times longer or more than the length of either the horizontal or vertical dimension. In some embodiments, the length of the flow channel is about 100,000 μm to about 500,000 μm, including any value therebetween. In some embodiments, the horizontal dimension is about 100 μm to about 1000 μm (e.g., about 150 to about 500 μm) and the vertical dimension is about 25 μm to about 200 μm, (e.g., about 40 to about 150 μm). It is noted that flow channels can have a variety of different spatial geometries in a microfluidic device and are therefore not limited to completely linear elements. For example, the flow channel may be or include one or more portions having the following shapes: curved, bent, spiral, inclined, descending, forked (e.g., multiple different flow paths), and any combination thereof. Additionally, the flow channel may have different cross-sectional areas along its path, expanding and contracting to provide the desired fluid flow therein. The flow channel may include valves, which may be of any type known in the art of microfluidics. Examples of microfluidic channels including valves are disclosed in U.S. Patent Nos. 6,408,878 and 9,227,200, each of which is incorporated herein by reference in its entirety.
[0028] As used herein, the term "obstacle" generally refers to a bump or similar type of structure large enough to partially (but not completely) impede movement of a target micro-object between two distinct regions or circuit elements in a microfluidic device. The two distinct regions / circuit elements can be, for example, a microfluidic isolation pen and a microfluidic channel, or a connecting region and a separating region of a microfluidic isolation pen.
[0029] As used herein, the term "constriction" generally refers to a narrowing in the width of a circuit element (or an interface between two circuit elements) in a microfluidic device. A constriction may be located, for example, at the interface between a microfluidic isolation pen and a microfluidic channel or at the interface between a separation region and a connection region of a microfluidic isolation pen.
[0030] As used herein, the term "transparent" refers to a material that transmits visible light without substantially altering the light as it passes through.
[0031] As used herein, the term "microscopic objects" generally refers to any microscopic object that can be separated and / or manipulated in accordance with the present disclosure. Non-limiting examples of microscopic objects include microparticles; microbeads (e.g., polystyrene beads, Luminex™ beads, etc.); ); magnetic beads; microrods; microwires; inanimate micro-objects such as quantum dots; cells; biological organelles; vesicles or complexes; synthetic vesicles; liposomes (e.g., synthetic or derived from membrane preparations); biological micro-objects such as lipid nanorafts; or combinations of inanimate and biological micro-objects (e.g., microbeads attached to cells, liposome-coated microbeads, liposome-coated magnetic beads, etc.). Beads may contain covalently or non-covalently attached moieties / molecules such as fluorescent labels, proteins, carbohydrates, antigens, small molecule signaling moieties or other chemical / biological species that can be used in assays. Lipid nanorafts The method is described, for example, in Ritchie et al. (2009) "Reconstitution of Membrane Proteins in Phospholipid Bilayer Nanodiscs", Methods Enzymol., 464:211-231.
[0032] As used herein, the term "cell" is used synonymously with the term "biological cell." Non-limiting examples of biological cells include eukaryotic cells, plant cells, animal cells, such as mammalian cells, reptile cells, avian cells, fish cells, etc., prokaryotic cells, bacterial cells, fungal cells, protozoan cells, etc., cells dissociated from tissues, such as muscle, cartilage, fat, skin, liver, lung, nervous tissue, etc., immune cells, such as T cells, B cells, natural killer cells, macrophages, etc., embryos (e.g., zygotes), oocytes, eggs, sperm cells, hybridomas, cultured cells, cells from cell lines, cancer cells, infected cells, transfected and / or transformed cells, reporter cells, etc. Mammalian cells can be derived, for example, from humans, mice, rats, horses, goats, sheep, cows, primates, etc.
[0033] A colony of living cells is a "clone" if all of the living cells in the reproductive colony are daughter cells derived from a single parent cell. In certain embodiments, all daughter cells in a clonal colony are derived from a single parent cell by 10 or fewer divisions. In other embodiments, all daughter cells in a clonal colony are derived from a single parent cell by 14 or fewer divisions. In other embodiments, all daughter cells in a clonal colony are derived from a single parent cell by 17 or fewer divisions. In other embodiments, all daughter cells in a clonal colony are derived from a single parent cell by 20 or fewer divisions. The term "clonal cells" refers to cells of the same clonal colony.
[0034] As used herein, a "colony" of biological cells refers to two or more cells (e.g., about 2 to about 20, about 4 to about 40, about 6 to about 60, about 8 to about 80, about 10 to about 100, about 20 to about 200, about 40 to about 400, about 60 to about 600, about 80 to about 800, about 100 to about 1000, or more than 1000 cells).
[0035] As used herein, the term "sustaining cells" refers to providing an environment, including both fluid and gaseous components, and optionally, surfaces that provide the conditions necessary to sustain cell survival and / or proliferation.
[0036] As used herein, the term "proliferation," when referring to cells, refers to an increase in cell number.
[0037] As referred to herein, "gas permeable" means that a material or structure is permeable to at least one of oxygen, carbon dioxide, or nitrogen. In certain embodiments, a gas permeable material or structure is permeable to more than one of oxygen, carbon dioxide, and nitrogen, and may even be permeable to all three of these gases.
[0038] A "component" of a fluid medium is any chemical or biochemical molecule present in the medium, including solvent molecules, ions, small molecules, antibiotics, nucleotides and nucleosides, nucleic acids, amino acids, peptides, proteins, sugars, carbohydrates, lipids, fatty acids, cholesterol, metabolites, etc.
[0039] As used herein with respect to a fluid medium, "diffuse" and "diffusion" refer to the thermodynamic movement of a component of the fluid medium down a concentration gradient.
[0040] The phrase "flow of medium" refers to the bulk movement of a fluid medium primarily due to any mechanism other than diffusion. For example, flow of medium may include the movement of a fluid medium from one point to another due to a pressure difference between the points. Such flow may include continuous, pulsed, periodic, random, intermittent, or back and forth flow of liquid, or any combination thereof. When one fluid medium flows into another, turbulence and mixing of the media can occur.
[0041] The phrase "substantially no flow" refers to a flow rate of a fluid medium that, when averaged over time, is less than the diffusion rate of a component of a material (e.g., an analyte of interest) into or within the fluid medium. The diffusion rate of a component of such a material can depend on, for example, temperature, size of the component, and strength of interaction between the component and the fluid medium.
[0042] As used herein with respect to different regions within a microfluidic device, the phrase "fluidically connected" means that when the different regions are substantially filled with fluid, such as a fluid medium, the fluids in each of the regions are connected to form a single fluid. This does not mean that the fluids (or fluid medium) in the different regions are necessarily of identical composition. Rather, fluids in different fluidly connected regions of a microfluidic device may have different compositions (e.g., different concentrations of solutes, such as proteins, carbohydrates, ions, or other molecules) within the flow stream as solutes move down their respective concentration gradients and / or as the fluids flow through the device.
[0043] As used herein, a "flow path" refers to one or more fluidly connected circuit elements (e.g., channels, regions, chambers, etc.) that define and are exposed to the trajectory of a flow of medium. Thus, a flow path is an example of a sweep region of a microfluidic device. Other circuit elements (e.g., non-sweep regions) may be fluidly connected to a circuit element that includes a flow path without being exposed to the flow of medium in the flow path.
[0044] As used herein, "isolating a micro-object" refers to confining a micro-object to a defined area within a microfluidic device.
[0045] A microfluidic (or nanofluidic) device may include a "sweep" region and a "non-sweep" region. As used herein, a "sweep" region is comprised of one or more fluidly connected circuit elements of a microfluidic circuit, each of which receives a flow of medium when fluid flows through the microfluidic circuit. The circuit elements of a sweep region may include, for example, all or part of a region, a channel, and a chamber. As used herein, a "non-sweep" region is comprised of one or more fluidly connected circuit elements of a microfluidic circuit, each of which does not receive substantially a flux of fluid when fluid flows through the microfluidic circuit. A non-sweep region may be fluidly connected to a sweep region if the fluid connection is structured to allow diffusion but not substantially allow flow of medium between the sweep region and the non-sweep region. Thus, a microfluidic device may be structured to substantially isolate the non-sweep region from the flow of medium in the sweep region while allowing substantially only diffusive fluid communication between the sweep region and the non-sweep region. For example, a flow channel of a microfluidic device is an example of a sweep region, while a separation region of a microfluidic device (described in more detail below) is an example of a non-sweep region.
[0046] As used herein, a "non-sweeping" rate of fluid medium flow means a flow rate sufficient to cause components of a second fluid medium in a separation region of the isolation pen to diffuse into a first fluid medium in the flow region and / or cause components of the first fluid medium to diffuse into a second fluid medium in the separation region, and further, the first medium does not substantially flow into the separation region.
[0047] Surface Modification. Surfaces of materials, devices and / or apparatus for the manipulation and storage of biological materials may have native properties that are not optimized for short-term and / or long-term contact with such materials, which may include, but are not limited to, micro-objects (including, but not limited to, biological micro-objects such as biological cells), biomolecules, fragments of biomolecules or biological micro-objects, and any combination thereof. Associated with native surfaces in contact with one or more biological materials. It may be useful to modify one or more surfaces of a material, device or apparatus to reduce one or more undesirable phenomena. In other embodiments, it may be useful to enhance the surface properties of a material, device and / or apparatus to introduce desired features to the surface and thereby extend the handling, operation or processing capabilities of the material, device and / or apparatus. To this end, molecules are needed that can modify surfaces to reduce undesirable properties or introduce desirable properties.
[0048] Described herein is a microfluidic device having an enclosure including a base, a cover, and a microfluidic circuit material that defines a fluid circuit therein, where at least one inner surface of the base, the cover, and the microfluidic circuit material has a first covalent surface modification including a first binding group and a first portion that is a first surface contacting moiety or a first reactive moiety; and at least one inner surface of the base, the cover, and the microfluidic circuit material has a second covalent surface modification including a second binding group and a second portion that is a second surface contacting moiety or a second reactive moiety, where the first binding group and the second binding group are different from each other, or the first covalently attached moiety is different from the second covalently attached moiety. The first surface modification can be a covalently modified surface and the second surface modification can be a functionalized surface. In other embodiments, the first surface modification can be a first covalently modified surface and the second surface modification can be a second covalently modified surface having either a different binding group or a different surface-modified ligand.
[0049] Modification Reagent: Surface-Modifying Compound. In various embodiments, the surface-modifying compound may comprise a surface-modifying ligand, which may be a non-polymeric moiety, such as an alkyl moiety, a substituted alkyl moiety, such as a fluoroalkyl moiety (including but not limited to a perfluoroalkyl moiety), or an alkylene oxide moiety, an amino acid moiety, an alcohol moiety, an amino moiety, a carboxylic acid moiety, a phosphonic acid moiety, a sulfonic acid moiety, a sulfamic acid moiety, or a saccharide moiety, that covalently modifies the surface to which it is attached. The surface-modifying compound also comprises a linking moiety, which is a group that covalently bonds the surface-modifying ligand to the surface, as shown diagrammatically in Formula 1. Depending on the composition of the surface, the linking moiety may be a silicon-containing moiety, such as -Si(T)2W, where W is -T, -SH, or -NH2; T is independently OH, OC, 1~6 alkyl or halo or combinations thereof; a phosphonic acid moiety or an activated form thereof, a maleimide moiety, a terminal olefin, or any suitable linking moiety known in the art. The surface-modifying ligand is covalently attached to the modified surface via a linking group LG, which is the product of the reaction of the linking moiety with a functional group on the surface, including hydroxide, oxide, amine, or sulfur. The linking group LG can include siloxy, phosphonate, alkyl sulfide, and the like. In some embodiments, the linking group LG can be a siloxy or phosphonate group.
[0050] Formula 1. [ka]
[0051] In one embodiment, the surface modifying compound has formula XXXII: VL sm -Surface-modifying ligand Formula XXXII wherein the binding moiety V is -P(O)(OH)2 or -Si(T)2W; W is -T, -SH or -NH2 and is a moiety configured to bind to a surface. Each T is independently OH, OC 1~6 is alkyl or halo. smis a linker containing 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur and phosphorus atoms, and further containing 0, 1, 2, 3 or 4 linking groups CG. The number of non-hydrogen atoms forming CG is determined by the number of linking groups L sm Not included in the size of L sm The surface-modified ligand may contain 0, 1, 2 or 3 CGs.
[0052] In one embodiment, the surface modifying compound of formula XXXII has formula I: V-(CH2) n - Surface-modifying ligand Formula I wherein the binding moiety V is -P(O)(OH)Q- or -Si(T)2W; W is -T, -SH or -NH2 and is a moiety configured to bind to a surface; Q is -OH and is a moiety configured to bind to a surface; and n is an integer from about 3 to 21. In some embodiments, n is an integer from about 7 to 21. Each T is independently selected from OH, OC 1~6 alkyl or halo, where alkyl includes, but is not limited to, methyl, ethyl, n-propyl, 2-propyl, n-butyl, etc. In certain embodiments, T is OH, OC 1~3 Alkyl or Cl. The surface modifying ligand may contain 0, 1, 2 or 3 CG.
[0053] In one embodiment, the compound of formula I has formula II: [ka] where W, T and n are as defined above for formula I. The surface modifying ligand may contain 0, 1, 2 or 3 CGs.
[0054] In other embodiments, the compound of formula I has formula III: [ka] wherein R is C 1~6 alkyl, and n is an integer from 3 to 21. The surface modifying ligand may contain 0, 1, 2 or 3 CGs.
[0055] The surface-modifying compounds used to covalently modify the surfaces of the interior surfaces of the microfluidic devices described herein introduce surface-modifying ligands with surface-contacting moieties that support the growth, survival, or mobility of biological cells. The surface-modifying ligands that include surface-contacting moieties may include anionic, cationic, or zwitterionic moieties, or any combination thereof. Without intending to be bound by theory, by presenting cationic, anionic, and / or zwitterionic moieties on the interior surfaces of the enclosures of the microfluidic devices, the surface-modifying ligands of the covalently modified surfaces may form strong hydrogen bonds with water molecules such that the resulting hydrated water serves as a layer (or "shield") that separates the biological microobjects from interactions with non-biomolecules (e.g., silicon and / or silicon oxide of the substrate). Furthermore, in embodiments in which the covalently modified surfaces are used with coating agents, the anionic, cationic, and / or zwitterionic moieties of the surface-modifying ligands ... surface-modifying ligands may form strong hydrogen bonds with water molecules such that the resulting hydrated water serves as a layer (or "shield") that separates the biological microobjects from interactions with non-biomolecules (e.g., silicon and / or silicon oxide of the substrate). and / or zwitterions may form ionic bonds with charged moieties of non-covalent coating agents (e.g., proteins in solution) present in the medium (e.g., coating solution and / or fluid medium for supporting biological cells) in the enclosure. In other embodiments, the surface-modified ligands may include at least one amino acid that may include two or more types of amino acids. Thus, the surface-modified ligands may include peptides or proteins. In certain embodiments, the surface-modified ligands may include amino acids that may provide a zwitterionic surface to support cell growth, survival, mobility, or any combination thereof.
[0056] In yet other embodiments, the surface-modifying ligand may exhibit hydrophilic surface-contacting moieties at opposing ends of its enclosure, including, but not limited to, at least one alkylene oxide moiety. One useful class of alkylene ether-containing polymers is polyethylene glycol (PEG M). w <100,000 Da). In certain embodiments, the PEG has an M of about 100 Da, 300 Da, 500 Da, 1000 Da, or 5000 Da. w In other embodiments, the hydrophilic surface-modified ligands may include one or more saccharides. The covalently attached saccharides may be monosaccharides, disaccharides, or polysaccharides. Similar to the charged moieties described above, the hydrophilic surface-modified ligands may form strong hydrogen bonds with water molecules such that the resulting hydration water acts as a layer (or "shield") that separates the biological micro-object from interactions with non-biomolecules (e.g., silicon and / or silicon oxide of the substrate).
[0057] The surface-modifying ligand may alternatively contain one or more amino groups as surface contacting moieties. The amino groups may be substituted amine moieties, guanidine moieties, nitrogen-containing heterocyclic moieties or heteroaryl moieties. The amino-containing moieties may have a structure that allows for pH adjustment of the environment within the microfluidic device. In some embodiments of the microfluidic devices described herein, the environment may be adjusted within the pen (which may be the same as or different from the isolation pen described herein) that opens into the flow region and / or within the flow region (which may include a channel).
[0058] In various embodiments, the surface modifying compound comprises a linear backbone of 8 to 26 atoms, where the atoms are carbon, oxygen, nitrogen, or sulfur; and a linking moiety selected from -P(O)(OH)2 and -Si(Y)3, where Y is Cl, O-C 1~3The linear backbone may include a cyclic alkyl group or an aryl group, which is an alkyl or OH, and the non-backbone substituents of the carbon atoms of the linear backbone are hydrogen or fluorine. The surface modifying compound may be attached to a functional group (including hydroxide, oxide, amine or sulfur) on the surface through a linking moiety. A first end of the linear backbone is attached to the linking moiety through a bond to the phosphorus or silicon of the linking moiety, and a second end of the linear backbone is distal to the surface and is not attached to the surface. Independently for each carbon of the linear backbone, the non-backbone substituents are either all hydrogen or all fluorine. In some embodiments, the linear backbone may be all carbon atoms. A linear backbone having all carbon backbone atoms may have non-backbone substituents that are all hydrogen atoms.
[0059] In one embodiment, the linear backbone of the surface modifying compound is linked to the linker L sm and may include two carbon atoms disposed at a first end of the linear backbone (e.g., directly bonded to the attachment moiety), and the non-backbone substituent for each of the two carbons may be hydrogen. In some embodiments, the linear backbone may include a sulfur atom. In some embodiments, the linear backbone may include two sulfur atoms, and the two sulfur atoms are disposed adjacent to each other. When two sulfur atoms disposed adjacent to each other are present in the linear backbone, the two sulfur atoms are not disposed at the first end (e.g., neither of the two sulfur atoms is directly bonded to the attachment moiety) or at the second end of the linear backbone (e.g., located at the end of the modified compound that is distal to attachment to the surface). In some embodiments, the disulfide bond of the linear backbone may be a substituted or unsubstituted ... The linker moiety may be a cleavable motif, allowing for removal of part or all of the surface-modified ligand. Other cleavable motifs include the linker L of the surface-modified compounds described herein. sm may be included in
[0060] In certain embodiments, the surface-modifying compound may contain 0, 1, 2, 3 or 4 linking groups CG as described herein. The surface-modifying compound may be formed from two or more moieties linked together to provide a linking group and a surface-modifying ligand, where CG is linked by a linker L. smor it may be part of a surface-modifying ligand (which may also contain a surface-contacting portion).
[0061] In some embodiments, the surface modifying compound may include carbon atoms forming a linear chain (e.g., at least 10 carbons or at least 14, 16, 18, 20, 22 or more carbons) and may be an unbranched alkyl moiety. In some embodiments, the alkyl group may include a substituted alkyl group (e.g., some of the carbons in the alkyl group may be fluorinated or perfluorinated). In some embodiments, the alkyl group may include a first segment that may include a perfluoroalkyl group bonded to a second segment that may include an unsubstituted alkyl group, and the first and second segments may be bonded directly or indirectly (e.g., by an ether bond). The first segment of the alkyl group may be located distal to the linking group and the second segment of the alkyl group may be located proximal to the linking moiety.
[0062] In other embodiments of the surface-modifying compound, the linear backbone may include one or more oxygen atoms. Each of the one or more oxygen atoms may not be directly bonded to another oxygen, sulfur or nitrogen, and may not be located at the first end of the linear backbone. In some embodiments, when the linear backbone includes one or more oxygen atoms, each of the one or more oxygen atoms may not be located at the second end of the linear backbone. In some embodiments, each of the one or more oxygen atoms may be located within the linear backbone such that at least two backbone atoms adjacent to each oxygen atom proximal to the first end of the linear backbone are carbon atoms containing hydrogen non-backbone substituents, and at least two backbone atoms adjacent to each oxygen atom distal to the first end of the linear backbone are carbons containing hydrogen substituents.
[0063] Covalent modifications are introduced to the surface upon reaction with a compound of formula XXXII to give a compound of formula XXXI: [ka] where LG is -W-Si(OZ)2O- or -OP(O)2O-; W is O, S or N, Z is a bond to an adjacent silicon atom or a bond to the surface; sm is a linker comprising 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur and phosphorus atoms, and further comprising 0, 1, 2, 3 or 4 linking groups CG; and [ka] is the surface. In some embodiments, n is an integer from 7 to 21.
[0064] In one embodiment, the covalent modification has formula VIII: [ka] where W is O, S or N; Z is a bond to an adjacent silicon atom or a bond to the surface; n is an integer from 3 to 21; and [ka] is a surface. In some embodiments, W is O. In various embodiments, n is an integer from 7 to 21. The surface-modifying ligand can include 0, 1, 2, or 3 CGs.
[0065] In other embodiments, the covalent modification has formula IX: [ka] wherein n and [ka] are each defined as above. Z is a bond to the adjacent phosphorus atom or a bond to the surface. The surface modifying ligand may contain 0, 1, 2 or 3 CGs.
[0066] In one embodiment, the surface modifying ligand has the formula X: [ka] where L is a linker; and the surface contacting moiety is a moiety that provides improved contact properties to biological microobjects, as described herein.
[0067] In another embodiment, the surface modifying ligand of the modified surface has the formula X: [ka] where L is a linker; and the surface contacting moiety is a moiety that provides improved contact properties to biological micro-objects.
[0068] The linker L may be a bond or may contain 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur, and phosphorus atoms, subject to chemical bond limitations as known in the art. In some embodiments, the linker L may contain 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur, and phosphorus atoms, subject to chemical bond limitations as known in the art. The linker L or surface contacting moiety may contain 0, 1, or 3 linking groups CG.
[0069] Bonding group CG. CG is a linking group, including but not limited to, triazolylenyl, carboxamide, imide, ether, ester, keto, sulfone, which may result from linking a surface contacting moiety to the remainder of a surface-modifying reagent of formula XXXII or to a surface-modifying compound of formula I, formula II, or formula III (e.g., formed as part of the synthesis of a surface-modified ligand). It can be any moiety such as an amide, a sulfonate, a cyclooctyl-fused diazine, an alkene, or an aromatic moiety.
[0070] In certain other embodiments, CG is a moiety resulting from the reaction of a reactive moiety of a functionalization reagent of formula XXXIII, formula IV, or formula VI with the respective reactive counterpart moiety of a surface-modifying reagent described herein. For example, a functionalization reagent having an azide reactive moiety may form a triazolyl CG moiety upon forming a covalently modified surface of formula XXXI, formula VIII, or formula IX.
[0071] The linking group CG may be a triazolyl moiety, which may be further substituted and may have one or more additional ring systems fused to the triazolyl moiety. The additional fused ring systems may themselves be further substituted with additional fused rings to provide a point of attachment to the linker L-surface contact moiety. In some embodiments, the triazolyl moiety is fused to a cyclooctynyl ring system, which may be further substituted with either additional fused rings, including but not limited to dibenzocyclooctynyl, or other substitutions such as fluorine (difluorinated cyclooctyne (DIFO)).
[0072] CG can be a non-covalent pair in some embodiments. For example, the non-covalent binding of biotin with streptavidin provides a very stable binding pair and can be a CG. Furthermore, since streptavidin has four binding sites, two parts of the surface-modified ligand, surface-modified reagent, or functionalized surface can be bound by a series of biotin / streptavidin / biotin. For example, the functionalized surface has a biotin-reactive portion, where streptavidin is introduced to bind to the biotin-reactive portion, where finally a second biotinylated portion (such as biotin-fibronectin) is introduced and bound to another of the binding sites on streptavidin. The product is a covalent surface modification with a surface contact portion of fibronectin, and the series of biotin / streptavidin / biotin is considered to be a single binding group CG. Streptavidin serves to link two similarly functionalized portions together.
[0073] Surface contact part. The surface-contacting moiety of the surface-modified ligand may be any surface-contacting moiety described herein and elsewhere in this disclosure, and may include non-polymeric or polymeric moieties. Surface-contacting moieties include alkyl or fluoroalkyl (which may include perfluoroalkyl) moieties; mono- or polysaccharides (which may include, but are not limited to, dextran); alcohols (including, but are not limited to, propargyl alcohol); polysaccharides, including, but not limited to, polyvinyl alcohol; The surface contacting moiety may include a hydric alcohol; an alkylene ether, including but not limited to, polyethylene glycol; a polyelectrolyte, including but not limited to, polyacrylic acid or polyvinylphosphonic acid; an amino group, including but not limited to, alkylated amines, hydroxyalkylated amino groups, derivatives thereof, such as guanidinium, and heterocyclic groups containing a non-aromatized nitrogen ring atom, such as, but not limited to, morpholinyl or piperazinyl; a carboxylic acid, including but not limited to, propiolic acid, which may provide a carboxylate anionic surface; a phosphonic acid, including but not limited to, ethynylphosphonic acid, which may provide a phosphonate anionic surface; a sulfonate anion; a carboxybetaine; a sulfobetaine; a sulfamic acid; or an amino acid. The alkyl or perfluoroalkyl moiety may have a backbone chain length of greater than 10 carbons. In other embodiments, the surface contacting moiety may include a saccharide moiety, which may be a dextran. In other embodiments, the surface contacting moiety may include an alkylene ether moiety. The alkylene ether moiety may be polyethylene glycol.
[0074] In various embodiments, the surface contacting moiety can be that of a surface-modifying ligand that includes a non-polymeric moiety such as an alkyl moiety, a substituted alkyl moiety such as a fluoroalkyl moiety (including but not limited to a perfluoroalkyl moiety), an amino acid moiety, an alcohol moiety, an amino moiety, a carboxylic acid moiety, a phosphonic acid moiety, a sulfonic acid moiety, a sulfamic acid moiety, or a saccharide moiety. Alternatively, the surface contacting moiety can include a polymeric moiety that can be any of the moieties described above.
[0075] In certain embodiments, the surface contacting moiety may include carbon atoms forming a linear chain (e.g., a linear chain of at least 10 carbons or at least 14, 16, 18, 20, 22 or more carbons) and may be an unbranched alkyl moiety. In certain embodiments, the alkyl group may include a substituted alkyl group (e.g., some of the carbons in the alkyl group may be fluorinated or perfluorinated). In certain embodiments, the alkyl group may include a first segment that may include a perfluoroalkyl group bonded to a second segment that may include an unsubstituted alkyl group, and the first and second segments may be bonded directly or indirectly (e.g., by an ether bond). The first segment of the alkyl group may be located distal to the linking group and the second segment of the alkyl group may be located proximal to the linking group.
[0076] Cuttable part. The surface-modifying ligand is a linker L of the surface-modifying compound. sm In some embodiments, the cleavable moiety may further comprise a cleavable moiety that may be located within the linker L of the surface-modifying ligand, and the linker L of the surface-modifying compound or the surface-modifying reagent may be part of the surface-contacting portion of the surface-modifying compound or the surface-modifying reagent. In some embodiments, the cleavable moiety may further comprise a cleavable moiety that may be located within the linker L of the functionalized surface of Formula XXX, Formula V, or Formula VII. mThe cleavable moiety may be comprised within a surface-modifying ligand or functionalized surface. The cleavage moiety may be configured to allow for rupture of the covalently modified surface. In certain embodiments, rupture may be useful to facilitate transport of one or more living cells after a period of culture. The cleavage moiety may be a UV-cleavable moiety such as a nitro-substituted benzyl ester (e.g., a photocleavable moiety such as BroadPharm Catalog No. BP-22675); a substituted 1,2-diphenylethyl ketoester moiety (e.g., a benzyl derivative such as BroadPharm Catalog No. BP 22689), or a moiety that may be cleaved under certain chemical conditions. For example, a disulfide bond may be cleaved under conditions (e.g., reducing conditions such as dithiothreitol) that would not interfere with the growth or survival of living cells on the covalently modified surface. Other useful cleavable moieties that may be incorporated within the surface-modifying ligand or functionalized surface may include vicinal diol moieties that are cleavable by sodium periodate. Sodium periodate cleavage is another non-cytotoxic cleavage reagent. Diazo moieties that are cleavable by dithionite may also be useful cleavable moieties. Additionally, the 5,5,dimethyl-exo-cyclohexen-yl-1,3,dione moiety may be a useful cleavable moiety for use in surface-modifying ligands or functionalized surfaces of Formula XXX, Formula V, or Formula VII, and may be cleaved by hydrazine solution. .
[0077] Modification reagent: Surface functionalization reagent. The surfaces can be covalently modified with a functionalizing reagent to introduce functionalizing surface modifications to one or more surfaces of the microfluidic device.
[0078] The functionalizing reagent has the formula XXXIII: VL fm -R x Formula XXXIII wherein V is -P(O)(OH)2 or -Si(T)2W; W is -T, -SH or -NH2 and is a moiety configured to bind to a surface; T is independently OH, OC 1~6 alkyl or halo; L fmis a linker containing 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur and phosphorus atoms, and further containing 0, 1 or 2 linking groups CG; and R x is a reactive moiety.
[0079] Reactive part. The reactive moiety may be either an alkyne moiety, an azide moiety, an amine moiety, a carboxylic acid moiety, a biotin moiety, a streptavidin moiety, an olefin moiety, a transcyclooctene moiety, a s-tetrazine moiety, a thiol moiety, a maleimide moiety, a halide moiety, a cyano moiety, an isocyanate moiety, an epoxide moiety, a hydroxylamine moiety, a masked hydroxyl, such as acetate, or a sulfonyl fluoride moiety. This list of reactive moieties is not limiting and any suitable reactive moiety may be selected for use with an appropriate reactive pair moiety. While most reactive moieties react with their respective reactive pair moieties to form covalently linked CGs, the high binding affinity between biotin and streptavidin allows for its use as a reactive moiety / reactive pair moiety.
[0080] The functionalized surface formed by reaction of the functionalizing reagent XXXIII has the formula XXX: [ka] where LG is -W-Si(OZ)2O- or -OP(O)2O-; W is O, S or N, Z is a bond to an adjacent silicon atom or a bond to the surface, and L fm and R x is as defined for formula XXXIII.
[0081] In certain embodiments, the functionalizing reagent of formula XXXIII has formula IV: [ka] wherein R is O-C 1~6alkyl, and n is an integer from 3 to 21. The azide is a reactive moiety R x In some embodiments of compounds of formula IV, n can be an integer from 7 to 21. For compounds of formula IV, each R can be independently selected from H or C1-C6 alkyl, where alkyl includes, but is not limited to, methyl, ethyl, n-propyl, 2-propyl, n-butyl, and the like. In some embodiments, R can be C1-C3 alkyl. In some embodiments, R can be methyl or ethyl. In various embodiments, each of the three instances of R is methyl or each of the three instances of R is ethyl. In other embodiments, n can be 9, 14, or 16. In yet other embodiments, n can be 9.
[0082] The functionalized surface formed by reaction of a surface with a surface functionalization reagent of formula IV has the formula V: [ka] where W is O, S or N and Z is another surface functionalization ligand that is also attached to the surface (-WSi(OZ)2(CH2) n -N3) to an adjacent silicon atom or to a surface, n is an integer from 3 to 21, and [ka] is the surface. In some embodiments, n can be an integer from about 7 to 21. In some embodiments, W can be O. In various embodiments, each R can be independently selected from H or C1-C6 alkyl, where alkyl includes, but is not limited to, methyl, ethyl, n-propyl, 2-propyl, n-butyl, and the like. In some embodiments, R can be C1-C3 alkyl. In some embodiments, R can be methyl or ethyl. In various embodiments, each of the three instances of R is methyl or each of the three instances of R is ethyl. In other embodiments, n can be an integer from 7 to 21. In some embodiments, n can be an integer from 9 to 21, 10 to 21, 11 to 21, 12 to 21, 13 to 21, 14 to 21, 15 to 21, 16 to 21, 17 to 21, or 18 to 21. In still other embodiments, n can be an integer from 10 to 18, from 12 to 18, from 13 to 18, or from 14 to 18. In other embodiments, n can be 9, 14, or 16. In still other embodiments, n can be 9.
[0083] In other embodiments, the surface functionalization reagent of formula XXXIII has formula VI: [ka] where n is an integer from 3 to 21, and each R is independently H or C1-C6 alkyl. The alkyne can be a compound of formula VI, x In certain embodiments, n can be an integer from about 7 to 21. In various embodiments, each R can be independently selected from H or C1-C6 alkyl, where alkyl includes, but is not limited to, methyl, ethyl, n-propyl, 2-propyl, n-butyl, and the like. In certain embodiments, R can be C1-C3 alkyl. In certain embodiments, R can be methyl or ethyl. In various embodiments, Each of the three instances of R is methyl or each of the three instances of R is ethyl. In some embodiments, n can be an integer from 9 to 21, 10 to 21, 11 to 21, 12 to 21, 13 to 21, 14 to 21, 15 to 21, 16 to 21, 17 to 21, or 18 to 21. In still other embodiments, n can be an integer from 10 to 18, 12 to 18, 13 to 18, or 14 to 18. In other embodiments, n can be 9, 14, or 16. In still other embodiments, n can be 9.
[0084] The compound of formula VI is covalently attached to the surface by reaction of the siloxane moiety with a nucleophilic group on the surface to form a compound of formula VII: [ka] wherein W, Z and n are defined above for formula V, and [ka] is the surface.
[0085] Covalently modified surfaces formed from the functionalized surface. Once the surface functionalization reagent has been linked to the surface, the reactive moieties of the resulting functionalized surface of formula XXX, formula V or formula VII can then be reacted with a surface-modifying reagent having a reactive pair moiety selected to be a suitable reaction partner for the reactive moiety of the functionalized surface. The surface-modifying reagent can be represented by formula XII: RP-L-Surface contact part Formula XII The structure of the present invention is: wherein RP is a reactive pair moiety; L is a linker, and the surface contacting moiety is a moiety that provides improved contact properties to biological micro-objects. The linker L can be a bond or can contain 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur and phosphorus atoms, subject to chemical bond limitations as known in the art. In some embodiments, the linker L can contain 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur and phosphorus atoms, subject to chemical bond limitations as known in the art. The linker L or the surface contacting moiety can contain 0, 1, 2 or 3 binding groups CG. The surface contacting moiety can be any surface contacting moiety described herein.
[0086] Reaction vs. part. The reactive pair moiety RP is a moiety that can react with a reactive moiety of a functionalized surface. For example, the reactive moiety R x may be an alkyne and the corresponding reactive moiety R P may be an azide. x can be an azide and R P can be an alkyne. x Other pairs of reactive pairs of moieties RP include, but are not limited to, cyano and azide; carboxylic acid and amine; olefin and nucleophile; amine and sulfonyl fluoride; transcyclooctene and s-tetrazine, thiol and maleimide; halide and nucleophile; isocyanate and amine; epoxide and nucleophile; hydroxylamine and aldehyde or ester; and masked hydroxyl, such as acetate and nucleophile. Rx: A special case of an RP pair is biotin and streptavidin, which is not a covalent pair but is x :RP pairs because they are exemplary stable non-covalent pairs that can be used as RP pairs.
[0087] The functionalized surface is R xIn the case where the reactive moiety R has an azide or alkynyl moiety as R, the surface-modifying reagent has a reactive pair moiety R, which is an alkyne or azide, respectively, which can react to form a triazolyl moiety by a cyclization reaction ("click reaction"), as is known in the art. x Or the reactive moiety R P is an acyclic alkyne. In other embodiments, the reactive moiety R x Or the reactive pair RP moiety is a cyclized alkyne, which may be a moiety of a cyclooctyne. In some embodiments, the cyclooctyne may be strained. The cyclooctyne may have an additional cyclic ring fused to the cyclooctyne, such as a benzo group, which may be a dibenzocyclooctyne. In other embodiments, the cyclooctyne may have a fluoro substituent. When the alkyne of the surface modification reagent is a cyclooctyne, the surface contacting portion of the reagent is attached to the cyclooctyne via a linker L, which may be attached to any suitable position on the cyclooctyne. When the alkyne of the functionalized surface is a cyclooctyne, the linking group that connects the cyclooctyne to the surface is attached to the cyclooctyne at any suitable position on the cyclooctyne.
[0088] Formula XXX: [ka] The covalently modified surface resulting from the reaction of the functionalized surface of formula XII with a surface modification reagent of formula XXXI: [ka] wherein LG, L sm , surface-modified ligands, and [ka] is as defined above, and L sm Or the surface modified ligand comprises at least one CG and may further have 2, 3 or 4 CGs.
[0089] In one embodiment, the covalently modified surface formed from the functionalized surface of Formula XXXI, Formula V, or Formula VII has a formula VIII: [ka] wherein W, Z, n and [ka] are each defined as above. The surface-modifying ligand may contain 0, 1, 2 or 3 CGs.
[0090] In one embodiment, the covalently modified surface formed from the functionalized surface of formula XXXI has formula IX: [ka] wherein Z, n and [ka] are each defined as above. The surface-modifying ligand may contain 0, 1, 2 or 3 CGs.
[0091] Further functionalization of the functionalized surface. In yet other embodiments, the functionalized surface of Formula XXX has Formula XXXIV: RP-L fm -R x2 Formula XXXIV wherein R P is a reactive moiety for reacting with a reactive moiety of formula XXX; R x2 is a reactive moiety selected so as not to react with the reactive moieties of the functionalized surface of formula XXX; and L fmis a linker containing 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur and phosphorus atoms, and further containing 0, 1 or 2 linking groups CG. x2 is the R of the functionalized surface x In some non-limiting examples, the R of the functionalized surface is selected to have an orthogonal reactive pair moiety that does not interfere with the binding of the RP to the moiety. x is an azide, R x2 can be selected to be an amine, epoxide, or sulfonyl fluoride. This capability allows for control in the further elaboration of the functionalized surface.
[0092] The product is a functionalized surface of formula XXXV, where the second functionalized surface has one, two or three CGs: [ka] wherein R x2 is as defined for formula XXXIV, and L fm and LG is as defined above for formula XXX. When a functionalized surface of formula V or formula VII is reacted with a secondary functionalization reagent of formula XXXIV, the product is a functionalized surface of formula XXXV, where LG is -W-Si(OZ)2O- and W is O, S, or N. In some embodiments, W is O.
[0093] The functionalized surface of formula XXXV may be represented by formula XXXI: [ka] wherein LG, L sm and the surface-modified ligand is as defined above, by further reaction with a surface-modifying reagent of formula XII. In this embodiment, the surface modification (e.g., the covalently modified surface) is sm Contains at least two CGs.
[0094] 2H shows a cross-sectional view of a microfluidic device 290 including an exemplary covalently modified surface 298. As illustrated, the covalently modified surface 298 (shown diagrammatically) may include a monolayer of closely packed molecules covalently bonded to both the inner surface 294 of the substrate 286 and the inner surface 292 of the cover 288 of the microfluidic device 290. The covalently modified surface 298 may be disposed on substantially all of the inner surfaces 294, 292 proximal to and facing inwardly relative to the enclosure 284 of the microfluidic device 290, including, in certain embodiments and as described above, surfaces of the microfluidic circuit material (not shown) used to define circuit elements and / or structures within the microfluidic device 290. In alternative embodiments, the covalently modified surface 298 may be disposed on only one or some of the inner surfaces of the microfluidic device 290.
[0095] In the embodiment shown diagrammatically in FIG. 2H, the covalently modified surface 298 comprises a monolayer of substituted siloxane molecules, each molecule covalently bonded to the inner surface 292, 294 of the microfluidic device 290 via a siloxy linker 296. For simplicity, additional silicon oxide bonds are shown linking adjacent silicon atoms, but the invention is not so limited. In certain embodiments, the surface-modified ligands 298 may comprise any type of non-polymeric molecule described herein (e.g., fluorinated alkyl groups, polyethylene glycol-containing groups, alkyl groups containing carboxylic acid substituents) at their enclosure-facing ends (i.e., the portion of the monolayer of surface-modified ligands 298 that is not bonded to the inner surfaces 292, 294 and is proximal to the enclosure 284). Although FIG. 2H is illustrated as having non-polymeric surface-modified ligands, polymeric moieties are also suitable surface-contacting moieties and / or surface-modified ligands and may be incorporated into the covalently modified surfaces described herein.
[0096] In other embodiments, the surface-modified ligands 298 used to covalently modify the interior surfaces 292, 294 of the microfluidic device 290 may include anionic, cationic, or zwitterionic moieties, or any combination thereof. Without intending to be bound by theory, it is believed that by presenting cationic, anionic, and / or zwitterionic moieties on the interior surfaces of the enclosure 284 of the microfluidic circuit 120, the surface-modified ligands of the covalently modified surface 298 form strong hydrogen bonds with water molecules such that the resulting hydrated water acts as a layer (or "shield") that isolates the biological micro-objects from interactions with non-biomolecules (e.g., silicon and / or silicon oxide of the substrate). It can be formed.
[0097] The surface to be modified. The surface that can be modified by any of the compounds of formula XXXII, I, II, III, XXXIII, IV, VI, XII, or XXXIV can be a metal, a metal oxide, glass, or a polymer. Some materials that can have covalently modified or functionalized surfaces introduced therein include, but are not limited to, silicon and its oxides, silicone, aluminum or its oxides (Al2O3), indium tantalum oxide (ITO), titanium dioxide (TiO2), zirconium oxide (ZrO2), hafnium (IV) oxide (HfO2), tantalum (V) oxide (Ta2O5), or any combination thereof. The polymer can include any suitable polymer. Suitable polymers include, but are not limited to, (e.g., rubber, plastic, elastomer, silicone, organosilicon such as polydimethylsiloxane ("PDMS"), etc.), which can be gas permeable. Other examples include cast glass, patternable materials such as silicone polymers (e.g., photopatternable silicone or "PPS"), photoresists (e.g., SU8, SU9, SU10, SU11, SU12, SU13, SU14, SU15, SU16, SU17, SU18, SU19, SU20, SU21, SU22, SU23, SU24, SU25, SU26, SU27, SU28, SU29, SU30, SU31, SU32, SU33, SU34, SU35, SU36, SU37, SU38, SU39, SU39, SU39, SU39, SU39, SU39, SU39, SU39, SU39, SU31, SU32, SU34, SU35, SU35, SU36, SU37, SU38, SU39, SU39, In other embodiments, the surface of a material such as natural fiber or wood may be modified with a compound of any of Formula XXXII, I, II, III, XXXIII, IV, VI, XII or XXXIV to introduce a covalently modified surface of Formula XXXI, Formula VIII or Formula IX or a functionalized surface of Formula XXX, Formula V, Formula VII or Formula XXXV.
[0098] The modified surface may contain nucleophilic moieties, including, but not limited to, hydroxides, aminos, and thiols. Nucleophilic moieties on the surface (e.g., hydroxides (alternatively referred to as oxides in some embodiments)) may react with a compound of any of formulas XXXII, I, II, III, XXXIII, IV, or VI to covalently bond the compound to the surface via a siloxy or phosphonate linking group to provide a functionalized surface. The modified surface may contain native nucleophilic moieties or may be treated with a reagent (e.g., piranha solution) or by plasma treatment to introduce nucleophilic moieties (e.g., hydroxides (alternatively referred to as oxides)).
[0099] Physical and performance properties of covalently modified surfaces. In certain embodiments, the covalently modified surface of Formula XXXI, Formula VIII, or Formula IX can have a thickness of less than 10 nm (e.g., less than about 7 nm, less than about 5 nm, or about 1.5 to 3.0 nm), particularly for spin-coated perfluorotetrahydrofuranyl polymers such as CYTOP®, which yields a typical thickness of about 30 to 50 nm. In contrast to other hydrophobic materials, the data presented in Table 1 are for silicon / silicon oxide native surfaces that have been converted to functionalized surfaces (e.g., Formula XV (specific members of the Formula V family) or surface-modified with surface contact moieties (e.g., Formula XVI and Formula XVII, specific embodiments of the modified surfaces of Formula VIII). Contact angle measurements were performed using the static sessile drop method (Drelich, J. Colloid Interface Sci. 179, 37-50, 1996). The thickness was measured by ellipsometry.
[0100] [Table 1]
[0101] As expected, the modification of silicon / silicon oxide surface to have functionalized surface of formula XV resulted in modified surface with increased contact angle with water of about 80°. This is in contrast to the contact angle with water of plasma-cleaned silicon surface, which is less than 10°. Further refinement of functionalized surface to provide modified surface of formula XVI (containing PEG moiety) results in much more hydrophilic surface with reduced contact angle of 35°. Modified surface with surface of formula XVII (containing dextran) had contact angle of 40°.
[0102] Other analytical methods suitable for characterizing the surface include infrared spectroscopy and / or X-ray photoelectron spectroscopy.
[0103] In certain embodiments, the modified surface of Formula XXXI, Formula VIII, or Formula IX forms a monolayer. The uniformity and homogeneity of the monolayer modified surface may provide advantageous performance, especially when the monolayer modified surface has other functional attributes. For example, the modified surface of Formula XXXI, Formula VIII, or Formula IX may also include an electrode-activated substrate, and may optionally further include a dielectric layer, as found in materials, devices, and / or apparatuses having dielectrophoretic or electrowetting configurations. The lack of unsaturation in the perfluoroalkyl moieties of the modified surface may minimize "charge trapping" compared to monolayers containing, for example, olefinic or aromatic moieties. Furthermore, the densely packed nature of the monolayer formed on the surface of Formula XXXI, Formula VIII, or Formula IX may minimize the possibility of cations being tunneled through the monolayer to the underlying metal, metal oxide, glass, or polymer substrate. Without being bound by theory, disruption of the substrate surface by the addition of cations to the substrate composition may disrupt the electrical properties of the substrate, thereby reducing its ability to function electrokinetically.
[0104] Additionally, the ability to introduce modified surfaces by covalent bonding may enhance the dielectric strength of the modified surface and protect the underlying material from breakdown under the application of an electric field. The uniformity and thinness of the dielectrophoretic or electrowetting surfaces of materials, devices and / or apparatus having covalently modified structures of Formula XXXI, Formula VIII or Formula IX may further provide advantageous benefits to such modified dielectrophoretic and / or electrowetting surfaces when the materials, devices and / or apparatus are optically actuated.
[0105] In some embodiments, the modified surface does not require a fully formed monolayer to function properly for actuation. The physical thickness and uniformity of the layer on the surface of any of Formula XXXI, Formula VIII, Formula IX, Formula XXX, Formula V, Formula VII, or Formula XXXV can be measured using an ellipsometer.
[0106] Multiple covalent surface modifications and multilayer surfaces. A microfluidic device may have two or more regions within the microfluidic device having covalently modified surface modifications, with each region having only one type of covalently attached moiety. Alternatively, a microfluidic device may include two or more different types of covalently attached moieties on a single selected surface (e.g., a common interior surface of the microfluidic device) or on all of the interior surfaces of the microfluidic device.
[0107] For example, a first covalent surface modification of a surface may have a defined number of non-hydrogen atoms as part of a linker and / or surface-modifying ligand, and a second covalent surface modification of this surface may include a surface contacting moiety having one or more charged moieties covalently attached to a linker having a greater number of non-hydrogen atoms, which may potentially provide the ability to present the charged moiety further away from the so-modified surface in closer contact with biological microobjects within a microfluidic environment.
[0108] In another case, the modified surface may have a first covalent surface modification with a first type of non-sterically bulky surface contact moiety and fewer non-hydrogen atoms in the linker that connects the first covalent surface modification to the surface. The modified surface may have a second covalent surface modification with a sterically bulky surface contact moiety and a linker with a larger number of non-hydrogen atoms. This mixture of covalent surface modifications may help to present sterically bulky surface contact moieties while preventing undesirable interactions with the silicon / silicon oxide, hafnium oxide or alumina that constitutes the surface itself. In another example, the covalently attached moieties may provide a zwitterionic surface that presents randomly oppositely charged surface contact moieties on the surface.
[0109] In other embodiments, the covalently modified surface may have increased hydrophilic and / or amphiphilic properties by introducing a combination of a first covalent surface modification and a second covalent surface modification. The introduction of a combination of a first and a second covalent surface modification may be controlled or can provide customizable hydrophilic, amphiphilic or hydrophobic properties to surfaces (including common internal surfaces of microfluidic devices). The increased hydrophilic and / or amphiphilic nature of the covalently modified surfaces can provide hydrophilic functionality and / or hydrophobic moieties to which biological micro-objects can bind without irreversible adhesion. These bonds can provide a beneficial environment during cell culture compared to the native unmodified surfaces of the microfluidic devices.
[0110] Each of these properties may increase the durability, functionality and / or biocompatibility of the modified surface. Each of these properties may further benefit the viability (including growth rate and / or cell doubling rate), properties of colonies formed on covalently modified surfaces having the structure of Formula XXXI, Formula VIII or Formula IX. Improved viability may include providing surface contacting moieties that provide suitable anchoring sites for adherent cells that provide sufficient mechanical resistance to promote growth. Covalently modified surfaces of Formula XXXI, Formula VIII or Formula IX may improve the transportability (including viability upon export) of micro-objects or biomolecules on the modified surface and within devices and / or apparatuses having the covalently modified surfaces. In certain other embodiments, covalently modified surfaces of Formula XXXI, Formula VIII or Formula IX may provide surface contacting moieties that prevent motile cells from migrating from certain areas (e.g., isolation pens) of a microfluidic device, thereby minimizing cell migration from selected areas. The mobility of the cells is inhibited in this case, preventing the self-propelled migration of the cells from one isolation pen to another, and minimizing contamination from isolation pen to isolation pen. However, the modulation of such an inhibition effect can be obtained by selecting the ratio of different covalent surface modifications such that the cells are still able to be removed from the isolation pen at the desired time under forces such as gravity or dielectrophoresis (which can be actuated by light).
[0111] The combination of covalent surface modifications can be any combination of covalently modified surfaces and / or functionalized surfaces or secondary functionalized surfaces described herein. Any combination of binding groups, linkers, reactive moieties and / or surface contacting moieties can be selected for the microfluidic device having the first and second covalent surface modifications, the first and second covalent surface modifications being different from each other. The first and second covalent surface modifications can be any of Formula XXX, Formula V, Formula VII, Formula XXXI, Formula VIII and / or Formula IX.
[0112] In some embodiments, the microfluidic device may have one or both of the first and second covalent surface modifications as functionalized surfaces for further modification by the user. A microfluidic device having one or two functionalized surfaces with different reactive moieties, linkers and / or binding groups may be reacted with a surface modification reagent (e.g., a reagent of formula XII) to provide a covalently modified surface, or may be further functionalized by reaction with a secondary functionalization reagent (e.g., a reagent of formula XXXIV) to provide a secondary functionalized surface. Orthogonal chemistry (e.g., reactive moieties and reactive counter moieties and reaction conditions) may be selected to allow selective reaction of one functionalized surface in the presence of a second functionalized surface or in the presence of a covalently modified surface, as known in the art. In one non-limiting example, when an alkyne is present as the first reactive moiety (Rx or Rx2) of the first covalent surface modification, it is designed to react with an azide as the reactive counter moiety. The second covalent surface modification can have a second reactive moiety selected to be an amine or a carboxylic acid that does not participate in a "click" type reaction.
[0113] In some embodiments, the covalently modified surface may comprise a combination of a functionalized surface of formula XXX, formula V or formula VII; and a first covalent surface modification of formula XXXI, formula VIII or formula IX. The combination of the functionalized surface and the first covalent surface modification of formula XXXI, formula VIII or formula IX may be randomly distributed on the covalently modified surface. In other embodiments, the covalently modified surface may comprise a functionalized surface of formula XXX, formula V or formula VII adjacent to a second region comprising a first covalent surface modification of formula XXXI, formula VIII or formula IX. In other embodiments, the covalently modified surface may have a first region having a surface. In other embodiments, the covalently modified surface may include a plurality of regions having a first covalent surface modification of Formula XXX, Formula VIII or Formula IX separated from one another by a functionalized surface modification of Formula XXXI, Formula V or Formula VII. In yet other embodiments, the covalently modified surface may have a plurality of regions comprising a functionalized surface of Formula XXX, Formula V or Formula VII separated from one another by a first covalent surface modification of Formula XXXI, Formula VIII or Formula IX.
[0114] In other embodiments, the covalently modified surface may have a combination of a first covalent surface modification of formula XXXI, formula VIII or formula IX; and a second covalent surface modification of formula XXXI, formula VIII or formula IX, where the first and second covalent surface modifications are different. In some embodiments, the first and second covalent surface modifications that are different from each other may be randomly distributed on the covalently modified surface. In some other embodiments, the covalently modified surface may have a first region having a first covalent surface modification of formula XXXI, formula VIII or formula IX adjacent to a second region having a second covalent surface modification of formula XXXI, formula VIII or formula IX. In yet other embodiments, the covalently modified surface may have multiple regions having a first covalent surface modification of formula XXXI, formula VIII or formula IX separated from each other by a second covalent surface modification of formula XXXI, formula VIII or formula IX.
[0115] In further embodiments, the covalently modified surface may have a combination of a first covalent surface modification of formula XXX, formula V or formula VII; and a second covalent surface modification of formula XXX, formula V or formula VII, where the first and second covalent surface modifications are different and the reactive moieties of the first covalent surface modification do not react with the reactive moieties of the second covalent surface modification. In certain embodiments, the first and second covalent surface modifications may be randomly distributed on the surface. In certain other embodiments, the covalently modified surface may include a first region having a first covalent surface modification of formula XXX, formula V or formula VII adjacent to a second region having a second covalent surface modification of formula XXX, formula V or formula VII. In yet other embodiments, the covalently modified surface may have multiple regions comprising a first covalent surface modification of formula XXX, formula V or formula VII separated from each other by a second covalent surface modification of formula XXX, formula V or formula VII.
[0116] Multiple surface modifications to modulate adhesion. In certain embodiments, it may be useful to modulate the ability of cells to adhere to surfaces in the microfluidic device. Surfaces with substantially hydrophilic properties may not provide anchoring points for cells that require mechanical stress of adhesion to grow and proliferate properly. Surfaces that exhibit an excess of such anchoring moieties may prevent problem-free growing adherent cells from being removed from within the isolation pen and from the microfluidic device. The composite surface second covalent surface modification includes surface contacting moieties that serve to anchor the adherent cells. The structures of the surfaces described herein and the methods of making them provide the ability to select the amount of anchoring moieties that may be desirable for a particular use. It has been unexpectedly discovered that only a small percentage of adhesive motifs may be required to provide a sufficient adhesion-enhancing environment. In certain embodiments, the adhesion-enhancing moieties are created before the cells are introduced into the microfluidic device. Alternatively, the adhesion-enhancing modified surface may be provided before the cells are introduced, and the further addition of another adhesion-enhancing moiety may be performed, which is designed to bind the first modified surface covalently or non-covalently (e.g., as a base for biotin / streptavidin binding).
[0117] In certain embodiments, the adhesion enhancing surface modification may modify the surface with a random pattern of individual molecules of the surface-modified ligand. In certain other embodiments, a more focused pattern of adhesion enhancing surface modification may include multiple ligands, such as positively charged lysine side chains, which may create small regions of surface modification surrounded by the remainder of the surface, which may have hydrophilic surface modifications to modulate adhesion enhancement. This can be introduced by using a polymer containing multiple adhesion enhancing motifs. This can be further refined by the use of dendritic polymers with multiple adhesion enhancing ligands. The dendritic polymer type surface modifying compound or reagent can be present in a very small proportion compared to a second surface modification having only hydrophilic surface contacting moieties while still providing adhesion enhancement. Furthermore, the dendritic polymer type surface modifying compound or reagent itself can have a mixed combination of final functionalities that can further tune the overall surface behavior.
[0118] In certain embodiments, it may be desirable to provide a site-selective introduction of a surface. It may be desirable to provide a first type of surface in a microfluidic channel, while providing a surface in an isolation pen that opens into the channel that provides the ability to culture adherent cells without problems and easily remove them using dielectrophoretic forces when needed. In certain embodiments, the adhesion-enhancing modification may include a cleavable moiety. The cleavable moiety may be cleavable under conditions that are compatible with the cells cultured therein, such that the cleavable moiety may be cleaved at any desired time point and the properties of the surface may be changed so as not to enhance adhesion. Removal is facilitated at that point, since the cleaved surface at the bottom may usefully be free of fouling. Although the examples described herein focus on modulating adhesion and motility, the use of these site-selectively modified surfaces is not so limited. A variety of surface modifications may be incorporated into surfaces having first and second surface modifications according to the present disclosure for any type of benefit of the cells cultured therein.
[0119] Adhesive motif. In general, surface modifications with positively charged surface contact moieties, such as poly-L-lysine, amines, etc., can be used within the modified surfaces of the present disclosure. Another motif that can be used includes the tripeptide sequence RGD, which is available as a biotinylation reagent and is easily adapted to the methods described herein. Other larger biomolecules that can be used include fibronectin, laminin, or collagen, among others. Surprisingly, surface modifications with the structure of formula XXVI, which include polyglutamic acid surface contact moieties, have shown the ability to induce adherent cells to bind and grow viably. Another motif that can be useful in providing adhesion sites is elastin-like peptide (ELP), which includes a repeat sequence of VPGXG, where X is a variable amino acid that can modulate the effect of the motif.
[0120] Site-selective introduction of different surfaces. In some embodiments, the surface of the flow region (e.g., a microfluidic channel) may be modified with a first covalent surface modification and the surface of at least one isolation pen may be modified with a second covalent surface modification, the first and second covalent surface modifications having different surface contact moieties, different reactive moieties, or a combination thereof. The first and second covalent surface modifications may be selected from any of Formula XXX, Formula V, Formula VII, Formula XXXI, Formula VIII, and / or Formula IX. When the first and second covalent surface modifications both include functionalized surfaces of Formula XXX, Formula V, or Formula VII, an orthogonal reaction chemistry is selected for the selection of the first reactive moiety and the second reactive moiety. In various embodiments, all surfaces of the flow region may be modified with a first covalent surface modification and all surfaces of at least one isolation pen may be modified with a second covalent modification.
[0121] In some embodiments, a microfluidic device may have a surface with a combination of first and second covalent surface modifications selected from a surface of Formula V, Formula XVI, Formula XVII, Formula XVIII, Formula XIX, Formula XX, Formula XXI, Formula XXII, Formula XXIII, Formula XXIV, Formula XXV, Formula XXVI, Formula XXVII, Formula XXVIII, Formula XXIX, Formula XXXVI, Formula XXXVII, Formula XXXVIII, Formula XXXIX, or Formula XL. In other embodiments, a microfluidic device may have a surface with a combination of first and second covalent surface modifications selected from a surface of Formula V, Formula XVI, Formula XVII, Formula XVIII, Formula XIX, Formula XX, Formula XXI, Formula XXII. a second region of the microfluidic device (e.g., a flow region having the first covalent surface modification and a separation pen having the second covalent surface modification) that has a second covalent surface modification that can be selected from a surface of Formula XXIII, Formula XXIV, Formula XXV, Formula XXVI, Formula XXVII, [Formula XXVIII, Formula XXIX, Formula XXXVI, Formula XXXVII, Formula XXXVIII, Formula XXXIX, or Formula XL.
[0122] Methods for preparing covalently modified surfaces. Surfaces of materials that may be used as components of a device or apparatus may be modified prior to assembly of the device or apparatus. Alternatively, a partially or fully constructed device or apparatus may be modified such that all surfaces that contact biomaterials, including biomolecules and / or microobjects (which may include biological microobjects), are modified simultaneously. In some embodiments, the entire interior of the device and / or apparatus may be modified even if there are different materials on different surfaces within the device and / or apparatus. In some embodiments, a partially or fully constructed device and / or apparatus may be a microfluidic device or a component thereof as described herein.
[0123] The surface to be modified may be cleaned prior to modification to ensure that nucleophilic moieties on the surface are not covered, for example, by oil or adhesive, and are freely available for reaction. Cleaning may be performed by any suitable method, including treatment with solvents including alcohol or acetone, ultrasonic treatment, steam cleaning, etc. Alternatively or in addition, such pre-cleaning may involve treating the cover, microfluidic circuit material and / or substrate in an oxygen plasma cleaner, which may remove various impurities, while simultaneously introducing an oxidized surface (e.g., an oxide on the surface that may be covalently modified as described herein). Alternatively, a liquid-phase treatment such as a mixture of hydrochloric acid and hydrogen peroxide or a mixture of sulfuric acid and hydrogen peroxide (e.g., piranha solution, which may have a ratio of sulfuric acid to hydrogen peroxide of about 3:1 to about 7:1) may be used instead of the oxygen plasma cleaner.
[0124] This can advantageously provide more sites for modification on the surface, thereby providing a more densely packed modified surface layer.
[0125] A method of covalently modifying a surface includes modifying the surface with a surface-modifying reagent of Formula XXXII, Formula I, or Formula III. Introducing the covalently modified surface comprises attaching the surface to a compound of formula XXXII: VL sm -Surface-modifying ligand Formula XXXII wherein V, Lsm and the surface modifying ligand are defined above; reacting the reagent of formula XXXII with a nucleophilic moiety on the surface; and forming a compound of formula XXXI: [ka] (Wherein, LG is and forming a covalently modified surface of formula XXXII. In some embodiments, the surface modifying compound of formula XXXII is a compound and a surface [ka] is represented by formula I or formula III: V-(CH2) n - Surface-modifying ligand Formula I [ka] wherein the resulting covalently modified surface is represented by formula VIII: [ka] where Z is a bond to an adjacent silicon atom or a bond to the surface, and [ka] is defined as above.
[0126] In other embodiments, the surface produced by reaction of a surface modifying compound of formula XXXI has a structure represented by formula IX: [ka] wherein Z is a bond to an adjacent phosphorus atom or a bond to the surface, and [ka] is defined as above.
[0127] A method of covalently modifying a surface includes functionalizing the surface with a functionalizing reagent of formula XXXIII, formula IV or formula VI. Covalently functionalizing a surface with a functionalizing reagent of formula XXXIII comprises covalently functionalizing the surface with a functionalizing reagent of formula XXXIII: VL fm -R x Formula XXXIII reacting the reagent of formula XXXIII with a nucleophilic moiety on the surface; and contacting the reagent of formula XXXIII with a nucleophilic moiety on the surface. [ka] (In the formula, V, L fm , R x and LG is as defined above). and forming a functionalized surface of
[0128] In certain embodiments, the functionalizing reagent of formula XXXIII has the following formula: [ka] Formula V or Formula VII is a functionalizing agent having one of the structures: [ka] wherein W, Z and n are as defined above, and [ka] is a surface. In some embodiments, W is O. Each of R can independently be H or C1-C6 alkyl. In some embodiments, n can be an integer from 7 to 21. In other embodiments, n can be 9, 14, or 16. In other embodiments, n is 9. In some embodiments, R is a C1-C3 alkyl. In other embodiments, R is methyl or ethyl. In yet other embodiments, R is methyl.
[0129] In the case of surface modification reactions and surface functionalization reactions. In certain embodiments, the nucleophilic moieties on the surface are hydroxide, amino, or thiol. In certain other embodiments, the nucleophilic moieties on the surface can be hydroxide. The surface can be a metal, metal oxide, glass, polymer, or any combination thereof. The surface material that can be modified by this method can be any material described herein.
[0130] The contacting step can be carried out by contacting the surface with a liquid solution containing a modifying reagent of Formula XXXIII, Formula IV, Formula VI, Formula XXXII, Formula I and / or Formula III, which can be any combination described herein. For example, the surface can be exposed to a solution containing 0.01 mM, 0.1 mM, 0.5 mM, 1 mM, 10 mM or 100 mM of a modifying reagent of Formula XXXIII, Formula IV, Formula VI, Formula XXXII, Formula I and / or Formula III. The reaction can be carried out at ambient temperature and can be for about 2 hours, 4 hours, 8 hours, 12 hours, 18 hours, 24 hours or more. The reaction may be carried out for a period of time ranging from any value therebetween. Examples of solvents include, but are not limited to, dimethylformamide (DMF), acetonitrile (ACN), toluene, 1,3 bistrifluorobenzene, or Fluorinert™ (3M) fluorinated solvents. An acid, such as acetic acid, if present, may be added to the solution to increase the reaction rate by promoting hydrolysis of the trialkoxy groups.
[0131] Alternatively, the surface may be contacted with a gas phase containing a modifying reagent of formula XXXIII, formula IV, formula VI, formula XXXII, formula I and / or formula III, which may be any combination described herein. In some embodiments, when the reaction step is carried out by contacting the surface with a modifying reagent of formula XXXIII, formula IV, formula VI, formula XXXII, formula I and / or formula III in the gas phase, a controlled amount of water vapor is also present. The controlled amount of water vapor may be provided by placing a preselected amount of magnesium sulfate heptahydrate in the same chamber or enclosure containing the object having the surface to be modified. In other embodiments, a controlled amount of water may be introduced into the reaction chamber or enclosure by an external water vapor supply. The reaction may be carried out under reduced pressure compared to atmospheric pressure.
[0132] The reaction may be carried out at a temperature of greater than about 95° C. or from about 100° C. to about 200° C. In various embodiments, the reaction may be carried out at a temperature of about 100° C., 110° C., 120° C., 130° C., 140° C., 150° C., 160° C., 170° C., 180° C., 190° C. or about 200° C. The reaction may be continued for about 2 hours, 6 hours, 8 hours, 18 hours, 24 hours, 48 hours, 72 hours, 84 hours or more.
[0133] The modified and / or functionalized surface may be a monolayer in some embodiments. In some embodiments, the modified and / or functionalized surface may include at least one surface of a microfluidic circuit element of a microfluidic chip. In other embodiments, the modified and / or functionalized surface may include all of the surfaces that face the fluid-bearing portion of the microfluidic device. For example, in the exemplary microfluidic device 200, 230, the inner surface of the upper electrode 210, the inner surface 208 of the electrode-activating substrate 206, the surface of the microfluidic circuit material 116 (see Figures 1B, 2A, 2B), all of which face the microfluidic channel 122, pens 224, 226, 228 may be functionalized. Similarly, in Figures 2D-2F, the inner surface of the microfluidic circuit material 260, the surface of the isolation structure 272 that defines the isolation pen 270, or all of the surfaces that face the microfluidic circuit 262 may be modified by reaction with a modification reagent of Formula XXXIII, Formula IV, Formula VI, Formula XXXII, Formula I, and / or Formula III.
[0134] Further modification of the functionalized surface. The method of covalently modifying a surface comprises the step of reacting a compound of formula XXX: [ka] (In the formula, LG, L fm and R x are defined as above, and [ka] is the surface) providing a functionalized surface having a structure of reactive moiety R xinto Formula XII: RP-L-Surface contact part Formula XII and reacting the surface-modifying reagent with a structure of: (wherein RP is a reactive pair moiety; L is a linker, and the surface-contacting moiety is as defined above). Subject to chemical bonding limitations as known in the art, the linker L may be a bond or may contain 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur, and phosphorus atoms. In an embodiment, subject to chemical bonding limitations as known in the art, the linker L may contain 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur, and phosphorus atoms. The linker L or the surface-contacting moiety may contain 0, 1, 2, or 3 linking groups CG, thereby forming a surface-modifying reagent of formula XXXI: [ka] to produce a covalently modified surface having the structure sm is as defined above.
[0135] In one embodiment, the functionalized surface of Formula XXX has Formula V or Formula VII: [ka] where W is O, S or N, Z is a bond to an adjacent silicon atom attached to the surface or a bond to the surface, and n is an integer from about 3 to 21, and in some embodiments, n is an integer from 7 to 21. The adjacent silicon atom to which Z is attached can be incorporated into another surface modifying molecule as described above. The resulting covalently modified surface has the formula VIII: [ka] wherein S, Z, n and [ka] is as defined above for formula V or formula VII, respectively. When Z is a bond to an adjacent silicon atom, the silicon atom may be represented by the following formula: [ka] The surface-modifying molecule may be a part of another surface-modifying molecule.
[0136] In some embodiments, n is an integer from 9 to 21. In other embodiments, n is 9, 14, or 16. In other embodiments, n is 9. In some embodiments, W is O.
[0137] In other embodiments, the product covalently modified surface having a structure of formula XXXI has formula IX: [ka] where Z is a bond to the adjacent phosphorus atom or a bond to the surface, and [ka] is defined as above.
[0138] Alkyne functionalized surface (R x) or in the surface modification reagent of formula XII (RP reaction pair moiety), it may be an acyclic alkyne, and its reaction with azide in a "click" cyclization reaction may be catalyzed by a copper(I) salt. When a copper(I) salt is used to catalyze the reaction, the reaction mixture may optionally include other reagents that may enhance the rate or extent of the reaction. When the alkyne of the surface modification reagent or functionalized surface is a cyclooctyne, the "click" cyclization reaction of the corresponding functionalized surface or surface modification reagent with azide may be copper-free. The "click" cyclization reaction thereby attaches the surface modification ligand to the functionalized surface to form a covalently modified surface. The cyclization reaction may be catalyzed by a copper(I) salt, and may optionally include other reagents that may enhance the rate or extent of the reaction. As described above for functionalized surfaces, the covalently modified surface may be at least one surface of a microfluidic device. In certain embodiments, the covalently modified surface may include substantially all of the fluid-facing surfaces within the microfluidic device.
[0139] copper catalyst. Any suitable copper(I) catalyst may be used. In some embodiments, copper(I) iodide, copper(I) chloride, copper(I) bromide, or another copper(I) salt. In other embodiments, a copper(II) salt may be used in combination with a reducing agent, such as ascorbate, to generate copper(I) species in situ. Copper sulfate or copper acetate are non-limiting examples of suitable copper(II) salts. In other embodiments, a reducing agent, such as ascorbate, may be present in combination with a copper(I) salt to ensure sufficient copper(I) species over the course of the reaction. Copper metal may be used to provide Cu(I) species in the redox reaction and also generate Cu(II) species. Copper coordination complexes, such as [CuBr(PPh3)3], copper silicotungstate complexes, [Cu(CH3CN)4]PF6, or (Eto)3P CuI may be used. In still other embodiments, silica-supported copper catalysts, copper nanoclusters, or copper / cuprous oxide nanoparticles may be used as catalysts.
[0140] Other reaction accelerators. As mentioned above, even if oxygen is not strictly excluded from the reaction, a reducing agent such as sodium ascorbate may be used to maintain the copper(I) species throughout the reaction. Other auxiliary ligands may be included in the reaction mixture to stabilize the copper(I) species. Triazolyl-containing ligands may be used, including but not limited to tris(benzyl-1H-1,2,3-triazol-4-yl)methylamine (TBTA) or 3[tris(3-hydroxypropyltriazolylmethyl)amine (THPTA). Another type of auxiliary ligand that may be used to facilitate the reaction is sulfonated bathophenanthroline, which is also water soluble and may be used when oxygen can be excluded.
[0141] Other chemical bonds as known in the art can be used to attach surface-modifying reagents to the functionalized surfaces described for reactive pair moieties.
[0142] Solvents and reaction conditions. If the inner surface of the microfluidic device is a functionalized surface that reacts with a surface-modifying reagent, the reaction can be carried out by flowing a solution of the surface-modifying reagent into and through the microfluidic device. In various embodiments, the surface-modifying reagent solution can be an aqueous solution. Other useful solvents include aqueous dimethylsulfoxide (DMSO), DMF, acetonitrile, or alcohol can be used. The reaction can be carried out at room temperature or at an elevated temperature. In certain embodiments, the reaction is carried out at a temperature ranging from about 15° C. to about 60° C.; about 15° C. to about 55° C.; about 15° C. to about 50° C.; about 20° C. to about 45° C. In certain embodiments, the reaction to convert the functionalized surface of the microfluidic device to a covalently modified surface is carried out at a temperature of about 15° C., 20° C., 25° C., 30° C., 35° C., 40° C., 45° C., 50° C., 55° C., or about 60° C.
[0143] A method for generating combined surfaces. A method of preparing a covalently modified surface on at least one interior surface of a microfluidic device having a base, a cover, and an enclosure including microfluidic circuit material defining a fluid circuit therein comprises contacting the at least one interior surface with a first modification reagent and a second modification reagent; reacting the first modification reagent with a first nucleophilic moiety on the at least one interior surface; reacting the second modification reagent with a second nucleophilic moiety on the at least one interior surface; and forming at least one covalently modified surface comprising a first covalent surface modification comprising a first binding group and a first moiety that is a first surface contacting moiety or a first reactive moiety, and a second covalent surface modification comprising a second binding group and a second moiety that is a second surface contacting moiety or a second reactive moiety, wherein the first binding group is different from the second binding group or the first moiety is different from the second moiety.
[0144] In some embodiments, the reaction of the first modification reagent with the surface can be carried out simultaneously with the reaction of the second modification reagent. For example, when the first and second modification reagents are both surface modification compounds (e.g., Formula XXXII, Formula I, Formula II, Formula III), a mixture of two surface modification reagents, such as, but not limited to, two different siloxane reagents, can be reacted simultaneously by chemical vapor deposition. The ratio of the two reagents can be varied to obtain different percentages of the two surface modifications (e.g., surface-modified ligands) as needed. In another example, the surface can be a functionalized surface, and the first and second modification reagents are surface modification reagents (e.g., Formula XII) and / or secondary functionalization reagents (Formula XXXIV), and a mixture of the two modification reagents can be reacted simultaneously with the reactive moieties of the functionalized surface.
[0145] In other embodiments, the reaction of the first modification reagent with the surface can occur before or after reacting the second modification reagent with at least one interior surface of the microfluidic device. For example, the surface can be a functionalized surface (having a surface of Formula XXX, Formula V, or Formula VII) and the first modification reagent is Drugs are orthogonal R x2or a secondary functionalization reagent that can introduce a surface-modifying reagent. The reaction can be carried out with a limited amount of the secondary functionalization reagent, thereby limiting the amount of reactive moieties R x Alternatively, the first reaction may be performed with a limited amount of surface modification reagent, so that not all reactive moieties are attached. This may be done, for example, to introduce longer linker regions to these first introduced surface modifications. The next reaction may introduce the desired surface contact moieties to all exposed reactive moieties, or may introduce a second surface modification by using a surface modification reagent that can react only with the original unreacted reactive moiety sites. Orthogonal R x2 If is introduced, the further reaction is R x2 reacts only with the reactive moieties R of the original functionalized surface. x This can be done using suitable surface modification reagents that do not react with
[0146] In some embodiments, the reaction of the first and second modifying reagents with the surface can occur at random locations on the surface. In other embodiments, the reaction of the first modifying reagent can occur within a first region of the surface, and the reaction of the second modifying reagent can occur within a second region of the surface adjacent to the first region. For example, a surface within a channel of a microfluidic device can be selectively modified with a first surface modification, and a surface within an isolation pen adjacent to the surface within the channel can be selectively modified with a second, different surface modification.
[0147] In yet other embodiments, the reaction of a first modification reagent can occur within a plurality of first regions spaced apart from one another on at least one surface, and the reaction of a second modification reaction can occur in a second region surrounding the plurality of first regions spaced apart from one another.
[0148] In various embodiments, modification of one or more surfaces of the microfluidic device to introduce a combination of a first surface modification and a second surface modification can be performed after the microfluidic device is assembled. In one non-limiting example, the first and second surface modifications can be introduced by chemical vapor deposition after assembly of the microfluidic device. In another non-limiting example, a functionalized surface can be introduced having a first surface modification with a first reactive moiety and a second surface modification with a second orthogonal reactive moiety. Differential conversion to two different surface-modified ligands with two different surface contacting moieties can follow. In another embodiment, the microfluidic device can have a single functionalized surface of formula XXX, formula V or formula VII, which can be differentially modified by a mixture of two surface-modifying reagents or a mixture of a surface-modifying reagent and a secondary functionalizing reagent (followed by conversion of the secondary functionalized surface to a surface-modified ligand with a second different surface contacting moiety.
[0149] In some embodiments, at least one of the first and second surface modification combinations may be performed prior to assembly of the microfluidic device. In some embodiments, at least one surface modification may be performed after assembly of the microfluidic device.
[0150] In an embodiment, a method for making a microfluidic device includes forming a first modified surface of one of the base or cover before assembly of the microfluidic device; assembling the microfluidic device, including assembling the first covalently modified surface of one of the base or cover with the microfluidic circuit material and the other unmodified of the cover or base; and forming a second modified surface on the unmodified surface of the assembled microfluidic device. For example, the first surface modification can be introduced on a portion of the cover of the microfluidic device before assembly, and there can still be an unreacted portion of the cover remaining. The microfluidic device can be assembled and then reacted with a second surface modification (e.g., a surface modification compound of formula XXXII, formula I, formula II, formula III), which not only reacts with all of the remaining unmodified areas on the inner surface of the cover, but also with all of the remaining inner surfaces of the base and the microfluidic circuit material.
[0151] In some embodiments, the covalently modified surface is represented by Formula XXX, Formula V, or Formula VII. and a first covalently modified surface of formula XXXI, formula VIII or formula IX disposed therein. The method comprises combining a functionalized surface of formula XXX, formula V or formula VII with a first covalently modified surface of formula XXXIV: RP-L fm -R x2 Formula XXXIV with a secondary functionalizing reagent.
[0152] and generating a secondary functionalized surface of Formula XXX in the presence of a first covalently modified surface of Formula XXXI, Formula VIII, or Formula IX. The method may further include reacting the secondary functionalized surface of Formula XXX with a surface-modifying reagent having a structure of Formula XII, thereby generating a second covalently modified surface of Formula XXXI, Formula VIII, or Formula IX in the presence of the first covalently modified surface of Formula XXXI, Formula VIII, or Formula IX.
[0153] Alternatively, the method may further include reacting the first formed functionalized surface of Formula XXX, Formula V, or Formula VII with a surface-modifying reagent having the structure of Formula XII, thereby producing a second covalently modified surface of Formula XXXI, Formula VIII, or Formula IX in the presence of the first covalently modified surface of Formula XXXI, Formula VIII, or Formula IX.
[0154] use. Materials, devices and / or equipment having one or more surfaces suitable for modification to introduce surfaces having the structure of Formula XXXI, Formula VIII or Formula IX described above include, but are not limited to, flow cytometry cells, apheresis centrifugation equipment, tubing and containment vessels; or microfluidic devices for handling cells, cell fragments, proteins or nucleic acids for any type of biological analytical process or biomaterial sorting process. Surfaces having the structure of Formula XXXI, Formula VIII or Formula IX are not limited to microscale materials, devices and / or equipment and in some non-limiting examples may be used in large scale biological production equipment, medical equipment or water purification equipment and its analysis equipment.
[0155] Filling method. Loading of biological or micro-objects (such as, but not limited to, beads) may include the use of flow, gravity, dielectrophoretic (DEP) forces, electrowetting, magnetic forces, or any combination thereof, as described herein. DEP forces may be generated optically, such as by an optoelectronic tweezers (OET) configuration, and / or electrically, such as by activation of one or more electrode regions in a temporal / spatial pattern. Similarly, electrowetting forces may be provided optically, such as by an optical electrowetting (OEW) configuration, and / or electrically, such as by activation of one or more electrode regions in a temporal / spatial pattern.
[0156] Microfluidic devices and systems for manipulating and observing such devices. FIG. 1A shows an example of a microfluidic device 100 and system 150 that can be used to maintain, isolate, assay, or culture biological micro-objects. A perspective view of the microfluidic device 100 is shown with a partial cutaway view of its cover 110 to provide a partial view of the microfluidic device 100. The microfluidic device 100 generally includes a microfluidic circuit 120 including a flow path 106 through which a fluid medium 180 can flow, which optionally transports one or more micro-objects (not shown) into and / or through the microfluidic circuit 120. Although a single microfluidic circuit 120 is shown in FIG. 1A, a suitable microfluidic device may include multiple (e.g., two or three) such microfluidic circuits. Nevertheless, the microfluidic device 100 may be configured to be a nanofluidic device. As shown in FIG. 1A, the microfluidic circuit 120 may include multiple microfluidic isolation pens 124, 126, 128, and 130, each of which may have one or more openings in fluid communication with the flow path 106. 1A, the isolation pen may have only one opening in fluid communication with the flow channel 106. As described further below, the microfluidic isolation pen includes various features and structures optimized to retain micro-objects within a microfluidic device, such as microfluidic device 100, even when medium 180 is flowing through the flow channel 106. However, before moving to this, a brief description of microfluidic device 100 and system 150 will be provided.
[0157] As generally shown in FIG. 1A, the microfluidic circuit 120 is defined by an enclosure 102. Although the enclosure 102 can be physically structured in different configurations, in the example shown in FIG. 1A, the enclosure 102 is shown as including a support structure 104 (e.g., a base), a microfluidic circuit structure 108, and a cover 110. The support structure 104, the microfluidic circuit structure 108, and the cover 110 can be attached to one another. For example, the microfluidic circuit structure 108 can be disposed on an inner surface 109 of the support structure 104, and the cover 110 can be disposed over the microfluidic circuit structure 108. Together with the support structure 104 and the cover 110, the microfluidic circuit structure 108 can define elements of the microfluidic circuit 120.
[0158] As shown in FIG. 1A, the support structure 104 may be at the bottom of the microfluidic circuit 120 and the cover 110 may be at the top of the microfluidic circuit 120. Alternatively, the support structure 104 and the cover 110 may be configured in other orientations. For example, the support structure 104 may be at the top of the microfluidic circuit 120 and the cover 110 may be at the bottom of the microfluidic circuit 120. Regardless, there may be one or more ports 107, each including a passageway into or out of the enclosure 102. Examples of passageways include valves, gates, through-holes, and the like. As shown, the port 107 is a through-hole created by a gap in the microfluidic circuit structure 108. However, the port 107 may be located in other components of the enclosure 102, such as the cover 110. Although only one port 107 is shown in FIG. 1A, the microfluidic circuit 120 may have two or more ports 107. For example, there may be a first port 107 that functions as an inlet for fluid to enter the microfluidic circuit 120, and there may be a second port 107 that functions as an outlet for fluid to exit the microfluidic circuit 120. Whether a port 107 functions as an inlet or an outlet may depend on the direction in which the fluid flows through the channel 106.
[0159] The support structure 104 may include one or more electrodes (not shown) and a substrate or multiple interconnected substrates. For example, the support structure 104 may include one or more semiconductor substrates, each of which is electrically connected to an electrode (e.g., all or a subset of the semiconductor substrates may be electrically connected to one electrode). The support structure 104 may further include a printed circuit board assembly ("PCBA"). For example, the semiconductor substrates may be mounted on a PCBA.
[0160] The microfluidic circuit structure 108 can define circuit elements of the microfluidic circuit 120. Such circuit elements can include spaces or regions, such as flow regions (which can include one or more flow channels), chambers, pens, traps, etc., that can be fluidically interconnected when the microfluidic circuit 120 is filled with fluid. In the microfluidic circuit 120 shown in FIG. 1A, the microfluidic circuit 108 includes a frame 114 and a microfluidic circuit material 116. The frame 114 can partially or completely surround the microfluidic circuit material 116. The frame 114 can be, for example, a relatively rigid structure that substantially surrounds the microfluidic circuit material 116. For example, the frame 114 can include a metallic material.
[0161] The microfluidic circuit material 116 may be patterned with cavities or the like to define the circuit elements and interconnections of the microfluidic circuit 120. may include a flexible material, such as a flexible polymer (e.g., rubber, plastic, elastomer, silicone, polydimethylsiloxane ("PDMS"), etc.), which may be gas permeable. Other examples of materials from which the microfluidic circuit material 116 may be comprised include molded glass, etchable materials such as silicone (photopatternable silicone or "PPS"), photoresist (e.g., SU8), etc. In some embodiments, such materials - and thus the microfluidic circuit material 116 - may be rigid and / or substantially impermeable to gas. Regardless, the microfluidic circuit material 116 may be disposed on the support structure 104 and within the frame 114.
[0162] The cover 110 may be an integral part of the frame 114 and / or the microfluidic circuit material 116. Alternatively, the cover 110 may be a structurally separate element, as shown in FIG. 1A. The cover 110 may comprise the same or different material as the frame 114 and / or the microfluidic circuit material 116. Similarly, the support structure 104 may be a separate structure from the frame 114 or the microfluidic circuit material 116, as shown, or may be an integral part of the frame 114 or the microfluidic circuit material 116. Similarly, the frame 114 and the microfluidic circuit material 116 may be separate structures, as shown in FIG. 1A, or may be integral parts of the same structure.
[0163] In some embodiments, the cover 110 can include a rigid material. The rigid material can be a material having similar properties as glass. In some embodiments, the cover 110 can include a deformable material. The deformable material can be a polymer, such as PDMS. In some embodiments, the cover 110 can include both rigid and deformable materials. For example, one or more portions of the cover 110 (e.g., one or more portions located on the isolation pens 124, 126, 128, 130) can include a deformable material that interfaces with the rigid material of the cover 110. In some embodiments, the cover 110 can further include one or more electrodes. The one or more electrodes can include a conductive oxide, such as indium-tin-oxide (ITO), which can be coated with glass or a similar insulating material. Alternatively, the one or more electrodes can be flexible electrodes, such as single-walled nanotubes, multi-walled nanotubes, nanowires, clusters of conductive nanoparticles, or combinations thereof, embedded in a deformable polymer, such as a polymer (e.g., PDMS). Flexible electrodes that can be used in microfluidic devices are described, for example, in U.S. Patent Application Publication No. 2012 / 0325665 (Chiou et al.), the contents of which are incorporated herein by reference. In some embodiments, the cover 110 can be modified (e.g., by adjusting all or a portion of the surface facing inward toward the microfluidic circuit 120) to support cell adhesion, survival, and / or growth. The modification can include a coating of a synthetic or natural polymer. In some embodiments, the cover 110 and / or the support structure 104 can be optically transparent. The cover 110 can also include at least one material (e.g., PDMS or PPS) that is gas permeable.
[0164] 1A also shows a system 150 for operating and controlling a microfluidic device such as microfluidic device 100. System 150 includes a power supply 192, an imaging device (integrated within imaging module 164 and not explicitly shown in FIG. 1A), and a tilt device 190 (part of tilt module 166 and not explicitly shown in FIG. 1A).
[0165] The power supply 192 provides power to the microfluidic device 100 and / or the tilt device 190 and can provide bias voltages or currents as needed. The power supply 192 can include, for example, one or more alternating current (AC) and / or direct current (DC) voltage or current sources. The imaging device 194 (part of the imaging module 164 described below) can include a device, such as a digital camera, that captures images within the microfluidic circuit 120. In some cases, the imaging device 194 can include a digital camera or other device with a fast frame rate and / or high sensitivity (e.g., The imaging device 194 may further include a detector having a stimulating radiation and / or light beam into the microfluidic circuit 120 and may also include mechanisms for collecting radiation and / or light beams reflected or emitted from the microfluidic circuit 120 (or micro-objects contained within the microfluidic circuit 120). The emitted light beam may be in the visible spectrum and may include, for example, fluorescent radiation. The reflected light beam may include reflected radiation emitted from an LED or a broad spectrum lamp, such as a mercury lamp (e.g., a high pressure mercury lamp) or a xenon arc lamp. As discussed with respect to FIG. 3B, the imaging device 194 may further include a microscope (or optical train), which may or may not include an eyepiece.
[0166] The system 150 further includes a tilt device 190 (part of the tilt module 166 described below) configured to rotate the microfluidic device 100 about one or more rotational axes. In some embodiments, the tilt device 190 is configured to support and / or hold the enclosure 102 including the microfluidic circuit 120 about at least one axis such that the microfluidic device 100 (and thus the microfluidic circuit 120) can be held in a horizontal orientation (i.e., 0° relative to the x-axis and y-axis), a vertical orientation (i.e., 90° relative to the x-axis and / or y-axis), or any orientation therebetween. The orientation of the microfluidic device 100 (and the microfluidic circuit 120) relative to the axes is referred to herein as the "tilt" of the microfluidic device 100 (and the microfluidic circuit 120). For example, the tilt device 190 can tilt the microfluidic device 100 relative to the x-axis by 0.1°, 0.2°, 0.3°, 0.4°, 0.5°, 0.6°, 0.7°, 0.8°, 0.9°, 1°, 2°, 3°, 4°, 5°, 10°, 15°, 20°, 25°, 30°, 35°, 40°, 45°, 50°, 55°, 60°, 65°, 70°, 75°, 80°, 90°, or any degree therebetween. The horizontal orientation (and thus the x-axis and y-axis) is defined as perpendicular to the vertical axis defined by gravity. The tilt device can tilt the microfluidic device 100 (and the microfluidic circuit 120) to any angle greater than 90° relative to the x-axis and / or y-axis, or can tilt the microfluidic device 100 (and the microfluidic circuit 120) 180° relative to the x-axis or y-axis to invert the microfluidic device 100 (and the microfluidic circuit 120). Similarly, in some embodiments, the tilt device 190 tilts the microfluidic device 100 (and the microfluidic circuit 120) about an axis of rotation defined by the flow channel 106 or some other portion of the microfluidic circuit 120.
[0167] In some cases, the microfluidic device 100 is tilted vertically such that the flow path 106 is above or below one or more isolation pens. The term "above" as used herein indicates that the flow path 106 is higher than the isolation pen or pens on a vertical axis defined by gravity (i.e., objects in the isolation pen above the flow path 106 have a higher gravitational potential energy than objects in the flow path). The term "below" as used herein indicates that the flow path 106 is lower than the isolation pen or pens on a vertical axis defined by gravity (i.e., objects in the isolation pen below the flow path 106 have a lower gravitational potential energy than objects in the flow path).
[0168] In some cases, the tilt device 190 tilts the microfluidic device 100 about an axis that is parallel to the flow channel 106. Additionally, the microfluidic device 100 can be tilted at an angle less than 90° such that the flow channel 106 is positioned above or below one or more isolation pens, rather than directly above or below the isolation pen. In other cases, the tilt device 190 tilts the microfluidic device 100 about an axis that is perpendicular to the flow channel 106. In yet other cases, the tilt device 190 tilts the microfluidic device 100 about an axis that is neither parallel nor perpendicular to the flow channel 106.
[0169] The system 150 may further include a medium source 178. The medium source 178 (e.g., a container 1A , the medium source 178 can be a separate device that is external to and separate from the microfluidic device 100. Alternatively, the medium source 178 can be located, in whole or in part, within the enclosure 102 of the microfluidic device 100. For example, the medium source 178 can include a reservoir that is part of the microfluidic device 100.
[0170] 1A also illustrates a simplified block diagram representation of an example of a control and monitoring device 152 that may form part of the system 150 and be utilized in conjunction with the microfluidic device 100. As shown, an example of such a control and monitoring device 152 includes a master controller 154 that includes a medium module 160 that controls a medium source 178, a motive module 162 that controls the movement and / or selection of micro-objects (not shown) and / or medium (e.g., droplets of medium) in the microfluidic circuit 120, an imaging module 164 that controls an imaging device 194 (e.g., a camera, a microscope, a light source, or any combination thereof) that captures images (e.g., digital images), and a tilt module 166 that controls a tilt device 190. The control device 152 may also include other modules 168 that control, monitor, or perform other functions related to the microfluidic device 100. As shown, the device 152 may further include a display device 170 and an input / output device 172.
[0171] The master controller 154 may include a control module 156 and a digital memory 158. The control module 156 may include, for example, a digital processor configured to operate according to machine-executable instructions (e.g., software, firmware, source code, etc.) stored as non-transitory data or signals in the memory 158. Alternatively or additionally, the control module 156 may include hardwired digital and / or analog circuitry. The medium module 160, the motive module 162, the imaging module 164, the tilt module 166, and / or the other modules 168 may be similarly configured. Thus, the functions, processes, acts, operations, or process steps discussed herein as being performed with respect to the microfluidic device 100 or any other microfluidic apparatus may be performed by any one or more of the master controller 154, the medium module 160, the motive module 162, the imaging module 164, the tilt module 166, and / or the other modules 168 configured as described above. Similarly, the master controller 154, the culture medium module 160, the motive module 162, the imaging module 164, the tilt module 166, and / or other modules 168 may be communicatively coupled to send and receive data used in any function, process, action, operation, or step discussed herein.
[0172] The medium module 160 controls the medium source 178. For example, the medium module 160 can control the medium source 178 to enter the enclosure 102 (e.g., via the inlet 107) with a selected fluid medium 180. The medium module 160 can also control the removal of the medium from the enclosure 102 (e.g., through an outlet (not shown)). Thus, one or more media can be selectively introduced into and removed from the microfluidic circuit 120. The medium module 160 can also control the flow of the fluid medium 180 in the flow channel 106 within the microfluidic circuit 120. For example, in some embodiments, the medium module 160 stops the flow of the medium 180 in the flow channel 106 and through the enclosure 102 before the tilt module 166 causes the tilt device 190 to tilt the microfluidic device 100 to the desired tilt angle.
[0173] The motor module 162 can be configured to control the selection, capture, and movement of micro-objects (not shown) in the microfluidic circuit 120. As described below with respect to Figures 1B and 1C, the enclosure 102 can be used in a dielectrophoresis (DEP) configuration, an optoelectronic tweezers (OET) configuration, or the like. 1A ), the motive module 162 can control the activation of electrodes and / or transistors (e.g., phototransistors) to select and move micro-objects (not shown) and / or droplets of medium (not shown) in the flow channel 106 and / or isolation pens 124, 126, 128, 130.
[0174] The imaging module 164 can control the imaging device 194. For example, the imaging module 164 can receive and process image data from the imaging device 194. The image data from the imaging device 194 can include any type of information captured by the imaging device 194 (e.g., the presence or absence of a micro-object, a droplet of medium, an accumulation of a label such as a fluorescent label, etc.). Using the information captured by the imaging device 194, the imaging module 164 can further calculate the position of the object (e.g., the micro-object, the droplet of medium) and / or the speed of movement of such object within the microfluidic device 100.
[0175] The tilt module 166 can control the tilt movement of the tilt device 190. Alternatively or additionally, the tilt module 166 can control the tilt rate and timing to optimize the transfer of the micro-objects to one or more isolation pens via gravity. The tilt module 166 is communicatively coupled to the imaging module 164 to receive data describing the movement of the micro-objects and / or droplets of medium in the microfluidic circuit 120. Using this data, the tilt module 166 can adjust the tilt of the microfluidic circuit 120 to adjust the rate at which the micro-objects and / or droplets of medium move within the microfluidic circuit 120. The tilt module 166 can also use this data to iteratively adjust the position of the micro-objects and / or droplets of medium within the microfluidic circuit 120.
[0176] In the example shown in FIG. 1A, the microfluidic circuit 120 is shown as including a microfluidic channel 122 and isolation pens 124, 126, 128, 130. Each pen includes an opening to the channel 122, but is otherwise closed so that the pen can substantially isolate the micro-objects within the pen from the fluid medium 180 and / or the flow path 106 of the channel 122 or from the micro-objects within other pens. The walls of the isolation pen extend from the inner surface 109 of the base to the inner surface of the cover 110, providing an enclosure. The opening of the pen to the microfluidic channel 122 is oriented at an angle to the flow 106 such that the flow 106 is not directed into the pen. The flow may be tangential or perpendicular to the plane of the opening of the pen. In some cases, the pens 124, 126, 128, 130 are configured to physically corral one or more micro-objects within the microfluidic circuit 120. Isolation pens according to the present disclosure can include a variety of shapes, surfaces, and features optimized for use with DEP, OET, OEW, fluid flow, and / or gravity, as discussed and illustrated in detail below.
[0177] Microfluidic circuit 120 may include any number of microfluidic isolation pens. Although five isolation pens are shown, microfluidic circuit 120 may have fewer or more isolation pens. As shown, microfluidic isolation pens 124, 126, 128, and 130 of microfluidic circuit 120 each include different features and shapes that may provide one or more advantages useful for maintaining, isolating, assaying, or culturing biological micro-objects. In some embodiments, microfluidic circuit 120 includes multiple identical microfluidic isolation pens.
[0178] 1A, one channel 122 and flow path 106 are shown. However, other embodiments may include multiple channels 122, each configured to include a flow path 106. The microfluidic circuit 120 further includes an inlet valve or port 107 in fluid communication with the flow path 106 and the fluid medium 180, such that the fluid medium 180 can access the channel 122 via the inlet 107. In some cases, the flow path 106 is a In some cases, one path is arranged in a zigzag pattern, such that the flow channel 106 travels across the microfluidic device 100 two or more times in alternating directions.
[0179] In some cases, the microfluidic circuit 120 includes multiple parallel channels 122 and flow paths 106, with the fluid medium 180 in each flow path 106 flowing in the same direction. In some cases, the fluid medium in each flow path 106 flows in at least one of a forward direction or a reverse direction. In some cases, multiple isolation pens are configured such that the isolation pens can be positioned in parallel with the target micro object (e.g., relative to the channel 122).
[0180] In some embodiments, the microfluidic circuit 120 further includes one or more micro-object traps 132. The traps 132 are generally formed in walls that form the boundaries of the channel 122 and may be located opposite one or more openings of the microfluidic isolation pens 124, 126, 128, 130. In some embodiments, the traps 132 are configured to receive or capture a single micro-object from the flow path 106. In some embodiments, the traps 132 are configured to receive or capture multiple micro-objects from the flow path 106. In some cases, the traps 132 include a volume approximately equal to the volume of one target micro-object.
[0181] The trap 132 may further include an opening configured to aid in the flow of the target micro-object into the trap 132. In some cases, the trap 132 includes an opening having a height and width approximately equal to the dimensions of one target micro-object, thereby preventing larger micro-objects from entering the micro-object trap. The trap 132 may further include other features configured to aid in the retention of the target micro-object within the trap 132. In some cases, the trap 132 is aligned with the opening of the microfluidic isolation pen and positioned on the opposite side of the channel 122 with respect to the opening of the microfluidic isolation pen, such that when the microfluidic device 100 is tilted about an axis parallel to the microfluidic channel 122, the trapped micro-object exits the trap 132 on a trajectory that drops the micro-object into the opening of the isolation pen. In some cases, the trap 132 includes a side passage 134 that is smaller than the target micro-object and that facilitates flow through the trap 132, thereby increasing the probability of trapping the micro-object within the trap 132.
[0182] In some embodiments, a dielectrophoretic (DEP) force is applied across the fluid medium 180 (e.g., in the flow channel and / or isolation pen) via one or more electrodes (not shown) to manipulate, transport, separate, and sort micro-objects disposed therein. For example, in some embodiments, a DEP force is applied to one or more portions of the microfluidic circuit 120 to transport a single micro-object from the flow channel 106 to a desired microfluidic isolation pen. In some embodiments, a DEP force is used to prevent micro-objects in an isolation pen (e.g., isolation pens 124, 126, 128, or 130) from being displaced from the isolation pen. Additionally, in some embodiments, a DEP force is used to selectively remove micro-objects from the isolation pen that were previously collected according to aspects of the present disclosure. In some embodiments, the DEP force includes an optoelectronic tweezers (OET) force.
[0183] In other embodiments, an opto-electrowetting (OEW) force is applied via one or more electrodes (not shown) to one or more locations (e.g., locations that help define a flow path and / or an isolation pen) on the support structure 104 (and / or cover 110) of the microfluidic device 100 to manipulate, transport, separate, and sort droplets disposed in the microfluidic circuit 120. For example, in some embodiments, an OEW force is applied to one or more locations on the support structure 104 (and / or cover 110) to transport a droplet from the flow path 106 to a desired microfluidic isolation pen. In some embodiments, an OEW force is used to displace a droplet in an isolation pen (e.g., isolation pens 124, 126, 128, or 130) from the isolation pen. Additionally, in some embodiments, OEW forces are used to selectively remove droplets from the separator pen that were previously collected in accordance with aspects of the present disclosure.
[0184] In some embodiments, the DEP and / or OEW forces are combined with other forces, such as flow and / or gravity, to manipulate, transport, separate, and sort the micro-objects and / or droplets within the microfluidic circuit 120. For example, the enclosure 102 can be tilted (e.g., by tilt device 190) to position the channel 106 and the micro-objects disposed within the channel 106 over a microfluidic isolation pen, and gravity can transport the micro-objects and / or droplets into the pen. In some embodiments, the DEP and / or OEW forces can be applied before the other forces. In other embodiments, the DEP and / or OEW forces can be applied after the other forces. In still other cases, the DEP and / or OEW forces can be applied simultaneously with or alternating with the other forces.
[0185] 1B, 1C, and 2A-2H show various embodiments of microfluidic devices that can be used in embodiments of the present disclosure. FIG. 1B shows an embodiment in which a microfluidic device 200 is configured as an optically actuated electrokinetic device. A variety of optically actuated electrokinetic devices are known in the art, including devices having an optoelectronic tweezers (OET) configuration and an optoelectrowetting (OEW) configuration. Examples of suitable OET configurations are shown in the following U.S. patent documents, each of which is incorporated herein by reference in its entirety: U.S. Patent No. RE44,711 (Wu et al.) (originally issued as U.S. Patent No. 7,612,355); and U.S. Patent No. 7,956,339 (Ohta et al.). Examples of OEW configurations are shown in U.S. Patent No. 6,958,132 (Chiou et al.) and U.S. Patent Application Publication No. 2012 / 0024. No. 708 (Chiou et al.), both of which are incorporated herein by reference in their entireties. Yet another example of an optically actuated electrokinetic device includes a combined OET / OEW configuration, examples of which are shown in U.S. Patent Application Publication Nos. 20150306598 (Khandros et al.) and 20150306599 (Khandros et al.) and their corresponding PCT publications WO 2015 / 164846 and WO 2015 / 164847, all of which are incorporated herein by reference in their entireties.
[0186] Examples of microfluidic devices having isolation pens in which biological micro-objects can be placed, cultured, and / or monitored are described, for example, in U.S. Patent Application Publication No. 2014 / 0116881 (ser. no. 14 / 060,117, filed October 22, 2013), U.S. Patent Application Publication No. 2015 / 0151298 (ser. no. 14 / 520,568, filed October 22, 2014), and U.S. Patent Application Publication No. 2015 / 0165436 (ser. no. 14 / 521,447, filed October 22, 2014), each of which is incorporated by reference in its entirety. U.S. Patent Application Publication Nos. 14 / 520,568 and 14 / 521,447 also describe exemplary methods for analyzing secretions of cells cultured in the microfluidic device. Each of the above applications further describes microfluidic devices configured to generate dielectrophoretic (DEP) forces, such as optoelectronic tweezers (OET), or configured to provide optoelectrowetting (OEW). For example, the optoelectronic tweezers device shown in Figure 2 of US Patent Application Publication No. 2014 / 0116881 is an example of a device that can be utilized in embodiments of the present disclosure to select and move individual or groups of biological micro-objects.
[0187] Powered microfluidic device configuration. As mentioned above, the control and monitoring equipment of the system can include a motive module for selecting and moving objects, such as micro-objects or droplets, in the microfluidic circuitry of the microfluidic device. The microfluidic device can have a variety of motive configurations depending on the type of object to be moved and other considerations. For example, a dielectrophoretic (DEP) configuration can be used to select and move micro-objects in the microfluidic circuitry. Thus, the microfluidic device can include a motive module for selecting and moving objects, such as micro-objects or droplets, in the microfluidic circuitry of the microfluidic device. The support structure 104 and / or cover 110 of the microfluidic device 100 can include DEP configurations that selectively induce DEP forces on micro-objects in the fluid medium 180 in the microfluidic circuit 120, thereby selecting, capturing, and / or moving individual micro-objects or groups of micro-objects. Alternatively, the support structure 104 and / or cover 110 of the microfluidic device 100 can include electrowetting (EW) configurations that selectively induce EW forces on droplets in the fluid medium 180 in the microfluidic circuit 120, thereby selecting, capturing, and / or moving individual droplets or groups of droplets.
[0188] An example of a microfluidic device 200 including a DEP arrangement is shown in FIG. 21B and FIG. 1C. For simplicity, FIG. 1B and FIG. 1C show side and top cross-sectional views, respectively, of a portion of the enclosure 102 of the microfluidic device 200 having the region / chamber 202, but it should be understood that the region / chamber 202 may be part of a fluidic circuit element having a more detailed structure, such as a growth chamber, an isolation pen, a flow region, or a flow channel. Additionally, the microfluidic device 200 may include other fluidic circuit elements. For example, the microfluidic device 200 may include multiple growth chambers, or isolation pens, such as those described herein with respect to the microfluidic device 100, and / or one or more flow regions or flow channels. The DEP arrangement may be incorporated into or may be selected as part of any such fluidic circuit element of the microfluidic device 200. It should be further understood that any of the microfluidic device components and system components described above or below may be incorporated into and / or used in conjunction with the microfluidic device 200. For example, the system 150 including the control and monitoring equipment 152 described above, including one or more of the medium module 160, the drive module 162, the imaging module 164, the tilt module 166, and other modules 168, may be used in conjunction with the microfluidic device 200.
[0189] 1B, the microfluidic device 200 includes a support structure 104 having a lower electrode 204 and an electrode-activated substrate 206 overlying the lower electrode 204, and a cover 110 having an upper electrode 210 spaced apart from the lower electrode 204. The upper electrode 210 and the electrode-activated substrate 206 define opposite sides of a region / chamber 202. Thus, a medium 180 contained in the region / chamber 202 provides a resistive connection between the upper electrode 210 and the electrode-activated substrate 206. Also shown is a power source 212 connected between the lower electrode 204 and the upper electrode 210 and configured to generate a bias voltage between the electrodes as needed for generation of a DEP force in the region / chamber 202. The power source 212 can be, for example, an alternating current (AC) power source.
[0190] In certain embodiments, the microfluidic device 200 shown in Figures 1B and 1C can have an optically actuated DEP configuration. Thus, a varying pattern of light 218 from a light source 216, which may be controlled by the actuator module 162, can selectively activate or deactivate a varying pattern of DEP electrodes in a region 214 of an inner surface 208 of an electrode-activated substrate 206. (A region 214 of a microfluidic device having a DEP configuration is referred to below as a "DEP electrode region.") As shown in Figure 1C, the light pattern 218 directed toward the inner surface 208 of the electrode-activated substrate 206 can illuminate selected DEP electrode regions 214a (shown in white) in a pattern such as a square. The non-illuminated DEP electrode regions 214 (hatched) are referred to below as "dark" DEP electrode regions 214. The relative electrical impedance through the DEP electrode-activated substrate 206 (i.e., from the lower electrode 204 to the inner surface 208 of the electrode-activated substrate 206 that interfaces with the medium 180 in the flow region 106) is greater than the relative electrical impedance through the medium 180 in the region / chamber 202 at each dark DEP electrode region 214 (i.e., from the inner surface 208 of the electrode-activated substrate 206 to the upper electrode 210 of the cover 110). However, the relative impedance through the medium 180 in the region / chamber 202 at each illuminated DEP electrode region 214a is less than the relative impedance through the medium 180 in the region / chamber 202 at each illuminated DEP electrode region 214a. 2 shows the relative impedance reduction through the electrode activation substrate 206.
[0191] When the power source 212 is activated, the above DEP configuration creates an electric field gradient within the fluid medium 180 between the illuminated DEP electrode region 214a and the adjacent dark DEP electrode region 214, which in turn generates a local DEP force that attracts or repels nearby micro-objects (not shown) within the fluid medium 180. Thus, DEP electrodes that attract or repel micro-objects within the fluid medium 180 can be selectively activated and deactivated at many different such DEP electrode regions 214 on the interior surface 208 of the region / chamber 202 by varying the light pattern 218 projected from the light source 216 onto the microfluidic device 200. Whether the DEP force attracts or repels nearby micro-objects may depend on parameters such as the frequency of the power source 212 and the dielectric properties of the medium 180 and / or the micro-objects (not shown).
[0192] 1C is merely an example. Any pattern of DEP electrode regions 214 can be illuminated (and thereby activated) by the light pattern 218 projected onto the microfluidic device 200, and the pattern of illuminated / activated DEP electrode regions 214 can be repeatedly changed by changing or moving the light pattern 218.
[0193] In some embodiments, the electrode-activated substrate 206 can include or consist of a photoconductive material. In such embodiments, the inner surface 208 of the electrode-activated substrate 206 can be featureless. For example, the electrode-activated substrate 206 can include or consist of a layer of hydrogenated amorphous silicon (a-Si:H). The a-Si:H can include, for example, about 8% to 40% hydrogen (calculated as the number of hydrogen atoms / total number of hydrogen and silicon atoms multiplied by 100). The layer of a-Si:H can have a thickness of about 500 nm to about 2.0 μm. In such embodiments, the DEP electrode regions 214 can be created in any pattern at any location on the inner surface 208 of the electrode-activated substrate 206 by the light pattern 218. Thus, the number and pattern of the DEP electrode regions 214 need not be fixed and can correspond to the light pattern 218. Examples of microfluidic devices having DEP configurations including a photoconductive layer as described above are described, for example, in U.S. Pat. No. RE44,711 (Wu et al.) (originally issued as U.S. Pat. No. 7,612,355), the entire contents of which are incorporated herein by reference.
[0194] In other embodiments, the electrode-activated substrate 206 can include a substrate including multiple doped layers, insulating layers (or regions), and conductive layers forming a semiconductor integrated circuit, such as known in the semiconductor art. For example, the electrode-activated substrate 206 can include multiple phototransistors, including, for example, lateral bipolar phototransistors, where each phototransistor corresponds to a DEP electrode region 214. Alternatively, the electrode-activated substrate 206 can include electrodes (e.g., conductive metal electrodes) controlled by a phototransistor switch, where each such electrode corresponds to a DEP electrode region 214. The electrode-activated substrate 206 can include such phototransistors or phototransistor-controlled electrodes in a pattern. The pattern can be, for example, an array of substantially square phototransistors or phototransistor-controlled electrodes arranged in a matrix, such as shown in FIG. 2B. Alternatively, the pattern can be an array of substantially hexagonal phototransistors or phototransistor-controlled electrodes forming a hexagonal lattice. Regardless of the pattern, the electrical circuit elements can form electrical connections between the DEP electrode regions 214 and the bottom electrode 210 on the inner surface 208 of the electrode-activated substrate 206, and those electrical connections (i.e., phototransistors or electrodes) can be selectively activated or deactivated by the light pattern 218. When not activated, each electrical connection passes through the electrode-activated substrate 206 (i.e., from the bottom electrode 204 to the inner surface 208 of the electrode-activated substrate 206 that interfaces with the medium 180 in the region / chamber 202). 8) is greater than the relative impedance through the medium 180 at the corresponding DEP electrode region 214 (i.e., from the inner surface 208 of the electrode-activating substrate 206 to the top electrode 210 of the cover 110). However, when activated by light in light pattern 218, the relative impedance through the electrode-activating substrate 206 is less than the relative impedance through the medium 180 at each illuminated DEP electrode region 214, thereby activating the DEP electrodes at the corresponding DEP electrode region 214, as described above. Thus, DEP electrodes that attract or repel small objects (not shown) in the medium 180 can be selectively activated and deactivated at many different DEP electrode regions 214 on the inner surface 208 of the electrode-activating substrate 206 in the region / chamber 202, as determined by light pattern 218.
[0195] Examples of microfluidic devices having electrode-activated substrates that include phototransistors are described, for example, in U.S. Pat. No. 7,956,339 (Ohta et al.) (see, for example, the device 300 shown in FIGS. 21 and 22 and the description thereof), the entire contents of which are incorporated herein by reference. Examples of microfluidic devices having electrode-activated substrates that include electrodes controlled by phototransistor switches are described, for example, in U.S. Patent Application Publication No. 2014 / 0124370 (Short et al.) (see, for example, the device 300 shown throughout the drawings). See devices 200, 400, 500, 600, and 900 and descriptions thereof, the entire contents of which are incorporated herein by reference.
[0196] In some embodiments of the microfluidic device in a DEP configuration, the upper electrode 210 is part of a first wall (or cover 110) of the enclosure 102, and the electrode-activated substrate 206 and the lower electrode 204 are part of a second wall (or support structure 104) of the enclosure 102. The region / chamber 202 can be between the first and second walls. In other embodiments, the electrode 210 is part of the second wall (or support structure 104), and one or both of the electrode-activated substrate 206 and / or the electrode 210 are part of the first wall (or cover 110). Additionally, the light source 216 can alternatively be used to illuminate the enclosure 102 from below.
[0197] 1B and 1C with a DEP configuration, the motor module 162 can select a micro-object (not shown) in the medium 180 in the region / chamber 202 by projecting a light pattern 218 onto the micro-fluidic device 200 to activate a first set of one or more DEP electrodes at the DEP electrode region 214a of the inner surface 208 of the electrode activation substrate 206 in a pattern (e.g., a square pattern 220) that surrounds and captures the micro-object. The motor module 162 can then move the light pattern 218 relative to the micro-fluidic device 200 to move the in situ generated and captured micro-object by activating a second set of one or more DEP electrodes at the DEP electrode region 214. Alternatively, the micro-fluidic device 200 can be moved relative to the light pattern 218.
[0198] In other embodiments, the microfluidic device 200 can have a DEP configuration that does not rely on photoactivation of DEP electrodes on the inner surface 208 of the electrode-activating substrate 206. For example, the electrode-activating substrate 206 can include selectively addressable and energizable electrodes located opposite a surface (e.g., cover 110) that includes at least one electrode. Switches (e.g., transistor switches in a semiconductor substrate) can be selectively opened and closed to activate or deactivate DEP electrodes at the DEP electrode regions 214, thereby generating a net DEP force on micro-objects (not shown) in the region / chamber 202 in the vicinity of the activated DEP electrodes. Depending on the frequency of the power source 212 and characteristics such as the dielectric properties of the medium (not shown) and / or the micro-objects in the region / chamber 202, the DEP force can attract or repel nearby micro-objects. A set of DEP electrodes (e.g., a square pattern 220) can be selectively opened and closed to activate or deactivate DEP electrodes at the DEP electrode regions 214, thereby generating a net DEP force on micro-objects (not shown) in the region / chamber 202 in the vicinity of the activated DEP electrodes. Depending on the frequency of the power source 212 and characteristics such as the dielectric properties of the medium (not shown) and / or the micro-objects in the region / chamber 202, the DEP force can attract or repel nearby micro-objects. By selectively activating or deactivating the DEP electrodes (in a set of DEP electrode regions 214 forming a region / chamber 202) one or more micro-objects in the region / chamber 202 can be captured and moved within the region / chamber 202. The motive module 162 of FIG. 1A controls such switches and thus can activate and deactivate individual electrodes of the DEP electrodes to select, capture, and move specific micro-objects (not shown) around the region / chamber 202. Microfluidic devices having DEP configurations including selectively addressable and energizable electrodes are known in the art and are described, for example, in U.S. Pat. Nos. 6,294,063 (Becker et al.) and 6,942,776 (Medoro), the entire contents of which are incorporated herein by reference.
[0199] As yet another alternative, the microfluidic device 200 can have an electrowetting (EW) configuration, which may be in place of the DEP configuration or may be located in a portion of the microfluidic device 200 separate from the portion having the DEP configuration. The EW configuration can be an opto-electrowetting configuration or an electrowetting-on-dielectric (EWOD) configuration, both of which are known in the art. In some EW configurations, the support structure 104 has an electrode-activated substrate 206 sandwiched between a dielectric layer (not shown) and a bottom electrode 204, as described below. The dielectric layer can include and / or be coated with a hydrophobic material. For a microfluidic device 200 having an EW configuration, the inner surface 208 of the support structure 104 is the inner surface of the dielectric layer or a hydrophobic coating thereof.
[0200] The dielectric layer (not shown) can include one or more oxide layers and can have a thickness of about 50 nm to about 250 nm (e.g., about 125 nm to about 175 nm). In certain embodiments, the dielectric layer can include a layer of an oxide, such as a metal oxide (e.g., aluminum oxide or hafnium oxide). In certain embodiments, the dielectric layer can include a dielectric material other than a metal oxide, such as silicon oxide or a nitride. Regardless of the exact composition and thickness, the dielectric layer can have an impedance of about 10 kOhms to about 50 kOhms.
[0201] In some embodiments, the surface of the dielectric layer facing inwardly towards the region / chamber 202 is coated with a hydrophobic material. The hydrophobic material may include, for example, fluorinated carbon molecules. Examples of fluorinated carbon molecules include perfluoropolymers such as polytetrafluoroethylene (e.g., TEFLON®) or poly(2,3-difluoromethylenyl-perfluorotetrahydrofuran) (e.g., CYTOP™). Hydrophobic Molecules of the material may be covalently bonded to the surface of the dielectric layer. For example, the molecules of the hydrophobic material may be covalently bonded to the surface of the dielectric layer by a linker such as a siloxane group, a phosphonic acid group, or a thiol group. Thus, in some embodiments, the hydrophobic material may comprise an alkyl-terminated siloxane, an alkyl-terminated phosphonic acid, or an alkyl-terminated thiol. The alkyl group may be a long chain hydrocarbon (e.g., having a chain of at least 10 carbons or at least 16, 18, 20, 22, or more carbons). Alternatively, a fluorinated (or perfluorinated) carbon chain may be used in place of the alkyl group. Thus, for example, the hydrophobic material may comprise a fluoroalkyl-terminated siloxane, a fluoroalkyl-terminated phosphonic acid, or a fluoroalkyl-terminated thiol. In some embodiments, the hydrophobic coating has a thickness of about 10 nm to about 50 nm. In other embodiments, the hydrophobic coating has a thickness of less than 10 nm (e.g., less than 5 nm or about 1.5 to 3.0 nm).
[0202] In some embodiments, the cover 110 of the microfluidic device 200 having an electrowetting configuration is also coated with a hydrophobic material (not shown). The hydrophobic material may be the same hydrophobic material used to coat the dielectric layer of the support structure 104, and the hydrophobic coating may be approximately the same thickness as the hydrophobic coating of the dielectric layer of the support structure 104. The cover 110 may have a thickness that is 0.1 mm to 1.5 mm. Additionally, the cover 110 may include an electrode-active substrate 206 sandwiched between a dielectric layer and an upper electrode 210, in the manner of the support structure 104. The electrode-active substrate 206 and the dielectric layer of the cover 110 may have the same composition and / or dimensions as the dielectric layer of the electrode-active substrate 206 and the support structure 104. Thus, the microfluidic device 200 may have two electrowetting surfaces.
[0203] In some embodiments, the electronically-activated substrate 206 can include a photoconductive material, such as the photoconductive materials described above. Thus, in certain embodiments, the electrode-activated substrate 206 can include a layer of hydrogenated amorphous silicon (a-Si:H) or can consist of a layer of a-Si:H. The a-Si:H can include, for example, about 8% to 40% hydrogen (calculated as the total number of hydrogen atoms and the total number of silicon atoms / total number of hydrogen atoms multiplied by 100). The layer of a-Si:H can have a thickness of about 500 nm to about 2.0 μm. Alternatively, the electronically-activated substrate 206 can include electrodes (e.g., conductive metal electrodes) controlled by phototransistor switches, as described above. Microfluidic devices having photoelectrowetting configurations are known in the art and / or can be constructed using electrode-activated substrates known in the art. For example, U.S. Pat. No. 6,958,132 (Chiou et al.), the entire contents of which are incorporated herein by reference, describes photoconductive electrodes such as a-Si:H. The above-cited U.S. Patent Application Publication No. 2014 / 0124370 (Short et al.) discloses an opto-electrowetting configuration having a photosensitive material, while the above-cited U.S. Patent Application Publication No. 2014 / 0124370 (Short et al.) discloses an opto-electrowetting configuration having a photosensitive material. An electrode-activated substrate having electrodes controlled by switches is disclosed.
[0204] Thus, the microfluidic device 200 can have an opto-electrowetting configuration, and the light pattern 218 can be used to activate light-responsive EW regions or light-responsive EW electrodes in the electrode-activated substrate 206. Such activated EW regions or EW electrodes in the electrode-activated substrate 206 can generate an electrowetting force at the inner surface 208 of the support structure 104 (i.e., the inner surface of an overlying dielectric layer or a hydrophobic coating thereof). By modifying the light pattern 218 incident on the electro-activated substrate 206 (or moving the microfluidic device 200 relative to the light source 216), a droplet (e.g., comprising an aqueous medium, an aqueous solution, or an aqueous solvent) contacting the inner surface 208 of the support structure 104 can move through an immiscible fluid (e.g., an oil medium) present in the region / chamber 202.
[0205] In other embodiments, the microfluidic device 200 can have an EWOD configuration, where the electrode-activated substrate 206 can include selectively addressable and energizable electrodes that do not rely on light for activation. Thus, the electrode-activated substrate 206 can include such electrowetting (EW) electrodes in a pattern. The pattern can be, for example, an array of generally square EW electrodes arranged in a matrix such as that shown in FIG. 2B. Alternatively, the pattern can be an array of generally hexagonal EW electrodes forming a hexagonal lattice. Regardless of the pattern, the EW electrodes can be selectively activated (or deactivated) by an electrical switch (e.g., a transistor switch in a semiconductor substrate). By selectively activating and deactivating the EW electrodes on the electrode-activated substrate 206, droplets (not shown) contacting the inner surface 208 of the overlying dielectric layer or its hydrophobic coating can be moved within the region / chamber 202. The motive module 162 of FIG. 1A can control such switches, and thus activate and deactivate individual EW electrodes to select and move specific droplets around the region / chamber 202. Microfluidic devices having EWOD configurations with selectively addressable and energizable electrodes are known in the art and are described, for example, in U.S. Pat. No. 8,685,344 (Sundarsan et al.), the entire contents of which are incorporated herein by reference.
[0206] Regardless of the configuration of the microfluidic device 200, the power supply 212 can be used to The power source 212 may provide an electrical potential (e.g., an AC power source potential) that powers the electrical circuitry of the device 200. The power source 212 may be the same as or a component of the power source 192 referenced in FIG. 1. The power source 212 may be configured to provide an AC voltage and / or current to the upper electrode 210 and the lower electrode 204. In the case of an AC voltage, the power source 212 may provide a frequency range and average or peak power (e.g., voltage or current) sufficient to generate a net DEP force (or electrowetting force) strong enough to capture and move individual micro objects (not shown) within the region / chamber 202, as described above, and / or to modify the wetting properties of the inner surface 208 (i.e., the dielectric layer and / or the hydrophobic coating thereon) of the support structure 104 within the region / chamber 202, as also described above. Such frequency ranges and average or peak power ranges are known in the art. See, for example, U.S. Pat. No. 6,958,132 (Chiou et al.), U.S. Pat. No. RE44,711 (Wu et al.) (originally a issued as U.S. Pat. No. 7,612,355, and U.S. Patent Application Publication Nos. 2014 / 0124370 (Short et al.) and 2015 / 0306598 (Khandros et al.). and 2015 / 0306599 (Khandros et al.).
[0207] Isolation pen. A non-limiting example of a typical isolation pen 224, 226, and 228 is shown in the microfluidic device 230 shown in Figures 2A-2C. Each isolation pen 224, 226, and 228 can include an isolation structure 232 that defines a separation region 240 and a connection region 236 that fluidly connects the separation region 240 to the channel 122. The connection region 236 can include a proximal opening 234 to the microfluidic channel 122 and a distal opening 238 to the separation region 240. The connection region 236 can be configured such that a maximum penetration depth of a flow of a fluid medium (not shown) flowing from the microfluidic channel 122 into the isolation pens 224, 226, 228 does not extend into the separation region 240. Therefore, due to the connection region 236, micro-objects (not shown) or other materials (not shown) placed in the separation region 240 of the isolation pens 224, 226, 228 can be isolated from the flow of the medium 180 in the channel 122 and substantially unaffected by the flow of the medium 180 in the microfluidic channel 122.
[0208] 2A-2C each have a single opening that opens directly into the microfluidic channel 122. The opening of the isolation pen opens laterally from the microfluidic channel 122. An electrode activation substrate 206 underlies both the microfluidic channel 122 and the isolation pens 224, 226, and 228. The top surface of the electrode activation substrate 206 within the isolation pen enclosure, which forms the floor of the isolation pen, is positioned at or near the same height as the top surface of the electrode activation substrate 206 within the microfluidic channel 122 (or flow region, if no channel is present), which forms the floor of the flow channel (or flow region, respectively) of the microfluidic device. The electrode-activated substrate 206 may be featureless or may have an irregular or patterned surface that varies from highest to lowest depressions of less than about 3 μm, less than about 2.5 μm, less than about 2 μm, less than about 1.5 μm, less than about 1 μm, less than about 0.9 μm, less than about 0.5 μm, less than about 0.4 μm, less than about 0.2 μm, less than about 0.1 μm, or less. The variation in elevation of the top surface of the substrate across both the microfluidic channel 122 (or flow region) and the isolation pen may be less than about 3%, less than about 2%, less than about 1%, less than about 0.9%, less than about 0.8%, less than about 0.5%, less than about 0.3%, or less than about 0.1% of the isolation pen wall height or the microfluidic device wall height. Although microfluidic device 200 has been described in detail, this also applies to any of the microfluidic devices 100, 230, 250, 280, 290 described herein.
[0209] Thus, the microfluidic channel 122 may be an example of a swept region, and the isolation region 240 of the isolation pens 224, 226, 228 may be an example of a non-swept region. As mentioned, the microfluidic channel 122 and the isolation pens 224, 226, 228 may be configured to contain one or more fluid media 180. In the example shown in Figures 2A-2B, the port 222 is a microfluidic The microfluidic channels 122 may be connected to the microfluidic channels 122 to allow fluid medium 180 to be introduced or removed from the microfluidic device 230. Prior to introducing the fluid medium 180, the microfluidic device may be primed with a gas, such as carbon dioxide gas. Once the microfluidic device 230 contains the fluid medium 180, a flow 242 of the fluid medium 180 in the microfluidic channels 122 may be selectively generated and stopped. For example, as shown, the ports 222 may be positioned at different locations (e.g., at both ends) of the microfluidic channel 122 to generate a flow 242 of medium from one port 222 acting as an inlet to another port 222 acting as an outlet.
[0210] 2C shows a detailed view of an example isolation pen 224 according to the present disclosure. An example of a minute object 246 is also shown.
[0211] As is known, a flow 242 of the fluid medium 180 in the microfluidic channel 122 beyond the proximal opening 234 of the isolation pen 224 can result in a secondary flow 244 of the medium 180 into and / or out of the isolation pen 224. To separate the micro objects 246 in the isolation region 240 of the isolation pen 224 from the secondary flow 244, the length L of the connection region 236 of the isolation pen 224 is con (i.e., from the proximal opening 234 to the distal opening 238) is the penetration depth D of the secondary flow 244 into the connection region 236 p The penetration depth D of the secondary flow 244 should be greater than p depends on various parameters related to the velocity of the fluid medium 180 flowing within the microfluidic channel 122 and the configuration of the proximal opening 234 of the microfluidic channel 122 and the connecting region 236 to the microfluidic channel 122. In a given microfluidic device, the configuration of the microfluidic channel 122 and the opening 234 are fixed, while the velocity of the flow 242 of the fluid medium 180 within the microfluidic channel 122 is variable. Thus, for each isolation pen 224, the penetration depth D of the secondary flow 244 is p is the length L of the connection area 236 conA maximum velocity Vmax of the flow 242 of the fluid medium 180 in the channel 122 can be identified that ensures that the flow rate of the flow 242 of the fluid medium 180 in the microfluidic channel 122 does not exceed the maximum velocity Vmax. As long as the flow rate of the flow 242 of the fluid medium 180 in the microfluidic channel 122 does not exceed the maximum velocity Vmax, the resulting secondary flow 244 into the microfluidic channel 122 and into the connection region 236 can be restricted and prevented from entering the separation region 240. Thus, the flow 242 of the medium 180 in the microfluidic channel 122 does not pull the micro-objects 246 out of the separation region 240. Rather, the micro-objects 246 disposed within the separation region 240 remain within the separation region 240 regardless of the flow 242 of the fluid medium 180 in the microfluidic channel 122.
[0212] Furthermore, the flow 242 of the fluid medium 180 in the microfluidic channel 122 does not move various particles (e.g., microparticles and / or nanoparticles) from the microfluidic channel 122 into the separation region 240 of the isolation pen 224, unless the flow rate of the flow 242 of the medium 180 in the microfluidic channel 122 exceeds Vmax. Thus, the length L of the connection region 236 is con The maximum penetration depth D of the secondary flow 244 p This can avoid contamination of one isolation pen 224 with various particles from the microfluidic channel 122 or another isolation pen (eg, isolation pens 226, 228 in FIG. 2D).
[0213] Because the microfluidic channel 122 and the connection region 236 of the isolation pens 224, 226, 228 can affect the flow 242 of the medium 180 in the microfluidic channel 122, the microfluidic channel 122 and the connection region 236 can be considered to be a sweep (or flow) region of the microfluidic device 230. On the other hand, the separation region 240 of the isolation pens 224, 226, 228 can be considered to be a non-sweep (or non-flow) region. For example, components (not shown) in the first fluid medium 180 in the microfluidic channel 122 can flow through the connection region 236 to the second fluid medium 248 in the separation region 240 substantially only by diffusion of the components of the first medium 180 from the microfluidic channel 122 through the connection region 236 to the second fluid medium 248 in the separation region 240. The first medium 180 may mix with the second fluid medium 248. Similarly, components of the second medium 248 in the separation region 240 (not shown) may mix with the first medium 180 in the microfluidic channel 122 substantially only by diffusion of the components of the second medium 248 from the separation region 240 through the connection region 236 and into the first medium 180 in the microfluidic channel 122. In some embodiments, the degree of fluid medium exchange between the separation region and the flow region of the isolation pen by diffusion is greater than about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, or about 99% of the fluid exchange. The first medium 180 may be the same medium as the second medium 248 or may be a different medium. Additionally, the first medium 180 and the second medium 248 can start out as the same medium and become different (e.g., through adjusting the second medium 248 by one or more cells in the separation region 240 or by altering the medium 180 flowing through the microfluidic channel 122).
[0214] The maximum penetration depth D of the secondary flow 244 caused by the flow 242 of the fluid medium 180 in the microfluidic channel 122 pmay depend on several parameters, as discussed above, including the shape of the microfluidic channel 122 (e.g., the channel may direct medium toward the connection region 236, may direct medium away from the connection region 236, or may direct medium in a direction substantially perpendicular to the proximal opening 234 of the connection region 236 to the microfluidic channel 122), the width W of the microfluidic channel 122 at the proximal opening 234, ch (or cross-sectional area) and the width W of the connection region 236 at the proximal opening 234 con (or cross-sectional area), the velocity V of the flow 242 of the fluid medium 180 within the microfluidic channel 122, the viscosity of the first medium 180 and / or the second medium 248, etc.
[0215] In some embodiments, the dimensions of the microfluidic channel 122 and the isolation pens 224, 226, 228 can be oriented relative to the vector of the flow 242 of the fluid medium 180 within the microfluidic channel 122 as follows: microfluidic channel width W ch (or the cross-sectional area of the microfluidic channel 122) can be approximately perpendicular to the flow 242 of the medium 180, and the width W con (or cross-sectional area) may be approximately parallel to the flow 242 of the medium 180 in the microfluidic channel 122 and / or the length L con can be approximately orthogonal to the flow 242 of the medium 180 in the microfluidic channel 122. The above are merely examples, and the relative positions of the microfluidic channel 122 and the isolation pens 224, 226, 228 can be other orientations with respect to each other.
[0216] As shown in FIG. 2C, the width W con can be uniform from the proximal opening 234 to the distal opening 238. Thus, the width W of the connection region 236 at the distal opening 238 con is the width W of the connection region 236 at the proximal opening 234 con Alternatively, the width W of the connection region 236 at the tip opening 238 may be any of the values identified herein. conis the width W of the connection region 236 at the proximal opening 234 con It can be a value greater than
[0217] As shown in FIG. 2C, the width of separation region 240 at distal opening 238 is equal to the width W of proximal region 236 at proximal opening 234. con Thus, the width of the separation region 240 at the distal opening 238 may be approximately equal to the width W of the connection region 236 at the proximal opening 234. con Alternatively, the width of separation region 240 at distal opening 238 may be any value identified herein for the width W of connection region 236 at proximal opening 234. con Additionally, the distal opening 238 may be smaller than the proximal opening 234, and the width W of the connection region 236 may be smaller than the width W of the connection region 236. con The connection region 236 may narrow between the proximal and distal openings 234 and 238. For example, the connection region 236 may narrow between the proximal and distal openings using a variety of different geometries (e.g., chamfering the connection region, beveling the connection region). Additionally, any portion or subportion of the connection region 236 may be narrowed (e.g., proximal opening 234, distal opening 238, etc.). 34).
[0218] 2D-2F show another exemplary embodiment of a microfluidic device 250 including a microfluidic circuit 262 and a flow channel 264 that are variations of the respective microfluidic devices 100, circuits 132, and channels 134 of FIG. 1A. The microfluidic device 250 also has a number of isolation pens 266 that are additional variations of the isolation pens 124, 126, 128, 130, 224, 226, or 228 described above. In particular, it should be understood that the isolation pen 266 of the device 250 shown in FIGS. 2D-2F can be replaced by any of the isolation pens 124, 126, 128, 130, 224, 226, or 228 described above in the devices 100, 200, 230, 280, 290. Similarly, microfluidic device 250 is another variation of microfluidic device 100 and may have the same or different DEP configurations as microfluidic devices 100, 200, 230, 280, 290 described above, as well as any other microfluidic system components described herein.
[0219] The microfluidic device 250 of Figures 2D-2F includes a support structure (not visible in Figures 2D-2F, but which may be the same as or generally similar to the support structure 104 of the device 100 shown in Figure 1A), a microfluidic circuit structure 256, and a cover (not visible in Figures 2F-2F, but which may be the same as or generally similar to the cover 122 of the device 100 shown in Figure 1A). The microfluidic circuit structure 256 includes a frame 252 and a microfluidic circuit material 260, which may be the same as or generally similar to the frame 114 and the microfluidic circuit material 116 of the device 100 shown in Figure 1A. As shown in Figure 2D, the microfluidic circuit 262 defined by the microfluidic circuit material 260 can include a plurality of channels 264 (two are shown, but there may be more channels) to which a plurality of isolation pens 266 are fluidly connected.
[0220] Each isolation pen 266 can include an isolation structure 272, an isolation region 270 within the isolation structure 272, and a connection region 268. From a proximal opening 274 of the microfluidic channel 264 to a distal opening 276 at the isolation structure 272, the connection region 268 fluidly connects the microfluidic channel 264 to the isolation region 270. In general, in accordance with the above discussion of Figures 2B and 2C, a flow 278 of the first fluid medium 254 within the channel 264 can result in a secondary flow 282 of the first medium 254 from the microfluidic channel 264 into and / or out of each connection region 268 of the isolation pen 266.
[0221] 2E, the connection region 268 of each isolation pen 266 generally includes an area extending between a proximal opening 274 of the channel 264 and a distal opening 276 of the isolation structure 272. The length L of the connection region 268 con is the maximum penetration depth D of the secondary flow 282 p , in which case the secondary flow 282 extends into the connection region 268 rather than being redirected towards the separation region 270 (as shown in FIG. 2D). Alternatively, as shown in FIG. 2F, the connection region 268 may have a maximum penetration depth D p Length L smaller than con In this latter situation, the length L of the connection region 268 may be longer than the length L of the connection region 268, in which case the secondary flow 282 extends through the connection region 268 and is redirected towards the separation region 270. c1 and L c2 The sum of these is the maximum penetration depth D p The length L of the connection region 268 is greater than 1 mm, and therefore the secondary flow 282 does not extend into the separation region 270. con is the penetration depth D p or the length L of the connection region 268 c1 and L c2 The sum of these is the penetration depth D p Regardless of whether the maximum speed V max The flow 278 of the first medium 254 in the channel 264 does not exceed a penetration depth D p2C ) and the micro-objects (not shown, but which may be the same as or generally similar to the micro-objects 246 shown in FIG. 2C ) in the separation region 270 of the isolation pen 266 are not drawn out of the separation region 270 by the flow 278 of the first medium 254 in the channel 264. The flow 278 in the channel 264 also does not draw various materials (not shown) from the channel 264 into the separation region 270 of the isolation pen 266. Thus, the only mechanism by which components in the first medium 254 in the microfluidic channel 264 can move from the microfluidic channel 264 into the second medium 258 in the separation region 270 of the isolation pen 266 is diffusion. Similarly, the only mechanism by which components in the second medium 258 in the separation region 270 of the isolation pen 266 can move from the separation region 270 into the first medium 254 in the microfluidic channel 264 is diffusion. The first medium 254 can be the same medium as the second medium 258, or the first medium 254 can be a different medium than the second medium 258. Alternatively, the first medium 254 and the second medium 258 can start with the same medium and become different through adjusting the second medium, for example, by one or more cells in the separation region 270 or by changing the medium flowing through the microfluidic channel 264.
[0222] As shown in FIG. 2E, the width W of the microfluidic channel 264 ch (i.e., taken transverse to the direction of fluid medium flow through the microfluidic channel, indicated by arrow 278 in FIG. 2D ) is the width W con1 2, and thus the width W of the tip opening 276 con2 However, the width of the proximal opening 274 may be approximately parallel to the con1 and the width W of the tip opening 276 con2 For example, the width W of the proximal opening 274 is not necessarily perpendicular to the width W of the proximal opening 274. con1 is oriented along an axis (not shown) and the width W of the distal opening 276 con2The angle between one axis and another axis about which it is oriented can be other than orthogonal and therefore other than 90°. Examples of alternatively oriented angles include the following angles: from about 30° to about 90°, from about 45° to about 90°, from about 60° to about 90°, etc.
[0223] In various embodiments of the isolation pen (e.g., 124, 126, 128, 130, 224, 226, 228, or 266), the separation region (e.g., 240 or 270) is configured to contain a plurality of minute objects. In other embodiments, the separation region may be configured to contain only one, two, three, four, five, or a similar relatively small number of minute objects. Thus, the volume of the separation region may be, for example, at least 1×10 6 cubic μm, at least 2×10 6 cubic μm, at least 4×10 6 cubic μm, at least 6×10 6 It may be of the order of cubic micrometers or larger.
[0224] In various embodiments of the isolation pen, the width W of the microfluidic channel (e.g., 122) at the proximal opening (e.g., 234) is ch is about 50 to 1000 μm, about 50 to 500 μm, about 50 to 400 μm, about 50 to 300 μm, about 50 to 250 μm, about 50 to 200 μm, about 50 to 150 μm, about 50 to 100 μm, about 70 to 500 μm, about 70 to 400 μm, about 70 to 300 μm, about 70 to 250 μm, about 70 to 200 μm, about 70-150 μm, about 90-400 μm, 90-300 μm, about 90-250 μm, about 90-200 μm, about 90-150 μm, about 100-300 μm, about 100-250 μm, about 100-200 μm, about 100-150 μm, or about 100-120 μm. In some other embodiments, the width W of the microfluidic channel (e.g., 122) at the proximal opening (e.g., 234) can be about 200 μm, about 70-150 μm, about 90-400 μm, about 90-300 μm, about 90-250 μm, about 100-200 μm, about 100-150 μm, or about 100-120 μm. ch The width W of the microfluidic channel 122 may be about 200 to 800 μm, about 200 to 700 μm, or about 200 to 600 μm. ch may be any width within any of the endpoints listed above.ch can be selected to be any of these widths in regions of the microfluidic channel other than the proximal opening of the isolation pen.
[0225] In some embodiments, the isolation pen has a height of about 30 to about 200 μm or about 50 to about 150 μm. 4 ~Approx. 3×10 6 square μm, approximately 2×10 4 ~Approx. 2×10 6 square μm, approximately 4×10 4 ~Approx. 1×10 6 square μm, approximately 2×10 4 ~Approx. 5×10 5 square μm, approximately 2×10 4 ~Approx. 1×10 5 μm squared, or approximately 2×10 5 ~Approx. 2×10 6 It has a cross-sectional area of 1 μm2.
[0226] In various embodiments of the isolation pen, the height H of the microfluidic channel (e.g., 122) at the proximal opening (e.g., 234) is ch can be any of the following heights: 20-100 μm, 20-90 μm, 20-80 μm, 20-70 μm, 20-60 μm, 20-50 μm, 30-100 μm, 30-90 μm, 30-80 μm, 30-70 μm, 30-60 μm, 30-50 μm, 40-100 μm, 40-90 μm, 40-80 μm, 40-70 μm, 40-60 μm, or 40-50 μm. The above are merely examples, and the height H of the microfluidic channel (e.g., 122) can be any of the following heights: 20-100 μm, 20-90 μm, 20-80 μm, 20-70 μm, 20-60 μm, 20-50 μm, 30-100 μm, 30-90 μm, 30-80 μm, 30-70 μm, 30-60 μm, 30-50 μm, 40-100 μm, 40-90 μm, 40-80 μm, 40-70 μm, 40-60 μm, or 40-50 μm. ch may be a height within any of the endpoints listed above. ch can be selected to be in any of these ranges in regions of the microfluidic channel other than the proximal opening of the isolation pen.
[0227] In various embodiments of the isolation pen, the cross-sectional area of the microfluidic channel (e.g., 122) at the proximal opening (e.g., 234) is about 500-50,000 μm 2 , 500-40,000 μm 2 , 500-30,000 μm 2 , 500-25,000 μm 2 , 500-20,000 μm 2 , 500-15,000 μm 2 , 500-10,000 μm 2 , 500-7,500 μm 2 , 500-5,000 μm 2 , 1,000-25,000 μm 2 , 1,000-20,000 μm 2 , 1,000-20,000 μm 2 , 1,000-30,000 μm 2 , 1,000-40,000 μm 2 , 1,000-50,000 μm 2 , 1,000-60,000 μm 2 , 1,000-70,000 μm 2 , 1,000-80,000 μm 2 , 1,000-90,000 μm 2 , 1,000-100,000 μm 2 , 1,000-120,000 μm 2 , 1,000-140,000 μm 2 , 1,000-160,000 μm 2 , 1,000-180,000 μm 2 , 1,000-200,000 μm 3 , ~15,000 square μm, 1,000~10,000 square μm, 1,000~7,500 square μm, 1,000~5,000 square μm, 2,000~20,000 square μm, 2,000~15,000 square μm, 2,000~10,000 square μm, 2,000 It can be ~7,500 sq. um, 2,000-6,000 sq. um, 3,000-20,000 sq. um, 3,000-15,000 sq. um, 3,000-10,000 sq. The above are merely examples, and the cross-sectional area of a microfluidic channel (eg, 122) at its proximal opening (eg, 234) may be within any of the endpoints listed above.
[0228] In various embodiments of the isolation pen, the length L of the connection region (e.g., 236) con The length L of the connection region (e.g., 236) may be about 1 to 600 μm, 5 to 550 μm, 10 to 500 μm, 15 to 400 μm, 20 to 300 μm, 20 to 500 μm, 40 to 400 μm, 60 to 300 μm, 80 to 200 μm, or about 100 to 150 μm. The above are merely examples, and the length L of the connection region (e.g., 236) may be about 1 to 600 μm, 5 to 550 μm, 10 to 500 μm, 15 to 400 μm, 20 to 300 μm, 20 to 500 μm, 40 to 400 μm, 60 to 300 μm, 80 to 200 μ con can be any length between any of the endpoints listed above.
[0229] In various embodiments of the isolation pen, the width W of the connection region (e.g., 236) at the proximal opening (e.g., 234) is conis approximately 20-500μm, 20-400μm, 20-300μm, 20-200μm, 20-150μm, 20-100μm, 20-80μm, 20-60μm, 30-400μm, 30-300μm, 30-200μm, 30-150μm, 30-100μm, 30-80μm, 30-60μm, 40-300μm, 40-200 The above are merely examples, and the width W of the connection region (e.g., 236) of the proximal opening (e.g., 234) may be 1 μm, 40-150 μm, 40-100 μm, 40-80 μm, 40-60 μm, 50-250 μm, 50-200 μm, 50-150 μm, 50-100 μm, 50-80 μm, 60-200 μm, 60-150 μm, 60-100 μm, 60-80 μm, 70-150 μm, 70-100 μm, or 80-100 μm. con can vary from the examples above (eg, any value within any of the endpoints listed above).
[0230] In various embodiments of the isolation pen, the width W of the connection region (e.g., 236) at the proximal opening (e.g., 234) is con can be at least as large as the maximum dimension of the micro-object (e.g., biological cell, which may be a T cell or a B cell) targeted by the isolation pen. The above is by way of example only, and the width W of the connection region (e.g., 236) at the proximal opening (e.g., 234) can be at least as large as the maximum dimension of the micro-object (e.g., biological cell, which may be a T cell or a B cell) targeted by the isolation pen. con is the above example (e.g., a width within any of the endpoints listed above) may differ from.
[0231] In various embodiments of the isolation pen, the width W of the proximal opening of the connection region pr may be at least as large as the maximum dimension of the micro-objects (e.g., biological micro-objects such as cells) for which the isolation pen is intended. For example, the width W pr may be about 50 μm, about 60 μm, about 100 μm, about 200 μm, about 300 μm, or about 50 to 300 μm, about 50 to 200 μm, about 50 to 100 μm, about 75 to 150 μm, about 75 to 100 μm, or about 200 to 300 μm.
[0232] In various embodiments of the isolation pen, the length L of the connection region (e.g., 236) con and the width W of the connection region (e.g., 236) at the proximal opening 234 con The ratio of the length L of the connection region 236 to the length L of the connection region 236 may be any of the following ratios or more: 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 6.0, 7.0, 8.0, 9.0, 10.0, or more. con and the width W of the connection region 236 at the proximal opening 234 con The ratio may be different from the above example.
[0233] In various embodiments of the microfluidic device 100, 200, 23, 250, 280, 290, V max is approximately 0.2 microliters / second, approximately 0.5 microliters / second, approximately 0.7 microliters / second, approximately 1.0 microliters / second, approximately 1.3 microliters / second, approximately 1.5 microliters / second, approximately 2.0 microliters / second, approximately 2.5 microliters / second, approximately 3.0 microliters / second, approximately 3.5 microliters / second, approximately 4.0 microliters / second, approximately 4.5 microliters / second, approximately 5.0 microliters / second, approximately 5.5 microliters / second. In one embodiment, the flow rate can be set to about 10.0 microliters / second, about 11.0 microliters / second, about 12.0 microliters / second, about 13.0 microliters / second, about 14.0 microliters / second, about 15.0 microliters / second, about 16.0 microliters / second, about 17.0 microliters / second, about 18.0 microliters / second, about 19.0 microliters / second, about 20.0 microliters / second, about 21.0 microliters / second, about 22.0 microliters / second, about 23.0 microliters / second, about 24.0 microliters / second, about 25.0 microliters / second, about 26.0 microliters / second, about 27.0 microliters / second, about 28.0 microliters / second, about 29.0 microliters / second, about 30.0 microliters / second, about 31.0 microliters / second, about 32.0 microliters / second, about 33.0 microliters / second, about 34.0 microliters / second, about 35.0 microliters / second, about 36.0 microliters / second, about 37.0 microliters / second, about 38.0 microliters / second, about 39.0 microliters / second, about 40.0 microliters / second, about 41.0 microliters / second, about 42.0 microliters / second, about 43.0 microliters / second, about 44.0 microliters / second, about 45.0 microliters / second, about 46.0 microliters / second, about 47.0 microliters / second, about 48.0 microliters / second, about 49.0 microliters / second, about 50.0 microliters / second, about 51.0 microliter
[0234] In various embodiments of a microfluidic device having an isolation pen, the volume of the isolation region (e.g., 240) of the isolation pen is, for example, at least 5×10 5 cubic μm, at least 8×10 5 cubic μm, at least 1×10 6 cubic μm, at least 2×10 6 cubic μm, at least 4×106 cubic μm, at least 6×10 6 cubic μm, at least 8×10 6 cubic μm, at least 1×10 7 cubic μm, at least 5×10 7 cubic μm, at least 1×10 8 cubic μm, at least 5×10 8 cubic μm, at least 8×10 8 In various embodiments of a microfluidic device having an isolation pen, the volume of the isolation pen can be about 5×10 5 cubic μm, approximately 6×10 5 cubic μm, approximately 8×10 5 cubic μm, approximately 1×10 6 cubic μm, approximately 2×10 6 cubic μm, approximately 4×10 6 cubic μm, approximately 8×10 6 cubic μm, approximately 1×10 7 cubic μm, approximately 3×10 7 cubic μm, approximately 5×10 7 cubic micrometer, or approximately 8 x 10 7 In some other embodiments, the volume of the separator pen can be from about 1 nanoliter to about 50 nanoliters, from 2 nanoliters to about 25 nanoliters, from 2 nanoliters to about 20 nanoliters, from about 2 nanoliters to about 15 nanoliters, or from about 2 nanoliters to about 10 nanoliters.
[0235] In various embodiments, the microfluidic device has isolation pens configured as in any embodiment described herein, where the microfluidic device has about 5 to about 10 isolation pens, about 10 to about 50 isolation pens, about 100 to about 500 isolation pens, about 200 to about 1000 isolation pens, about 500 to about 1500 isolation pens, about 1000 to about 2000 isolation pens, about 1000 to about 3500 isolation pens, about 3000 to about 7000 isolation pens, about 5000 to about 10,000 isolation pens, about 9000 to about 15,000 isolation pens, about 1000 to about 2000 isolation pens, about 1000 to about 3500 isolation pens, about 3000 to about 7000 isolation pens, about 5000 to about 10,000 isolation pens, about 10000 to about 2000 isolation pens, about 10 ...10000 to about 2000 isolation pens, about 10000 to about 2000 isolation pens, about 10000 to about 3500 isolation pens, about 3000 to about 7000 isolation pens, about 10000 to about 2000 isolation pens, about 10000 to about 2000 isolation pens, about 10000 to about 3500 isolation pens, The separator pens do not have to all be the same size and can include a variety of configurations (e.g., different widths, different features within the separator pen).
[0236] FIG. 2G illustrates a microfluidic device 280 according to one embodiment. The microfluidic device 280 illustrated in FIG. 2G is a stylized view of the microfluidic device 100. In practice, the microfluidic device 280 and its constituent circuit elements (e.g., the channels 122 and the isolation pen 128) have the dimensions discussed herein. The microfluidic circuit 120 illustrated in FIG. 2G has two ports 107, four separate channels 122, and four separate flow paths 106. The microfluidic device 280 further includes a number of isolation pens that communicate with each channel 122. In the microfluidic device illustrated in FIG. 2G, the isolation pens have a geometry similar to the pens illustrated in FIG. 2C, and thus have both connection and separation regions. Thus, the microfluidic circuit 120 has a swept region (e.g., the maximum penetration depth D of the channels 122 and the secondary flow 244). p The maximum penetration depth D of the connection region 236 in the p 236 that is not within the
[0237] 3A-3B show various embodiments of a system 150 that can be used to operate and monitor a microfluidic device (e.g., 100, 200, 230, 250, 280, 290) according to the present disclosure. As shown in FIG. 3A, the system 150 can include a structure ("nest") 300 configured to hold the microfluidic device 100 (not shown) or any other microfluidic device described herein. The nest 300 can include a socket 302 that can interface with a microfluidic device 320 (e.g., the optically actuated electrokinetic device 100) and provide an electrical connection from a power source 192 to the microfluidic device 320. The nest 300 can further include an integrated electrical signal generation subsystem 304. The electrical signal generation subsystem 304 can be configured to provide a bias voltage to the socket 302 such that a bias voltage is applied across a pair of electrodes in the microfluidic device 320 when the microfluidic device 320 is held by the socket 302. Thus, the electrical signal generation subsystem 304 may be part of the power source 192. The ability to apply a bias voltage to the microfluidic device 320 does not mean that the bias voltage is applied whenever the microfluidic device 320 is held by the socket 302. Rather, in most cases, the bias voltage is applied intermittently, for example, only as needed to facilitate the generation of electrokinetic forces, such as electrophoresis or electrowetting, within the microfluidic device 320.
[0238] 3A, the nest 300 can include a printed circuit board assembly (PCBA) 322. The electrical signal generation subsystem 304 can be mounted to and electrically integrated with the PCBA 322. The exemplary support also includes a socket 302 that is also mounted to the PCBA 322.
[0239] Typically, the electrical signal generation subsystem 304 includes a waveform generator (not shown). The electrical signal generation subsystem 304 may further include an oscilloscope (not shown) and / or a waveform amplifier circuit (not shown) configured to amplify the waveform received from the waveform generator. The oscilloscope, if present, may be configured to measure the waveform provided to the microfluidic device 320 held by the socket 302. In certain embodiments, the oscilloscope measures the waveform at a proximal position of the microfluidic device 320 (and at a distal position of the waveform generator), thereby ensuring greater accuracy in measuring the waveform actually applied to the device. Data obtained from the oscilloscope measurements may be provided, for example, as feedback to the waveform generator, which may then use such feedback to An example of a suitable combined waveform generator and oscilloscope is the Red Pitaya™.
[0240] In certain embodiments, the Nest 300 further includes a controller 308, such as a microprocessor, that is used to sense and / or control the electrical signal generation subsystem 304. Examples of suitable microprocessors include Arduino™ microprocessors, such as the Arduino Nano™. The controller 308 may include a processor. The controller 308 may be used to perform functions and analysis, or may communicate with an external master controller 154 (shown in FIG. 1A) to perform functions and analysis. In the embodiment shown in FIG. 3A, the controller 308 communicates with the master controller 154 through an interface 310 (e.g., a plug or connector).
[0241] In some embodiments, the Nest 300 can include an electrical signal generation subsystem 304 that includes a Red Pitaya™ waveform generator / oscilloscope unit ("Red Pitaya unit") and a waveform amplification circuit that amplifies the waveform generated by the Red Pitaya unit and passes the amplified voltage to the microfluidic device 100. In some embodiments, the Red Pitaya unit is configured to measure the amplified voltage at the microfluidic device 320 and then adjust its own output voltage as necessary so that the measured voltage at the microfluidic device 320 is at a desired value. In some embodiments, the waveform amplification circuit can have a +6.5V to -6.5V power supply generated by a pair of DC-DC converters mounted on the PCBA 322, resulting in the generation of up to 13 Vpp signals at the microfluidic device 100.
[0242] As shown in FIG. 3A, the support structure 300 (e.g., nest) can further include a thermal control subsystem 306. The thermal control subsystem 306 can be configured to regulate a temperature of the microfluidic device 320 held by the support structure 300. For example, the thermal control subsystem 306 can include a Peltier thermoelectric device (not shown) and a cooling unit (not shown). The Peltier thermoelectric device can have a first surface configured to interface with at least one surface of the microfluidic device 320. The cooling unit can be a cooling block (not shown), such as, for example, a liquid-cooled aluminum block. A second surface of the Peltier thermoelectric device (e.g., a surface opposite the first surface) can be configured to interface with a surface of such a cooling block. The cooling block can be connected to a fluid path 314 configured to circulate a cooling fluid through the cooling block. In the embodiment shown in FIG. 3A, the support structure 300 receives cooled fluid from an external reservoir (not shown), including an inlet 316 and an outlet 318, introduces the cooled fluid into a fluid line 314, passes the cooled fluid through a cooling block, and then returns the cooled fluid to the external reservoir. In some embodiments, the Peltier thermoelectric device, cooling unit, and / or fluid line 314 can be mounted to a case 312 of the support structure 300. In some embodiments, the thermal control subsystem 306 is configured to adjust the temperature of the Peltier thermoelectric device to achieve a target temperature of the microfluidic device 320. Adjustment of the temperature of the Peltier thermoelectric device can be achieved by a thermoelectric power source, such as, for example, a Pololu™ thermoelectric power source (Pololu Robotics and Electronics Corp.). The thermal control subsystem 306 includes an analyte control unit 316 for controlling the temperature of the Peltier thermoelectric device. A feedback circuit may be included, such as a temperature value provided by a logging circuit. Alternatively, the feedback circuit may be provided by a digital circuit.
[0243] In some embodiments, the Nest 300 can include a thermal control subsystem 306 having a feedback circuit that is an analog voltage divider (not shown) that includes a resistor (e.g., 1 k ohm + / - 0.1% resistance, temperature coefficient + / - 0.02 ppm / C0) and an NTC thermistor (e.g., having a nominal resistance of 1 k ohm + / - 0.01%). In some cases, the thermal control subsystem 306 measures the voltage from the feedback circuit and then uses the calculated temperature value as an input to an on-board PID control loop algorithm. PID Control The output from the loop algorithm can, for example, drive both the direction signal and the pulse width modulated signal pins on a Pololu™ motor drive device (not shown) to operate a thermoelectric power supply, thereby controlling a Peltier thermoelectric device.
[0244] The Nest 300 may include a serial port 350, and the serial port 324 may allow the microprocessor of the controller 308 to communicate with the external master controller 154 via an interface 310 (not shown). In addition, the microprocessor of the controller 308 may communicate with the electrical signal generation subsystem 304 and the thermal control subsystem 306 (e.g., via the Plink tool (not shown)). Thus, through a combination of the controller 308, the interface 310, and the serial port 324, the electrical signal generation subsystem 304 and the thermal control subsystem 306 can communicate with the external master controller 154. In this manner, the master controller 154 can assist the electrical signal generation subsystem 304 by, among other things, performing scaling calculations for output voltage adjustments. A graphical user interface (GUI) (not shown) provided via a display device 170 coupled to the external master controller 154 can be configured to plot temperature and waveform data obtained from the thermal control subsystem 306 and the electrical signal generation subsystem 304, respectively. Alternatively or additionally, the GUI can enable updates to the controller 308, the thermal control subsystem 306, and the electrical signal generation subsystem 304.
[0245] As mentioned above, the system 150 can include an imaging device 194. In some embodiments, the imaging device 194 includes a light modulation subsystem 330 (see FIG. 3B). The light modulation subsystem 330 can include a digital mirror device (DMD) or a micro-shutter array system (MSA), either of which can be configured to receive light from a light source 332 and send a subset of the received light to an optical train of the microscope 350. Alternatively, the light modulation subsystem 330 can include a device that generates its own light (thus eliminating the need for the light source 332), such as an organic light emitting diode display (OLED), a liquid crystal on silicon (LCOS) device, a ferroelectric liquid crystal on silicon device (FLCOS), or a transmissive liquid crystal display (LCD). The light modulation subsystem 330 can be, for example, a projector. Thus, the light modulation subsystem 330 can be capable of emitting both structured and unstructured light. In certain embodiments, the imaging module 164 and / or the driving module 162 of the system 150 can control the light modulation subsystem 330.
[0246] In certain embodiments, the imaging device 194 further includes a microscope 350. In such embodiments, the Nest 300 and the light modulation subsystem 330 may be individually configured to mount to the microscope 350. The microscope 350 may be configured to be, for example, a standard research-grade optical microscope or a fluorescent microscope. Thus, the Nest 300 may be configured to mount to a stage 344 of the microscope 350 and / or the light modulation subsystem 330 may be configured to mount to a port of the microscope 350. In other embodiments, the Nest 300 and the light modulation subsystem 330 described herein may be integral components of the microscope 350.
[0247] In certain embodiments, the microscope 350 may further include one or more detectors 348. In some embodiments, the detectors 348 are controlled by the imaging module 164. The detectors 348 may include an eyepiece, a charge-coupled device (CCD), a camera (e.g., a digital camera), or any combination thereof. When there are at least two detectors 348, one detector may be, for example, a high frame rate camera, while the other detector may be a high sensitivity camera. Additionally, the microscope 350 receives light reflected and / or emitted from the microfluidic device 320 and captures at least some of the reflected and / or emitted light. The microscope may include an optical train configured to image at least a portion of the sample onto one or more detectors 348. The optical train of the microscope may also include different tube lenses (not shown) at different detectors so that the final magnification at each detector may be different.
[0248] In certain embodiments, the imaging device 194 is configured to use at least two light sources. For example, a first light source 332 can be used to generate structured light (e.g., via a light modulation subsystem 330) and a second light source 334 can be used to provide unstructured light. The first light source 332 can generate structured light for optically actuated electrokinesis and / or fluorescence excitation and the second light source 334 can be used to provide bright field illumination. In these embodiments, the motive module 164 can be used to control the first light source 332 and the imaging device 194 can be configured to generate structured light for optically actuated electrokinesis and / or fluorescence excitation and the second light source 334 can be used to provide bright field illumination. The second light source 334 can be controlled using the imaging module 164. The optical train of the microscope 350 can be configured to (1) receive structured light from the light modulation subsystem 330 and focus the structured light onto at least a first region within a microfluidic device, such as an optically actuated electrokinetic device, when the device is held by the Nest 300, and (2) receive light reflected and / or emitted from the microfluidic device and focus at least a portion of such reflected and / or emitted light onto the detector 348. The optical train can be further configured to receive unstructured light from the second light source and focus the unstructured light onto at least a second region of the microfluidic device when the device is held by the Nest 300. In certain embodiments, the first and second regions of the microfluidic device can be overlapping regions. For example, the first region can be a subset of the second region. In other embodiments, the second light source 334 can additionally or alternatively include a laser, which can have any suitable wavelength of light. The diagram of the optical system shown in Figure 3B is only a schematic diagram, and the optical system may include additional filters, notch filters, lenses, etc. If second light source 334 includes one or more light sources for bright field and / or fluorescence excitation and laser illumination, the physical arrangement of the light sources may vary from that shown in Figure 3B, and the laser illumination may be introduced at any suitable physical location within the optical system. The schematic locations of light source 334 and light source 332 / light modulation subsystem 330 may also be swapped.
[0249] In FIG. 3B, a first light source 332 is shown providing light to a light modulation subsystem 330, which provides structured light to the optical train of a microscope 350 of system 355 (not shown). A second light source 334 is shown providing unstructured light to the optical train via a beam splitter 336. The structured light from the light modulation subsystem 330 and the unstructured light from the second light source 334, as shown in , travel together through the optical train from the beam splitter 336 to a second beam splitter (or dichroic filter 338, depending on the light provided by the light modulation subsystem 330), where the light reflects down through the objective lens 336 to the sample plane 342. The reflected and / or emitted light from the sample plane 342 then travels again through the objective lens 340, through the beam splitter and / or dichroic filter 338, and to the dichroic filter 346. Only a portion of the light that reaches the dichroic filter 346 is transmitted to reach a detector 348 .
[0250] In some embodiments, the second light source 334 emits blue light. With an appropriate dichroic filter 346, the blue light reflected from the sample plane 342 can be transmitted through the dichroic filter 346 and reach the detector 348. In contrast, the structured light coming from the light modulation subsystem 330 is reflected at the sample plane 342 but is not transmitted through the dichroic filter 346. In this example, the dichroic filter 346 filters out visible light having wavelengths longer than 495 nm. Such filtering of the light from the light modulation subsystem 330 is complete only if the light emitted from the light modulation subsystem does not contain any wavelengths shorter than 495 nm (as shown). In practice, the light modulation subsystem If the light coming from the stem 330 contains wavelengths shorter than 495 nm (e.g., blue wavelengths), some of the light from the light modulation subsystem is transmitted through the filter 346 to reach the detector 348. In such an embodiment, the filter 346 serves to change the balance between the amount of light reaching the detector 348 from the first light source 332 and the amount of light reaching the detector 348 from the second light source 334. This can be beneficial if the first light source 332 is much more powerful than the second light source 334. In other embodiments, the second light source 334 can emit red light and the dichroic filter 346 can filter out visible light other than red light (e.g., visible light having a wavelength shorter than 650 nm).
[0251] Coating solutions and coatings. Without intending to be limited by theory, maintenance of biological micro-objects (e.g., biological cells) within a microfluidic device (e.g., DEP-configured and / or EW-configured microfluidic device) may be facilitated when at least one or more interior surfaces of the microfluidic device are conditioned or coated to present a layer of organic and / or hydrophilic molecules that provide the primary interface between the microfluidic device and the biological micro-objects maintained therein (i.e., the biological micro-objects exhibit increased viability, greater growth, and / or greater mobility within the microfluidic device). In some embodiments, one or more of the interior surfaces of the microfluidic device (e.g., the interior surface of the electrode-activated substrate of a DEP-configured microfluidic device, the microfluidic cover, and / or the surface of the circuit material) may be treated or modified with a coating solution and / or coating agent to produce a desired layer of organic and / or hydrophilic molecules.
[0252] The coatings may be applied before or after the introduction of the biological micro-objects, or may be introduced simultaneously with the biological micro-objects. In some embodiments, the biological micro-objects may be carried in a fluid medium containing one or more coatings of a microfluidic device. In other embodiments, the interior surfaces of a microfluidic device (e.g., a DEP-configured microfluidic device) are treated or "primed" with a coating solution containing a coating prior to the introduction of the biological micro-objects into the microfluidic device.
[0253] In some embodiments, at least one surface of the microfluidic device includes a coating that provides a layer of organic and / or hydrophilic molecules suitable for the maintenance and / or growth of biological micro-objects (e.g., providing a conditioning surface as described below). In some embodiments, substantially all of the interior surfaces of the microfluidic device include the coating material. The coated interior surfaces may include surfaces of flow regions (e.g., channels), surfaces of chambers, surfaces of isolation pens, or combinations thereof. In some embodiments, each of the multiple isolation pens has at least one interior surface coated with the coating material. In other embodiments, each of the multiple flow regions or channels has at least one interior surface coated with the coating material. In some embodiments, at least one interior surface of each of the multiple isolation pens and each of the multiple channels is coated with the coating material.
[0254] Coatings / solutions. Any conventional coating agent / coating solution can be used, including, but not limited to, serum or serum factors, bovine serum albumin (BSA), polymers, detergents, enzymes, and any combination thereof.
[0255] Polymer-based coating material. At least one of the interior surfaces may include a coating material that includes a polymer. The polymer may be covalently or non-covalently bound (or non-specifically attached) to at least one of the surfaces. The polymer may have a wide variety of structural motifs, such as those found in block polymers (and copolymers), star polymers (star copolymers), and graft or comb polymers (graft copolymers), all of which may be suitable for the methods disclosed herein.
[0256] The polymer may include a polymer that includes an alkylene ether moiety. A wide range of alkylene ether-containing polymers may be suitable for use in the microfluidic devices described herein. One non-limiting, exemplary class of alkylene ether-containing polymers is the amphiphilic nonionic block copolymers that include blocks of polyethylene oxide (PEO) and polypropylene oxide (PPO) subunits in different ratios and at different locations within the polymer chain. Pluronic® polymers (BASF) are block copolymers of this type that are known in the art to be suitable for use in contact with living cells. The polymers have an average molecular mass M W and can range from about 2000 Da to about 20 KDa. In some embodiments, the PEO-PPO block copolymers can have a hydrophilic lipophilic balance (HLB) of greater than about 10 (e.g., 12-18). Specific Pluronic® polymers useful for providing coated surfaces include Pluronic® L44, L64, P85, and F127 (including F127NF). Another class of alkylene ether-containing polymers is polyethylene glycol (PEG M W <100,000 Da) or alternatively polyethylene oxide (PEO, M W In some embodiments, the PEG has an M of about 1000 Da, 5000 Da, 10,000 Da, or 20,000 Da. W may have:
[0257] In other embodiments, the coating material may include a polymer containing carboxylic acid moieties. The carboxylic acid subunits may be alkyl, alkenyl, or aromatic moiety-containing subunits. A non-limiting example is polylactic acid (PLA). In other embodiments, the coating material may include a polymer containing phosphate moieties either at the end of the polymer backbone or pendant from the polymer backbone. In yet other embodiments, the coating material may include a polymer containing sulfonic acid moieties. The sulfonic acid subunits may be alkyl, alkenyl, or aromatic moiety-containing subunits. A non-limiting example is polystyrene sulfonic acid (PSSA) or polyanethole sulfonic acid. In further embodiments, the coating material may include a polymer containing amine moieties. The polyamino polymer may include natural or synthetic polyamine polymers. Examples of natural polyamines include spermine, spermidine, and putrescine.
[0258] In other embodiments, the coating material may include a polymer that includes a saccharide moiety. In a non-limiting example, polysaccharides such as xanthan gum or dextran may be suitable for forming a material that can reduce or prevent cell impalement in a microfluidic device. For example, a dextran polymer having a size of about 3 kDa may be used to provide a coating material on a surface within a microfluidic device.
[0259] In other embodiments, the coating material may include a polymer that includes nucleotide moieties, i.e., nucleic acids, having ribonucleotide or deoxyribonucleotide moieties and capable of providing a polyelectrolyte surface. The nucleic acids may include only naturally occurring nucleotide moieties or may include non-naturally occurring nucleotide moieties, including nucleobase, ribose, phosphate moiety analogs, such as, but not limited to, 7-deazaadenine, pentose, methylphosphonate, or phosphorothioate moieties.
[0260] In yet other embodiments, the coating material may include a polymer that includes an amino acid moiety. The polymer that includes an amino acid moiety may include a natural amino acid-containing polymer or a non-natural amino acid-containing polymer, any of which may include a peptide, polypeptide, or protein. In one non-limiting example, as a coating agent, the protein may be bovine serum albumin (BSA) and / or serum (or a combination of multiple different sera) that includes albumin and / or one or more other similar proteins. The serum may be from any convenient source, including, but not limited to, fetal bovine serum, sheep serum, goat serum, horse serum, and the like. Depending on the particular embodiment, the protein may be from any convenient source, including, but not limited to, fetal bovine serum, sheep serum, goat serum, horse serum, and the like. In embodiments, the BSA in the coating solution is present at a concentration of about 1 mg / mL to about 100 mg / mL, including 5 mg / mL, 10 mg / mL, 20 mg / mL, 30 mg / mL, 40 mg / mL, 50 mg / mL, 60 mg / mL, 70 mg / mL, 80 mg / mL, 90 mg / mL, or any value greater than or between. In certain embodiments, the serum in the coating solution may be present at a concentration of about 20% (v / v) to about 50% v / v, including 25%, 30%, 35%, 40%, 45%, or any value greater than or between. In some embodiments, the BSA may be present as a coating agent in the coating solution at 5 mg / mL, while in other embodiments, the BSA may be present as a coating agent in the coating solution at 70 mg / mL. In certain embodiments, the serum is present as a coating agent in the coating solution at 30%. In some embodiments, extracellular matrix (ECM) proteins may be provided within the coating material to optimize cell attachment to foster cell growth. Cell matrix proteins that may be included in the coating material may include, but are not limited to, collagen, elastin, RGD-containing peptides (e.g., fibronectin), or laminin. In yet other embodiments, growth factors, cytokines, hormones, or other cell signaling species may be provided within the coating material of the microfluidic device.
[0261] In some embodiments, the coating material may include a polymer that includes two or more of an alkylene oxide moiety, a carboxylic acid moiety, a sulfonic acid moiety, a phosphate moiety, a saccharide moiety, a nucleotide moiety, or an amino acid moiety, hi other embodiments, the polymeric conditioned surface may include a mixture of two or more polymers each having an alkylene oxide moiety, a carboxylic acid moiety, a sulfonic acid moiety, a phosphate moiety, a saccharide moiety, a nucleotide moiety, and / or an amino acid moiety, which may be incorporated into the coating material independently or simultaneously.
[0262] Additionally, in embodiments in which a covalently modified surface is used with a coating agent, the anions, cations and / or zwitterions of the covalently modified surface may form ionic bonds with charged moieties of a non-covalent coating agent (e.g., a protein in solution) present in the fluid medium (e.g., a coating solution) in the enclosure.
[0263] Further details of suitable coating treatments and modifications can be found in U.S. Patent Application Publication No. 15 / 135,707, filed April 22, 2016, which is incorporated herein by reference in its entirety.
[0264] Additional system components that maintain cell viability within the isolation pen of the microfluidic device. To promote the growth and / or proliferation of cell populations, additional components of the system may provide environmental conditions that encourage the maintenance of functional cells. For example, such additional components may provide nutrients, cell growth signaling species, pH regulation, gas exchange, temperature control, and removal of waste products from the cells.
[0265] kit. In various embodiments, a kit for providing a microfluidic device having at least one covalently modified surface configured to support the growth, survival and / or transport of biological cells includes a microfluidic device including an enclosure including a base, a cover and microfluidic circuit material that defines a fluid circuit therein, wherein at least one inner surface of the base, cover and microfluidic circuit material has a first covalent surface modification including a first binding group, and a first portion that is a first surface contacting moiety or a first reactive moiety; at least one inner surface of the base, cover and microfluidic circuit material has a second covalent surface modification including a second binding group, and a second portion that is a second surface contacting moiety or a second reactive moiety, wherein the first binding group and the second binding group are different from one another, and / or the first portion is different from the second portion.
[0266] The first and second covalent surface modifications of the microfluidic device of the kit are represented by Formula XXX, Formula V, Formula VII, Formula XXXI, Formula VIII, and Formula IX, respectively. [ka] where LG is -W-Si(OZ)2O- or -OP(O)2O-; fm is a linker containing 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur and phosphorus atoms, and further containing 0 or 1 linking group CG; R x is a reactive moiety; W is O, S or N, Z is a bond to an adjacent silicon atom or a bond to the surface; n is an integer from 3 to 21, and L sm is a linker comprising 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur and phosphorus atoms, and further comprising 0, 1, 2, 3 or 4 linking groups CG; and [ka] is a surface. Kits may be provided that include any of the microfluidic devices described herein.
[0267] The kit comprises a compound of formula XII: RP-L-Surface contact part Formula XII The surface-modifying reagent may further include a surface-modifying reagent having the structure: wherein RP is a reactive pair moiety; L is a linker, and the surface-contacting moiety is a moiety that provides improved contact properties to biological micro-objects. L is a linker, and L comprises 1 to 200 non-hydrogen atoms selected from a bond or any combination of silicon, carbon, nitrogen, oxygen, sulfur, and phosphorus atoms, and comprises 0, 1, 2, or 3 linking groups CG. The surface-contacting moiety is as defined above. L and the surface-contacting moiety may have any combination in the surface-modifying reagent. Certain embodiments In the embodiment, the surface contacting moiety may comprise polyethylene glycol. In another embodiment, the surface contacting moiety may comprise dextran. The reactive pair moieties are configured to react with respective reactive moieties of the functionalized surface.
[0268] The kit comprises a compound of formula XXXIV: RP-L fm -R x2 Formula XXXIV wherein R P is a reactive moiety for reacting with a reactive moiety of Formula XXX, Formula V, or Formula VII; and L fm is a linker containing 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur and phosphorus atoms, and further containing 0 or 1 linking group CG. x2 is selected so as not to react with the reactive moieties of the functionalized surface.
[0269] The kit may further include other reagents to be used in producing a microfluidic device having at least one covalently modified surface of formula VIII. Suitable reaction media, buffers or reaction promoters may be provided in the kit. Auxiliary reagents and / or surface modification reagents and / or secondary functionalization reagents may be provided in separate containers.
[0270] Synthesis of compounds of formula IV. A method of synthesizing a compound having a structure of formula VI is provided, comprising reacting a compound of formula XIII with azide ion to produce a compound of formula VI as shown in formula 2, where h is 1 to 19, n is 3 to 21, and R is H or C1-C6 alkyl. In some embodiments, n is an integer from 7 to 21.
[0271] formula 2 [ka] The azide ion may be provided as sodium azide or any other suitable source of azide ion. The reaction may be carried out in any suitable solvent, such as acetonitrile or DMF. The reaction may be carried out at ambient temperature, which may range from about 15° C. to about 30° C. In certain embodiments, the ambient reaction temperature may range from about 20° C. to about 30° C. In certain embodiments, the reaction may be carried out at a temperature selected from 30° C., 40° C., 50° C., 60° C., or 70° C. The reaction may be carried out under an inert atmosphere.
[0272] In other embodiments, the compound of formula XIII: [ka] wherein h is an integer from 1 to 19, and R is independently selected from the group consisting of H and C1-C6 alkyl. Compounds of formula II can be useful starting materials for the synthesis of compounds having the structure of formula I. In some embodiments, h can be 5 to 19. In other embodiments, h can be 7 to 21, 8 to 21, 9 to 21, 10 to 21, 11 to 21, 12 to 21, 13 to 21, 14 to 21, 15 to 21, or 16 to 21. In other embodiments, h can be 7, 12, or 14. In some embodiments, h can be 10, 12, or 14. In some embodiments, h can be 12 or 14. In various embodiments, each of R can be Me or Et.
[0273] Synthesis of compounds of formula XIII. A method for synthesizing a compound having a structure of formula XIII is provided, comprising reacting an olefinic compound (compound 1) with a silane (compound 2) in the presence of a catalyst or initiator, thereby producing a compound having a structure of formula XIII (see formula 3).
[0274] formula 3 [ka]
[0275] In compounds 1 and 2 of formula 3 and formula XIII, h is an integer from 1 to 19, and each R is independently H or C1-C6 alkyl. In some embodiments, h is an integer from about 5 to 19. In some embodiments, R is C1-C6 alkyl.
[0276] In some embodiments, each R can be selected from methyl, ethyl, and propyl. In other embodiments, each R can be methyl. In various embodiments, h can be 7 to 19. In other embodiments, h can be 7, 12, or 14. In some embodiments, h can be 7.
[0277] In certain embodiments, the catalyst can be any suitable hydrosilylation catalyst. The catalyst can be a transition metal complex M(L) n where L is a ligand and M is a metal such as Fe(0), Co(I), Rh(I), Ni(0), Pd(0), Pt(II) or Pt(0). In certain embodiments, the metal of the hydrosilylation catalyst complex can be Co(I), Rh(I), Ni(0), Pt(II) or Pt(0). In still other embodiments, the metal can be Rh(I), Pt(II) or Pt(0). The ligand can be selected to produce an electron rich complex and can be any suitable ligand. Ligands include halogens (e.g., chlorine); olefins, nitriles, siloxanes (including simple tetraalkyldivinylsiloxanes or constrained SILOP ligands); aromatic moieties 2,2'-bis( diphenylphosphino)-sterically constrained biphenyl or binaphthyl ligands such as BINAP, BIPHEP, BINEPINE, or PHANEPHOS; 2,3-O-isopropylidene-2,3-dihydroxy-1,4-bis(diphenylphosphino)butyl (DIOP); (Some examples of suitable hydrosilylation catalysts include, but are not limited to, HPtCl 6·6H 2 O / iPrOH (Speier's catalyst); chloro(1,5-cyclooctadiene)Rh(1) dimer ([Rh(cod)Cl] 2 ; tris(triphenylphosphine)-rhodium(I) chloride; [PtCl2(NCR)2 (where R can be N(alkyl)2, especially methyl or N-piperidinyl, cyclic amines such as Ph, Ch2Ph); Karstedt's catalyst Pt2{[(CH2=CH2)SiMe2]O}3); and bis(imino)pyridine iron dinitrogen complex ( et PDI)Fe(N2)]2(mu2-azide).
[0278] In an embodiment, the catalyst can be a platinum(0) catalyst. The platinum(0) catalyst is Pt(0)-1,1,3,3-tetramethyl-1,3-divinyldisiloxane complex (compound 3): [ka] It could be.
[0279] In other embodiments, an initiator may be used which may be present in a range of about 0.5 equivalents to about 1.4 equivalents. In certain embodiments, the initiator may be a trialkylborane.
[0280] The reaction can be carried out in any solvent capable of dissolving the olefinic compound (compound 1 of formula 2), including but not limited to DMF, benzene, tetrahydrofuran, toluene, 1,3-bistrifluoromethylbenzene, among other fluorinated or partially fluorinated solvents. In some embodiments, toluene or dimethylformamide (DMF) can be used.
[0281] The reaction may be carried out under an inert atmosphere, which may be argon or nitrogen gas. Typically, the inert atmosphere will exclude water vapor.
[0282] Elevated temperatures can be used to facilitate the reaction, and the reaction may be carried out at temperatures ranging from about 60° C. to about 110° C. In certain embodiments, the reaction may be carried out at about 60° C., 65° C., 70° C., 75° C., 80° C., 85° C., 90° C., 95° C., 100° C., 105° C., or about 110° C. The reaction may be complete after about 6 hours, 10 hours, 14 hours, 18 hours, 24 hours, 30 hours, 48 hours, 60 hours, or any time therebetween.
[0283] In certain other embodiments, the compound of formula IV: [ka] A method for synthesizing a compound having the structure of formula XIV: [ka] may be provided, comprising reacting a compound having the structure of with an alcohol ROH, where h is an integer from 1 to 19; each X is Cl; ROH is methyl alcohol, ethyl alcohol, or propyl alcohol, thereby producing a compound of formula I, where h is an integer from 1 to 19 and R is a C1-C3 alkyl. In certain embodiments, the base may be pyridine. In certain embodiments, h is an integer from 5 to 19. In various embodiments, h may be 7, 12, or 14. In still other embodiments, R may be methyl.
[0284] Synthesis of compounds of formula L. A method for synthesizing a compound having a structure of formula L is provided, comprising reacting an olefinic compound (compound 1) with a silane (compound 2) in the presence of a catalyst or initiator, thereby producing a compound having a structure of formula L (see formula 1).
[0285] formula 4 [ka]
[0286] In compounds 101, 1032 of formula 4 and formula L, n can be an integer from 13 to 25; each Y can be independently halo, OH or OR, where halo is Br, Cl or F; and R is C1-C6 alkyl. In some embodiments, each Y is Cl. In other embodiments, each Y can be methoxy, ethoxy or propoxy. In various embodiments, n can be 13, 15, 17 or 19. In some embodiments, n can be 13 or 15.
[0287] In some embodiments, the compound of formula L can be a compound having the structure of formula LI and can be produced according to the method shown in formula 5. An olefinic compound (compound 1) can be reacted with a silane (compound 3) having three substituents OR, where R can be H or C1 to C6 alkyl. In some embodiments, each R can be selected from methyl, ethyl, and propyl. In other embodiments, each R can be methyl. In various embodiments, n can be 13, 15, 17, or 19. In some embodiments, n can be 13 or 15.
[0288] formula 5 [ka]
[0289] In other embodiments, the compound of formula L can be a compound having the structure of formula LII and can be produced according to the method shown in formula 6.
[0290] formula 6 [ka]
[0291] The olefinic compound, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,16-nonacosafluorohexadec-1-ene (compound 105) can be reacted with a trialkoxysilane (compound 104) in the presence of a catalyst or initiator to produce a molecule of formula LII. The catalyst can be any suitable hydrosilylation catalyst.
[0292] Synthesis of compounds of formula VI. Compounds of formula VI can be synthesized by a variety of routes, one of which can involve reacting a compound of formula IV with a metal acetylide. EXAMPLES
[0293] Working Example Systems and Microfluidic Devices: Manufactured by Berkeley Lights, Inc. Also manufactured by Berkeley Lights, Inc. The OptoSelect chip is a nanofluidic device controlled by an optical instrument configured to detect the presence of a phototransistor in the chip. The instrument included a mounting for the chip coupled to a temperature controller; pumps and fluid medium conditioning components; and an optical train including a camera and a structured light source suitable for activating a phototransistor in the chip. The OptoSelect™ chip is configured using OptoElectroPositioning (OEP™) technology, which provides an OET force that is activated by a phototransistor. Each chip contained a substrate with multiple NanoPen™ chambers (or separators). The isolation pens also contained multiple microfluidic channels fluidly connected to each other. Each isolation pen had a volume of approximately 1 × 10 6 It was cubic μm.
[0294] Priming solution: 0.1% Pluronic® F127 (Life Technologies® catalog no. Complete growth medium containing 100% glycerol (No. P6866).
[0295] Preparation for culture: The microfluidic device with the modified surface was loaded into the system and purged with 100% carbon dioxide at 15 psi for 5 minutes. Immediately after the carbon dioxide purge, the priming solution was perfused through the microfluidic device at 5 microliters / second for 8 minutes. Then, the culture medium was flowed through the microfluidic device at 5 microliters / second for 5 minutes.
[0296] Priming plan. 250 microliters of 100% carbon dioxide was flushed at a rate of 12 microliters / second. This was followed by 12 microliters of PBS containing 0.1% Pluronic® F27 (Life Technologies® Catalog No. P6866). The final priming step involved flushing 250 microliters of PBS at 12 microliters / second.
[0297] Perfusion plan. The perfusion method was one of two methods: Perfuse at 0.01 microliters / second for 1.2 hours; perfuse at 2 microliters / second for 64 seconds; repeat. 2. Perfuse at 0.02 microliters / second for 100 seconds; stop flow for 500 seconds; perfuse at 2 microliters / second for 64 seconds; repeat.
[0298] Example 1. Synthesis of (11-bromoundecyl)trimethoxysilane (Compound 4). 1.26 g (5.4 mmol) of 11-bromoundec-1-ene (Sigma Aldrich) is solubilized in 150 ml of dry toluene (Oakwood Products) in an argon-flushed reaction vessel equipped with a reflux condenser. Trimethoxysilane (1.77 g, 14.5 mmol, Sigma Aldrich catalog number 282626) is added via syringe through the septum. Add 1.5 g of hydrosilylation catalyst solution, (0.08 mmol) of hydrosilylation catalyst platinum(0)-1,3-divinyl-1,1,3,3-tetramethyldisiloxane complex (compound 3, 0.1 M in poly(dimethylsiloxane), Sigma Aldrich, catalog number 479527) via syringe to the reaction under argon purging. The reaction is then continued for 24 hours at a temperature of 80° C. under an argon atmosphere to produce (11-bromoundecyl)trimethoxysilane (compound 4). The reaction is cooled to room temperature under argon, filtered, the product is extracted into pentane, and the solvent is removed by rotary evaporation at reduced pressure. The product is purified by vacuum distillation.
[0299] Example 2. Synthesis of (11-azidoundecyl)trimethoxysilane (Compound 5). (13-11-azidoundecyltrimethoxysilane was synthesized from 11-bromoundecyltrimethoxysilane (Gelest) by replacing the bromide with sodium azide. In a typical reaction, 4.00 g of 11-bromoundecyltrimethoxysilane (Gelest catalog number SIB1908.0) was added to a solution containing 2.00 g of sodium azide (Sigma-Aldrich) in 60 mL of dry dimethylformamide (Acros). The solution was stirred at room temperature under nitrogen for 24 h. The solution was then filtered and the filtrate was extracted with dry pentane (Acros). The crude 11-azidoundecyltrimethoxysilane product was isolated by rotary evaporation. It was then concentrated and purified by two successive vacuum distillations and characterized using NMR and FTIR spectroscopy.
[0300] Example 3. Preparation of functionalized surfaces of silicon wafers. Silicon wafers (780 μm thick, 1 cm×1 cm) were treated in an oxygen plasma cleaner (Nordson Asymtek) for 5 min using a power of 100 W, a pressure of 240 mTorr, and an oxygen flow rate of 440 sccm. A separate foil box at the bottom of the vacuum reactor was Magnesium sulfate heptahydrate (0.5 g, Acros catalog no. The plasma treated silicon wafers were treated in a vacuum reactor with (11-azidoundecyl)trimethoxysilane (compound 5, 300 microliters) in the presence of (10034-99-8) in a foil boat at the bottom of the vacuum reactor. The chamber was then pumped to 750 mTorr using a vacuum pump and then sealed. The vacuum reactor was placed in an oven heated at 110° C. for 24-48 hours. This introduced a modified surface to the wafer, the functionalized surface being a cationically modified ... [ka] where Z is a bond to an adjacent silicon atom bonded to the surface or is a bond to the surface; [ka] is the surface. After cooling to room temperature and introducing argon into the vacuum chamber, the wafer was removed from the reactor. The wafer was rinsed with acetone, isopropanol and dried under a stream of nitrogen. The incorporation of the functionalized surface was confirmed by ellipsometry and contact angle goniometry.
[0301] Example 4. Modification of microfluidic circuit materials. One example of a microfluidic circuit material is photopatternable silicone, which was used to define fluidic circuits in a microfluidic device. Evidence of modification of this material was obtained. An ITO wafer with photopatterned silicone structures incorporated thereon was placed in an oxygen plasma cleaner (Nordson Asymtek) for 5 minutes using 100 W of power, 240 mTorr pressure, and 440 sccm oxygen flow rate. The plasma cleaned photopatterned ITO wafers were treated as described in Example 3 to introduce the modified surface of formula XV onto the photopatterned silicone. FTIR ATR (attenuated total reflectance) spectra were measured using a ThermoFisher Nicolet iS50 spectrometer with a liquid nitrogen cooled MCT detector. By pressing photopatterned silicone, the Harrick Vari-GATR accessory Spectra were collected by pressing the surface of a germanium crystal with the surface of Formula XV using a force of 200 N. When the modified photopatternable silicone material was pressed against the germanium crystal, the FTIR ATR of only the modified photopatterned silicone was obtained. 250 scans were collected at a resolution of 4 cm-1 and referenced against a background spectrum of a bare germanium crystal. The spectra were measured using an Omnic software equipped FTIR spectrometer. The images were visualized using software.
[0302] As shown in Figure 4, the peak at about 2098 cm-1 (410) is due to the azide asymmetric stretching. The peaks at 2924 cm-1 (414) and 2854 cm-1 (412) are due to the C-H stretching mode.
[0303] Notes: In the following examples of the incorporation of modified surfaces into microfluidic devices, contact angle and thickness measurements were performed on silicon wafers that had been modified in the same manner as the particular modified surfaces in the microfluidic devices.
[0304] Example 5. Fabrication of a microfluidic device with a modified inner surface of Formula XV. The OptoSelect device, with a first silicon electrode-activated substrate and a second ITO substrate on opposing walls and photopatterned silicone microfluidic circuit material separating the two substrates, was treated in an oxygen plasma cleaner (Nordson Asymtek) for 1 minute using 100 W of power, 240 mTorr pressure, and 440 sccm oxygen flow rate. Magnesium sulfate heptahydrate (0.5 g) was used as the water reactant source in a separate foil boat in the 3-Azidoundecyl 3-(2-methylphenyl)propanediol was added to a foil boat at the bottom of a vacuum reactor in the presence of Acros. The plasma-treated microfluidic device was treated in a vacuum reactor with 300 microliters of silyltrimethoxysilane (compound 5). The chamber was then pumped to 750 mTorr using a vacuum pump and then sealed. The vacuum reactor was placed in an oven heated to 110° C. for 24-48 hours. This introduced functionalized surfaces to all of the opposing inner surfaces of the microfluidic device, where the functionalized surfaces were functionalized with a compound represented by Formula XV: [ka] where Z is a bond to an adjacent silicon atom bonded to the surface or is a bond to the surface; [ka] is the surface. After cooling to room temperature and introducing argon into the vacuum chamber, the microfluidic device was removed from the reactor. The microfluidic device with the functionalized surface was then treated with alkynyl species to introduce the desired modified surface as described below in Examples 6 and 7.
[0305] Example 6. Introduction of polyethylene glycol (PEG) modified surfaces (Formula XVI) into microfluidic devices. Materials. Alkyne-modified PEG (j=MW approx. 5000 Da) (compound 6) was purchased from JenKem and used as received. [ka] Sodium ascorbate and copper sulfate pentahydrate were purchased from Sigma-Aldrich and used as received. (3[tris(3-hydroxypropyltriazolylmethyl)amine)THPTA rate accelerating ligand (Glen Research) was used as received.
[0306] The product microfluidic device from Example 5, having a surface of formula XV as described above, was reacted with the alkyne modified PEG (compound 5) by flowing at least 250 microliters of an aqueous solution containing 3.3 millimoles of alkyne modified PEG, 50 millimoles of copper sulfate, 55 millimoles of THPTA ligand, and 100 millimoles of sodium ascorbate through the microfluidic device having the 11-azidoundecylsiloxy surface modified ligand. The reaction was allowed to proceed at room temperature for at least 1 hour. Then, a compound of formula XVI: [ka] wherein Z is as defined above for formula VIII; [ka] is the surface) The microfluidic device with the PEG-modified surface of was rinsed by flowing at least 250 microliters of deionized water through the device. After completion of the cyclization reaction introducing the modified surface, the layer thickness increased from 1.4 nm (functionalized surface thickness) to 5 nm thick. In addition, the sessile water contact angle decreased from approximately 80° (functionalized surface of Formula XV) to 35° (surface of Formula XVI).
[0307] Example 7. Introduction of dextran-modified surfaces (Formula XVII) into microfluidic devices. The product microfluidic device from Example 5, having a surface of Formula XV as described above, was prepared by flowing at least 250 microliters of an aqueous solution containing 1.66 millimoles of DBCO-dextran through the microfluidic device having a surface modified azide ligand after deposition, to form a dibenzylcyclooctynyl (DBCO) modified dextran, weight average molecular weight 3000 Da (Compound 7, Nanocs): [ka] The reaction was allowed to proceed for at least 1 hour at room temperature. Then, the compound of formula XVII (one of two regioisomers is shown): [ka] wherein Z is as defined above for formula VIII; [ka] is the surface) The microfluidic device with the modified surface was rinsed by flowing at least 250 microliters of deionized water through the chip.
[0308] Example 8. Alternative introduction of polyethylene glycol (PEG) modified surfaces (Formula XVIII) into microfluidic devices. The product microfluidic device from Example 5, having a surface of formula XV as described above, was treated with dibenzylcyclooctynyl (DBCO) modified PEG, weight average molecular weight 5000 Da (compound 8, Broadpharm, catalog number BP-22461) by flowing at least 250 microliters of an aqueous solution containing 1.33 millimoles of DBCO-PEG through the microfluidic device having the surface modified azide ligand after deposition. The reaction was allowed to proceed at 40° C. for at least 1 hour. The microfluidic device having the modified surface of formula XVIII was then rinsed by flowing at least 250 microliters of deionized water through the chip. One of two positional isomers is shown. [ka]
[0309] Example 9. Introduction of poly-L-glutamic acid (PGA) modified surfaces (Formula XIX) into microfluidic devices. The microfluidic device, the product from Example 5, having a surface of Formula XV as described above, was prepared by flowing at least 250 microliters of a buffered saline solution (5.4×PBS pH 7.4) containing 1.33 millimolar alkyne-modified PGA, 500 micromolar copper sulfate, 550 micromolar THPTA ligand, and 5 millimolar sodium ascorbate through the microfluidic device having the 11-azidoundecylsiloxy surface-modified ligand. 15,000 Da) (Compound 8, Alamanda™ Polymer, Catalog No. AK-PLE100): [ka] The reaction was allowed to proceed for at least 1 hour at room temperature or for at least 15 minutes at 40°C. The microfluidic device with the PGA modified surface of formula XIV was then rinsed by flowing at least 250 microliters of deionized water through the device. After completion of the cyclization reaction introducing the modified surface, the layer thickness increased from 1.1 nm (functionalized surface thickness) to 5.2 nm thick. Furthermore, the droplet water contact angle decreased from approximately 80° (functionalized surface of formula X) to 17° (surface of formula XIX). [ka]
[0310] Example 10. Introduction of covalently modified surfaces of biotin-functionalized PEG surfaces (Formula XX) into microfluidic devices. The microfluidic device, the product from Example 5, having a surface of Formula XV as described above, was prepared by flowing at least 250 microliters of an aqueous solution containing 31.33 millimoles of Compound 9, 500 micromoles of copper sulfate, 550 micromoles of THPTA ligand, and 5 millimoles of sodium ascorbate through the microfluidic device having 11-azidoundecylsiloxy surface modified ligand (Formula XV). The microfluidic device was then modified with a biotin functionalized alkynyl PEG (PEG is 1 kDA, Compound 9, Nanocs, Cat. No. PG2-AKBN-1k) as described above. [ka] The reaction was allowed to proceed at room temperature for at least 1 hour. [ka] The microfluidic device with the biotinylated PEG-modified surface was rinsed by flowing at least 250 microliters of deionized water through the device. After completion of the cyclization reaction introducing the modified surface, the layer thickness increased from 1.4 nm (functionalized surface thickness) to 5 nm thick. Furthermore, the droplet water contact angle decreased from approximately 80° (functionalized surface of formula XV) to 39° (surface of formula XX).
[0311] Example 11. Introduction of covalently modified surfaces of photocleavable biotin-functionalized PEG surfaces (Formula XXI) into microfluidic devices. The product microfluidic device from Example 5, having a surface of formula XV as described above, was reacted with biotin-functionalized photocleavable alkyne PEG3 (compound 10, Broadpharm, catalog number BP-22677, containing a photocleavable nitro-substituted phenyl group as part of the linker L) while flowing at least 250 microliters of an aqueous solution containing 1.33 millimoles of compound 10, 500 micromoles of copper sulfate, 550 micromoles of THPTA ligand, and 5 millimoles of sodium ascorbate through the microfluidic device having 11-azidoundecylsiloxy surface-modified ligand. The reaction was allowed to proceed at room temperature for at least 1 hour. Then, a compound of formula XX1: [ka] The microfluidic device with the biotinylated PEG-modified surface was rinsed by flowing at least 250 microliters of deionized water through the device. After completion of the cyclization reaction introducing the modified surface, the layer thickness increased from 1.4 nm (functionalized surface thickness) to about 5 nm thick. Furthermore, the droplet water contact angle decreased from about 80° (functionalized surface of Formula XV) to 42° (surface of Formula XXI).
[0312] Example 12. Introduction of a propiolic acid modified surface (Formula XXII) into a microfluidic device. The microfluidic device, the product from Example 5, having a surface of Formula XV as described above, was modified with propiolic acid (HC≡CCOH, Sigma Aldrich, Cat. No. P) by flowing at least 250 microliters of a buffered saline solution (5.4×PBS pH 7.4) containing 1.33 millimolar propiolic acid, 500 micromolar copper sulfate, 550 micromolar THPTA ligand, and 5 millimolar sodium ascorbate through the microfluidic device having the 11-azidoundecylsiloxy surface modified ligand. The reaction was allowed to proceed for at least 1 hour at room temperature or for at least 2 hours at room temperature. Both were allowed to proceed for 15 minutes at 40°C. The microfluidic device with the carboxylic acid modified surface of formula XXII was then rinsed by flowing at least 250 microliters of deionized water through the device. After completion of the cyclization reaction introducing the modified surface, the layer thickness increased from 1.1 nm (functionalized surface thickness) to 2 nm thick. Furthermore, the sessile water contact angle decreased from approximately 80° (functionalized surface of formula XV) to 64° (surface of formula XXII). [ka]
[0313] Example 13. Introduction of amine-modified surfaces (Formula XXIII) into microfluidic devices. The product microfluidic device from Example 5, having a surface of Formula XV as described above, was modified with propargylamine (HC≡CCHNH, Sigma Aldrich) by flowing at least 250 microliters of buffered saline solution (5.4×PBS pH 7.4) containing 1.33 millimolar propargylamine, 500 micromolar copper sulfate, 550 micromolar THPTA ligand, and 5 millimolar sodium ascorbate through the microfluidic device having the 11-azidoundecylsiloxy surface modified ligand. The microfluidic device having an amine-modified surface of Formula XXIII was then reacted with 250 microliters of deionized water (catalog number P50900-5G). The reaction was allowed to proceed for at least 1 hour at room temperature or for at least 15 minutes at 40° C. The microfluidic device having an amine-modified surface of Formula XXIII was then rinsed by flowing at least 250 microliters of deionized water through the device. [ka]
[0314] Example 14. Introduction of PEG carboxylic acid modified surfaces (Formula XXIV) into microfluidic devices. The product microfluidic device from Example 5, having a surface of formula XV as described above, was reacted with alkyne PEG acid (PEG (f=5000 Da, compound 11) Nanocs, catalog number PG2-AKCA-5k) by flowing at least 250 microliters of buffered saline solution (5.4×PBS pH 7.4) containing 1.33 millimoles of compound 11, 500 micromoles of copper sulfate, 550 micromoles of THPTA ligand, and 5 millimoles of sodium ascorbate through the microfluidic device having the 11-azidoundecylsiloxy surface-modified ligand. The reaction was allowed to proceed at room temperature for at least 1 hour or at 40° C. for at least 15 minutes. The microfluidic device having a carboxylic acid-modified surface of formula XXIV was then rinsed by flowing at least 250 microliters of deionized water through the device. After completion of the cyclization reaction introducing the modified surface, the layer thickness increased from 1.1 nm (functionalized surface thickness) to 5 nm thick. Furthermore, the sessile water contact angle decreased from approximately 80° (formula XV functionalized surface) to 48° (formula XXIV surface). [ka]
[0315] Example 15. Introduction of polylysine modified surfaces (Formula XXV) into microfluidic devices. The microfluidic device, which is the product from Example 5, having a surface of formula XV as described above, was reacted with poly(lysine hydrobromide) graft-(4 pentyne amide, compound 12, PLKB100-g-AK20 Alamanda polymer, catalog number PLKB100-g-AK20, 100 lysine repeat units, 20% alkynylated, MW 21,000 Da) by flowing at least 250 microliters of buffered saline solution (5.4xPBS pH 7.4) containing 1.33 millimoles of compound 12, 500 micromoles of copper sulfate, 550 micromoles of THPTA ligand and 5 millimoles of sodium ascorbate through the microfluidic device having 11-azidoundecylsiloxy surface-modifying ligand. The reaction was allowed to proceed at room temperature for at least 1 hour or at 40°C for at least 15 minutes. The microfluidic device with the amine-modified surface of Formula XXV was then rinsed by flowing at least 250 microliters of deionized water through the device. After completion of the cyclization reaction introducing the modified surface, the layer thickness increased from 1.1 nm (functionalized surface thickness) to about 3 nm thick. In addition, the sessile water contact angle decreased from about 80° (functionalized surface of Formula XV) to 50° (surface of Formula XXV). [ka]
[0316] Example 16. Introduction of polyglutamic acid modified surfaces (Formula XXVI) into microfluidic devices. The product microfluidic device from Example 5, having a surface of formula XV as described above, was reacted with poly(glutamic acid) graft-(N-propargyl), compound 13, Alamanda polymer, catalog number PLE100-g-AK20, 20% alkynylated, 100 glutamic acid repeats, MW 15,000 Da) by flowing at least 250 microliters of buffered saline solution (5.4xPBS pH 7.4) containing 1.33 millimoles of compound 13, 500 micromoles of copper sulfate, 550 micromoles of THPTA ligand, and 5 millimoles of sodium ascorbate through the microfluidic device having 11-azidoundecylsiloxy surface-modified ligand. The reaction was allowed to proceed at room temperature for at least 1 hour or at 40°C for at least 15 minutes. The microfluidic device having a carboxylic acid-modified surface of formula XXVI was then rinsed by flowing at least 250 microliters of deionized water through the device. After completion of the cyclization reaction introducing the modified surface, the layer thickness varies from 1.1 nm (functionalized surface thickness) to about 3 nm. nm thick. Furthermore, the sessile water contact angle decreased from about 80° (for the functionalized surface of Formula XV) to 54° (for the surface of Formula XXVI). [ka]
[0317] Example 17. Introduction of biotinylated polyethylene glycol (PEG) modified surfaces with disulfide cleavable linkers (Formula XXVII) into microfluidic devices. The product microfluidic device from Example 5, having a surface of formula XV as described above, was treated with dibenzylcyclooctynyl (DBCO) SS biotin-modified PEG3, compound 14, Broadpharm, catalog number BP-22453) by flowing at least 250 microliters of an aqueous solution containing 1.33 micromoles of compound 14 through the microfluidic device having the surface-modified azide ligand after deposition. The reaction was allowed to proceed at 40°C for at least 1 hour. The microfluidic device having the modified surface of formula XXVII was then rinsed by flowing at least 250 microliters of deionized water through the chip. One of two positional isomers is shown. [ka] After completion of the cyclization reaction introducing the modified surface, the layer thickness increased from 1.1 nm (functionalized surface thickness) to about 2 nm thick. Furthermore, the sessile water contact angle decreased from about 80° (functionalized surface of formula XV) to 66° (surface of formula XXVII).
[0318] Example 18. Introduction of PEG5 carboxylic acid modified surfaces (Formula XXVIII) into microfluidic devices. The product microfluidic device from Example 5, having a surface of formula XV as described above, was treated with dibenzylcyclooctynyl (DBCO)-PEG5-acid, compound 15, Broadpharm, catalog number BP-22449) by flowing at least 250 microliters of an aqueous solution containing 1.33 micromoles of compound 15 through the microfluidic device having the surface modified azide ligand after deposition. The reaction was allowed to proceed at 40°C for at least 1 hour. The microfluidic device having the modified surface of formula XXVII was then rinsed by flowing at least 250 microliters of deionized water through the chip. The contact angle was measured at 47° and the thickness was 17.8 angstroms, each of which was measured as described herein. One of the two positional isomers is shown. [ka]
[0319] Example 19. Introduction of PEG3-modified surfaces (Formula XXIX) into microfluidic devices. A microfluidic device (Berkeley Lights, Inc.) with a first silicon electrode-activated substrate and a second ITO substrate on opposing walls and photopatterned silicone microfluidic circuit material separating the two substrates was operated at 100 W of power, 240 mTorr pressure, and 440 sccm The plasma was then placed in an oxygen plasma cleaner (Nordson Asymtek) for 1 min using an oxygen flow rate of The reaction was carried out in a separate foil boat at the bottom of the vacuum reactor in the presence of magnesium sulfate heptahydrate (0.5 g, Acros) as a source of water reactant. The plasma treated microfluidic device was treated in a vacuum reactor with methoxytriethyleneoxypropyltrimethoxysilane (compound 16, Gelest catalog number SIM6493.4, 300 microliters) in a 250 mL 200 mL 100 mL 15 ... [ka] where Z is a bond to an adjacent silicon atom bonded to the surface or is a bond to the surface; [ka] is the surface. After cooling to room temperature and introducing argon into the vacuum chamber, the microfluidic device was removed from the reactor. The contact angle for this surface was measured to be 55° and the average thickness was measured to be 10.2 Angstroms.
[0320] Example 20. Preparation of a phosphonate-binding surface (Formula XXXVI). Silicon chips (780 μm thick, 1 cm×1 cm) were pretreated as described above for Example 3 and subsequently treated with octadecylphosphonic acid (compound 17, Sigma Aldrich catalog number 715166) as in Example 19 to produce tetrahydrofuran-2-(2-methyl-2-propanediol) of formula XXXVI, where Z is the 2-amino acid residue of adjacent The bond is to the phosphorus atom in the bonding group LG or to the surface [ka] A covalently modified surface of 1,2-dichlorophenyl ether (COOH) was obtained. The contact angle was measured to be 110°. [ka]
[0321] Example 21. Introduction of a streptavidin-modified surface (Formula XXXVII or Formula XXXVIII) into a microfluidic device. Method A. The product microfluidic device from Example 5, having a surface of formula XV as described above, was treated with dibenzylcyclooctynyl (DBCO) streptavidin (SAV) compound 18, Nanocs, catalog number SV1-DB-1, where there are 2-7 DBCO for each molecule of SAV) by flowing at least 250 microliters of an aqueous solution containing 2 micromoles of compound 18 through the microfluidic device having the surface modified azide ligand after deposition. The reaction was allowed to proceed at room temperature for at least 1 hour. The microfluidic device having the modified surface of formula XXVII was then rinsed by flowing at least 250 microliters of 1×PBS through the device. [ka]
[0322] Method B. The modified surface, the product of the microfluidic device of Example 17, having a surface of Formula XXVII, was washed with water and dried by repeated flushes of gaseous carbon dioxide while heating the chip to 40° C. A solution of 2 micromolar SAV in 1×PBS (ThermoFisher Cat. No. 434301) was flowed into the microfluidic device and allowed to contact the biotinylated surface for 30 minutes. Excess SAV was removed by flowing 1×PBS through the microfluidic device to yield a surface of Formula XXXVIII: [ka] The surface was obtained.
[0323] Example 22. Introduction of a fibronectin surface (Formula XXXIX) in a microfluidic device. Method A. A microfluidic device having a modified surface of Formula XXXVIII, the product of Example 21, Method B, was incubated with 46 nM biotinylated bovine fibronectin (randomly biotinylated, Cytoskeleton Inc., Cat. No. FNR03A, FNR03) in 1×PBS. -B) and incubated at 37°C for 1 hour to produce a compound of formula XXXXIX: [ka] A fibronectin surface of 100 nm was obtained.
[0324] Modification in the presence of living cells. In one embodiment, biological cells are introduced into a microfluidic device having a surface of formula XXXVIII, and streptavidin is presented in the fluid region of the microfluidic device. After the cells are captured in the isolation pen, biotinylated fibronectin is introduced in PBS and incubated for 1 hour. Adhesion is observed.
[0325] Method B. A fibronectin surface is introduced by treating a microfluidic device having a surface of Formula XXXVII above with biotinylated fibronectin.
[0326] Method C. Biotinylated-fibronectin stock was prepared at 2.3 micromolar in PBS and streptavidin stock was prepared at 19.2 micromolar in PBS. The two were mixed at a 1:1 to 1:2 fibronectin to streptavidin ratio and diluted to a final concentration of at least 300 nanomolar in 1×PBS. The solution was incubated at room temperature for 15 minutes to allow binding of fibronectin and streptavidin to form a surface modification reagent with a biotin / streptavidin binding group, CG.
[0327] The modified surface, the product of the microfluidic device of Example 17, having a surface of Formula XXVII, was washed with water and dried by repeated flushes of gaseous carbon dioxide while heating the chip to 40° C. Preparative analysis of SAV bound to biotinylated fibronectin as described above. The surface modification reagent formed was then poured into the microfluidic device. The device was incubated at room temperature for at least 30 minutes to yield a modified surface of Formula XXXIX.
[0328] Further generalization. Furthermore, by flowing biotinylated proteins, peptides, small molecules or recognition motifs through the same process, any number of biologically relevant molecules can be introduced to the modified surface of the microfluidic device by binding to either the surface of Formula XXXVII or Formula XXXVIII. For example, biotinylated laminin can be flowed into a microfluidic device prepared as above having a surface of Formula XXXVII or XXXVIII to produce a modified surface with laminin surface contacting moieties (Formula XL): [ka] Generate.
[0329] Example 23. Introduction of the mixed surface of formula XLI in various ratios. The silicon wafer was plasma-treated in an oxygen plasma cleaner (Nordson Asymtek) for 1 min using 100 W power, 240 mTorr pressure, and 440 sccm oxygen flow rate. In a separate foil boat at the bottom of the vacuum reactor, magnesium sulfate heptahydrate (0.5 g, Acros) was added as a reactant source in a foil boat at the bottom of the vacuum reactor. In the present study, 3-azidoundecyl)trimethoxysilane (prepared as described above, compound 5) and methoxytriethyleneoxypropyltrimethoxysilane (Gelest Inc. Catalog No. 1) were used. The plasma-treated microfluidic devices were treated in a vacuum reactor with a mixture of 1,2-dichlorophenyl ether (log number SIM6493.4, with a molecular weight similar to that of compound 5) in various ratios. The chamber was then pumped to 750 mTorr using a vacuum pump and then sealed. The vacuum reactor was placed in an oven heated at 110 °C for 24-48 hours.
[0330] After cooling to room temperature and introducing argon into the vacuum chamber, the wafer was removed from the reactor. The wafer was rinsed with acetone, isopropanol, and dried under a stream of nitrogen. The mixture of formula XLI (where x and y are from 1 to 1×10 8 The modified surfaces of the azide (which may be present in any ratio of x:y or y:x) were evaluated for thickness, contact angle, and presence of azide in FTIR of the surface. Individual wafers were modified with mixtures of 1% undecyl azide:99% methoxy PEG3; 10% undecyl azide:90% methoxy PEG3; 50% undecyl azide:50% methoxy PEG3; and 100% undecyl azide. [ka]
[0331] As shown in Figure 5A, the overlaid FTIR traces clearly showed a decreasing amount of azide asymmetric stretch 510 at about 2098 cm-1. Figure 5B shows a magnified portion of the overlaid trace at the location of the azide asymmetric stretch for wafers having 10% Formula XV and 1% Formula XV, respectively. The relative amounts of azide were clearly distinguishable and correlated to the ratio of Formula XV:Formula XXIX used.
[0332] As shown in Table 2, when different ratios of the surface of Formula XV:Formula XXIX are present on the modified surface, the contact angle and thickness of the modified surface are also different, and the data indicates that the control of adhesion can be obtained by changing the ratio of materials during the chemical vapor deposition process. The change in contact angle also indicates that different performances were possible with different ratios of these surface modifications.
[0333] [Table 2]
[0334] Example 24. Introduction of modified surfaces (Formula XLII) having a mixture of a first surface modification containing PEG and a second surface modification of a block copolymer containing poly-L-lysine using a combination of surface modification reagents. A microfluidic device, the product from Example 5, having a surface of Formula XV as described above, was treated with a solution containing 1.3 mmolar Propargyl-PEG1-disulfide-PEG1-propargyl (compound 19, BroadPharm Inc. catalog number BP-23283) along with copper sulfate (in excess), THPTA ligand, and sodium ascorbate. The excess copper sulfate prevents disulfide cleavage by ascorbate during the reaction, which was carried out at 40° C. for about 15 minutes (and alternatively can be carried out at room temperature for about 1 hour). After the incubation period was completed, excess reagents and by-products were removed by flushing with water. The interior of the microfluidic device was dried by flushing with carbon dioxide gas while heating the microfluidic device to 40° C. to remove the alkynyl R x2A surface was obtained which was a secondary functionalized surface having moieties.
[0335] The microfluidic device was then treated with a mixture of two surface modification reagents to modify the alkynyl R x2 The microfluidic device was further modified with a secondary functionalized surface bearing moieties. The surface modification reagent was PEG-azide (5Kda, Aldrich Chemicals, Cat. No. 6 A mixture of 1.3 mM of 89475:Azide-PEG5k-block copolymer poly-l-lysine 100 (Alamanda polymer, MW 1600) was flowed into the microfluidic device, where the ratio of azide-PEG and azide-PEG5k-b-PLL was varied between 1:50000 and 50000:1 along with copper sulfate (excess), THPTA ligand and sodium ascorbate. The excess copper sulfate was added to the ascorbate in the reaction. To prevent disulfide cleavage by PEG, the reaction was carried out at 40°C for about 15 minutes (and alternatively at room temperature for about 1 hour). After the incubation period was completed, excess reagents and by-products were removed by flushing with water. The interior of the microfluidic device was dried by flushing with carbon dioxide gas while heating the microfluidic device to 40°C to provide the microfluidic device with a mixture of a first surface modification, PEG5K, which is hydrophilic, and a second surface modification, PEG5k-b-PLL, where the block of PLL provided a positive charge (Formula XLII). The ratio of azido-PEG and azido-PEG5k-b-PLL can be even higher, for example 10,000:1 or more, demonstrating that adhesion is observed even at a very low percentage of block copolymer poly-L-lysine surface contact moieties. [ka]
[0336] The modified surface of formula XLII is from 1 to 1×10 8 The x and y may be present in any ratio of x:y or y:x.
[0337] Alternative methods of modification. A microfluidic device having a surface of formula XV can be modified with DBCO-PEG4-alkyne (compound 20, Conju-Probes, Inc. catalog number CP-2039) instead of propargyl-PEG1-disulfide-PEG1-propargyl (compound 19) by flowing at least 250 microliters of an aqueous solution containing 1.0 millimolar DBCO-PEG through the microfluidic device having a surface of formula XV. The reaction was allowed to proceed at 40° C. for at least 1 hour. The microfluidic device having a modified surface of formula XVIII can then be rinsed by flowing at least 250 microliters of deionized water through the chip and processed as described in the previous paragraph to provide the microfluidic device with a mixture of a first surface modification, PEG5K, which is hydrophilic, and a second surface modification, PEG5k-b-PLL, where the block of PLL provides a positive charge (formula XLIII) and the linker portion of the surface modification is different from that of formula XLII. [ka]
[0338] The modified surface of formula XLIII is from 1 to 1×10 8 The x and y may be present in any ratio of x:y or y:x.
[0339] It is useful for culturing adherent cells. Either the surfaces of Formula XLII or XLIII were useful for providing anchoring points (e.g., clusters of positively charged poly-L-lysine provided within the block copolymer) for culturing adherent cells, such as, but not limited to, HeLa cells. HeLa cells were observed to flatten, grow and proliferate in culture on either of these surfaces (data not shown).
[0340] Example 25. Introduction of modified surfaces (Formula XLIV) having a mixture of a first surface modification containing PEG and a second surface modification of poly-L-lysine using a combination of surface modification reagents. The product microfluidic device from Example 5, having a surface of formula XV as described above, was prepared by polymerization of one of the following: alkyne-poly-L-lysine HBr salts (100-mer units, Alamanda polymer) and alkyne-modified PEG (j=MW approx. 5000 Da, compound 6, JenKem Technologies) with copper sulfate (excess), THPTA ligand and sodium ascorbate: The microfluidic device was treated with a 1.33 mmol solution containing a 1 stoichiometric mixture. The excess copper sulfate prevented disulfide cleavage by ascorbate during the reaction, which was carried out for about 15 minutes at 40° C. (and alternatively can be carried out at room temperature for about 1 hour). After the incubation period was completed, excess reagents and by-products were removed by flushing with water. The interior of the microfluidic device was dried by flushing with carbon dioxide gas while heating the microfluidic device to 40° C., providing the microfluidic device with a mixture of a first surface modification, PEG5K, which is hydrophilic, and a second surface modification, poly-L-lysine, which provides a positive charge (Formula XLIV). [ka]
[0341] On the surface of formula XLIV, ( * ) is a proprietary linker, and x and y are from 1 to 1×10 8 The x:y or y:x ratios may be any value.
[0342] Useful for culturing adherent cells. The surfaces of Formula XLIV were useful for providing anchoring points (e.g., clusters of positively charged poly-L-lysine provided within the block copolymer) for culturing adherent cells, such as, but not limited to, HeLa cells. HeLa cells were observed to flatten, grow, and proliferate in culture on both of these surfaces (data not shown).
[0343] Titration of Surface Modification 1:Surface Modification 2. The ratio of the first surface modification (PEG 5 kDa) and the second surface modification (poly-L-lysine) in Formula XLIV was modified to a ratio of 99 PEG 5 kDa:1 poly-L-lysine to adjust the number of points designed to promote adhesion. A 1% level of charged second surface modification (poly-L-lysine) was used to demonstrate laser bubble initiation of displacement followed by dielectrophoretic force of cells. removal was observed (data not shown).
[0344] Microfluidic devices having an inner surface modified with a first surface modification of PEG 5 kDa and a second surface modification of poly-L-lysine having a percentage of poly-L-lysine surface modification of about 0.00001% or 0.000001% are predicted to allow attachment of adherent cells (such as HeLa cells) without laser initiation of displacement while still allowing removal of cultured cells using dielectrophoretic forces.
[0345] Example 26. Introduction of mixed surfaces using a branched PEG linker (Formula XLV). A modified surface having a first cleavable biotinylation surface modification in combination with a second surface modification, which is a hydrophilic PEG, was introduced using a multi-branched PEG alkyne moiety. The amount of biotin reactive moiety present was controlled by adjusting the amount of biotin reactive moiety relative to the hydrophilic surface contacting moiety. Modification was performed by binding a moiety containing each of the surface contacting moieties to a branch of the multi-branched PEG alkyne while leaving enough alkyne reactive moieties on the multi-branched PEG to effect efficient modification of the surface of the microfluidic device. The following procedure is described for a 1:1 ratio of biotin moieties to PEG carboxylic acid moieties, but experiments were also performed with 100% biotin moieties; 10% biotin to 90% PEG carboxylic acid; and 1% biotin moieties to 99% PEG carboxylic acid moieties. [ka]
[0346] 1.3 mmol of 4-branched PEG (Creative PEGWorks Catalog No. PSB-495) A solution of 1.3 millimolar of 1:1 ratio of azido-disulfide-biotin (compound 20, BroadPharm catalog number BP-22877) and azido-PEG6-carboxylic acid (BroadPharm catalog number BP-20612) in aqueous solution was reacted with sodium ascorbate in the presence of 2-fold excess of copper sulfate to form di-modified hyperbranched PEG by incubation at room temperature for about 30 minutes. The solution of di-modified hyperbranched PEG was introduced onto a silicon wafer from Example 3, having a surface of formula XV, as described above, along with an additional aliquot of 2-fold excess of copper sulfate and sodium ascorbate. The remaining alkyne ligands of the hyperbranched PEG were reacted with the azide reactive moieties of the surface of formula XV to produce a mixed modified surface (formula XLV) having reactive moieties of biotin and surface contacting moieties of PEG-carboxylic acid.
[0347] This mixed surface was then further modified by the addition of a 1 micromolar solution of streptavidin (SAV) in PBS and incubated at room temperature for 15 minutes to produce a surface of formula XLVI, where the first surface contacting moiety is PEG-COOH and the second reactive moiety is SAV. The samples were washed and the thickness of the modified surface was measured.
[0348] The thickness of the modified layer is shown in Table 3 and varies predictably with different amounts of streptavidin bound to the available biotin surface contact moieties.
[0349] [Table 3]
[0350] The results show that a regulated surface was obtained with a combination of streptavidin reactive moieties and PEG COOH surface contacting moieties. Streptavidin can be further modified with biotinylated species such as biotin-fibronectin or any moiety that can be biotinylated to obtain a mixed surface of PEG COOH first contacting moieties (e.g., fibronectin) and second contacting moieties in any desired ratio.
[0351] Example 27. Introduction of site-selective surface modification of PEG5k (Formula XLVII) on poly-L-lysine in the first region and isolation pen of a microfluidic device. A previously prepared, dry, unprimed (e.g., not flushed with carbon dioxide gas) microfluidic device having a surface of Formula XV was treated with 1.0 to 3.3 millimolar aqueous solutions of dibenzylcyclooctynyl (DBCO) modified PEG, weight average molecular weight 5000 Da (compound 8, Broadpharm, catalog no. BP-22461) by drawing the solution through the microfluidic channels of the device at a pressure slightly below atmospheric pressure. As a result, the channels were filled with the reagent solution. However, due to the low pressure of fluid introduction and the unprimed nature of the surfaces within the microfluidic device, the D The BCO-modified PEG 5 kDa solution does not enter the isolation pen leading to the microfluidic channel. After 30 min of incubation at room temperature, 80 microliters of water was drawn through the channel at reduced pressure while washing remaining reagents from the microfluidic device. The solution was further controlled to flow only through the microfluidic channel. Further flushes with 1 microliter / sec water at low pressure continued for approximately 5 min. The surface-modified microfluidic channel was repeatedly flushed with carbon dioxide gas while the device was heated to 90 °C.
[0352] The dried microfluidic device with the first surface modification of PEG5K was then primed with carbon dioxide as described above. The isolation pen leading to the microfluidic channel was then primed with a 1:1 mixture of alkyne-poly-L-lysine HBr salt (100-mer unit, Alamanda polymer) and alkyne-modified PEG (j=MW approx. 5000 Da, compound 6, JenKem Technologies) along with copper sulfate (excess), THPTA ligand and sodium ascorbate. The microfluidic device was regioselectively modified by flowing a 1.33 micromolar solution containing the stoichiometric mixture. The excess copper sulfate prevented disulfide cleavage by ascorbate during the reaction, which was carried out for about 15 minutes at 40° C. (and alternatively can be carried out at room temperature for about 1 hour). After the incubation period was completed, excess reagents and by-products were removed by flushing with water. The interior of the microfluidic device was dried by flushing with carbon dioxide gas while heating the microfluidic device to 40° C., providing the microfluidic device with a first surface modification with only PEG5K in the microfluidic channel and a second regioselective surface modification with poly-L-lysine, which provides a positive charge to promote the adhesion of biological cells only in the isolation pen (Formula XLV). Of note is the ability to adjust the ratio of reagents used to modify the surface of the isolation pen. The ratio of PEG-5K:poly-L-lysine was varied from 0:100 to 99.9999:0.0001% and adhesion of HeLa cells was observed within the isolation pen, while migration of motile HeLa cells was inhibited simply by the presence of a hydrophilic surface within the channel.
[0353] Microfluidic devices having an inner surface modified with a first surface modification of PEG 5 kDa and a second surface modification of poly-L-lysine having a percentage of poly-L-lysine surface modification of about 0.00001% or 0.000001% are predicted to allow attachment of adherent cells (such as HeLa cells) without laser initiation of displacement while still allowing removal of cultured cells using dielectrophoretic forces.
[0354] Further generalization. Any type of surface modification reagent can be used to introduce the second surface modification in the isolation pen and is not limited to poly-L-lysine.
[0355] Secondary passivation of a microfluidic channel with a second surface modification only in the channel region. After the initial surface modification of a microfluidic channel as described above, unreacted reactive moieties (e.g., azides) may still be present in the channel. Without wishing to be bound by theory, this may occur if the modification reagent is bulky. Secondary passivation with a less sterically bulky surface modification reagent may allow the remaining reactive moieties to be utilized to add a second surface modification to the modified surface of the channel without modifying the surface of the isolation pen.
[0356] Microfluidic devices with PEG 5 kDa surface modification introduced only into the microfluidic channels were rinsed with water only after surface introduction. A second treatment with DBCO-PEG4-OH (Aldrich Cat. No. 761982) at a concentration of 1.3 micromolar in aqueous solution was performed as described above. The second surface modification reagent did not enter the isolation pen because the microfluidic device was not primed, and therefore only the channels were further modified. After washing, drying and heating, followed by carbon dioxide priming, the isolation pen was then used for site-selective modification. Decoration is carried out as described above.
[0357] Example 28. Cultivation of OKT3 cells in microfluidic devices with PEG-modified surfaces. material: OKT3 cells, a murine B lymphocyte hybridoma, were obtained from the American Type Culture Collection (ATCC) (catalog ATCC® CRL-8001™) and provided as a suspension cell line. 5 The culture was maintained by seeding 2 × 10 viable cells / mL and incubating at 37 °C with a 5% carbon dioxide gas environment. The cells were seeded every 2 to 3 days at 2 × 10 4cells / mL or 1 x 10 5 Cells were split at 100 cells / mL. Cells were frozen in 5% dimethyl sulfoxide (DMSO) / 95% complete growth medium.
[0358] Media: IMDM (Gibco, Cat. 12440053) with 20% fetal bovine serum (FBS) and 1% penicillin-streptomycin (10,000 U / mL) (Gibco, Catalog The complete medium was then filtered through a 0.2 μm PES, sterile membrane filter unit (Nalgene, 567-0020).
[0359] Priming and perfusion procedure: As described above in the General Experimental Details section.
[0360] Systems and Microfluidic Devices: As described above in the General Experimental Details section. The isolation pen contains approximately 7×10 5 It has a volume of cubic μm.
[0361] Modified microfluidic surfaces. The microfluidic device had a covalently attached PEG-modified surface (Formula XVI) prepared as described above in Example 6.
[0362] A suspension of OKT3 cells in medium was introduced into the microfluidic device by flowing the suspension through the fluid inlet and into the microfluidic channel. The cells were randomly loaded into the isolation pen by stopping the flow, tilting the tip, and allowing the cells to enter the isolation pen by gravity.
[0363] After loading the OKT3 cells into the isolation pen, the medium was perfused through the microfluidic channels of the nanofluidic chip for a period of 3 days. Figure 6A shows the growth of OKT3 cells on the PEG-modified surface of the isolation pen of the microfluidic device. The growth of OKT3 cells on the PEG surface was improved compared to the unmodified surface of a similar microfluidic device (data not shown).
[0364] The OKT3 cells were then removed from the isolation pen by OET. Figure 6B shows the extent of removal from the isolation pen at the end of the 20 minute period, indicating a superior ability to remove the grown OKT3 cells into the flow channel, which was improved compared to the ability to remove the OKT3 cells from a non-conditioned surface of a similar microfluidic device. The OKT3 cells were then removed from the microfluidic device (not shown).
[0365] Example 29: Cultivation and removal of T lymphocytes on dextran-modified microfluidic surfaces. material. CD3+ cells were from AllCells Inc. and were immunolabeled with anti-CD3 / anti-C at a ratio of 1 bead / 1 cell. The T cells were mixed with D28 magnetic beads (Dynabeads®, Thermofisher Scientific, Cat. No. 11453D). The mixture was incubated in a 37°C, 5% CO2 incubator for 5 hours in the same medium as the culture experiment itself. After incubation, the T cell / bead mixture was resuspended for use.
[0366] Culture medium. RPMI-1640 (GIBCO®, ThermoFisher Scientific, Cat. No. 1311611) No. 11875-127), 10% FBS, 2% human AB serum (50 U / ml IL2; R&D Systems).
[0367] Priming Instructions: As described above in the General Experimental Details section.
[0368] Perfusion plan: As described above in the General Experimental Details section.
[0369] Systems and Microfluidic Devices: As described above in the General Experimental Details section. The isolation pen contains approximately 7×10 5 It has a volume of cubic μm.
[0370] Modified microfluidic surfaces. The microfluidic device had a covalently bound dextran modified surface prepared as described above in Example 7.
[0371] The T cell (and bead) suspension was introduced into the microfluidic device by flowing the resuspension through the fluid inlet and into the microfluidic channel. The T cells / beads were randomly loaded into the isolation pen by stopping the flow, tilting the chip, and allowing gravity to force the T cells / beads into the growth chamber.
[0372] After loading the T cells / beads into the isolation pen, culture medium was perfused through the microfluidic channels of the nanofluidic chip over a period of 4 days. Figure 7A shows the growth of T cells on the dextran-modified surface of the isolation pen of the microfluidic device. The growth of T cells on the dextran surface was improved compared to the unmodified surface of a similar microfluidic device (data not shown).
[0373] The T cells were then removed from the isolation pen by gravity (e.g., tilting the microfluidic device). Figure 7B shows the extent of removal from the isolation pen at the end of the 20 minute period, indicating a superior ability to remove expanded T cells into the flow channel, which was improved compared to the ability to remove T cells from the unmodified surface of a similar microfluidic device (data not shown). The T cells were then removed from the microfluidic device (not shown).
[0374] In addition to any modifications shown above, many other variations and alternative configurations may be devised by those skilled in the art without departing from the spirit and scope of the present specification. Thus, while the information has been described above with specificity and detail with respect to what are presently considered to be the most practical and preferred embodiments, it will be apparent to those skilled in the art that many modifications, including but not limited to form, function, method of operation and use, may be made without departing from the principles and concepts described herein. As used herein, the examples and embodiments are intended to be merely illustrative in all respects and should not be construed as limiting in any way. Although the term process is used herein, the term refers to various portions of the method being described. It should also be noted that these are merely used to illustrate the principles of the method and are not intended to describe starting or stopping points for any portion of the method or to be otherwise limiting.
[0375] Enumeration of Certain Embodiments of the Disclosure 1. A microfluidic device comprising an enclosure comprising a base, a cover and a microfluidic circuit material defining a fluid circuit therein, wherein at least one inner surface of the base, the cover and the microfluidic circuit material has a plurality of first covalent surface modifications each comprising a first binding group, and a first moiety that is a first surface contacting moiety or a first reactive moiety; and at least one inner surface of the base, the cover and the microfluidic circuit material has a plurality of second covalent surface modifications each comprising a second binding group, and a second moiety that is a second surface contacting moiety or a second reactive moiety, wherein the first binding group and the second binding group are different from each other and / or the first moiety is different from the second moiety.
[0376] 2. The microfluidic device of embodiment 1, wherein the first and second moieties are each capable of being covalently attached to the surface via a linking group LG independently selected from -W-Si(OZ)2O- and -OP(O)2O-, where W is O, S or N, and Z is a bond to a silicon atom in an adjacent linking group LG or a bond to the surface.
[0377] 3. The microfluidic device of embodiment 1 or 2, wherein the first surface contacting moiety may comprise one or more of an alkyl, fluoroalkyl, monosaccharide, polysaccharide, alcohol, polyalcohol, alkylene ether, polyelectrolyte, amino, carboxylic acid, phosphonic acid, sulfonate anion, carboxybetaine, sulfobetaine, sulfamic acid, amino acid moiety or cleavable moiety; and / or the second surface contacting moiety may comprise one or more of an alkyl, fluoroalkyl, monosaccharide, polysaccharide, alcohol, polyalcohol, alkylene ether, polyelectrolyte, amino, carboxylic acid, phosphonic acid, sulfonate anion, carboxybetaine, sulfobetaine, sulfamic acid, amino acid moiety or cleavable moiety.
[0378] 4. The microfluidic device of embodiment 1 or 2, wherein the first surface contacting moiety may comprise a polyethylene glycol moiety, a dextran moiety, a proteinaceous moiety, a polycarboxylic acid, a polylysine moiety, or any combination thereof; and / or the second surface contacting moiety may comprise a polyethylene glycol moiety, a dextran moiety, a proteinaceous moiety, a polycarboxylic acid, a polylysine moiety, or any combination thereof.
[0379] 5. The microfluidic device of any one of embodiments 1 to 4, wherein the first reactive moiety can be an alkyne moiety, an azide moiety, a carboxylic acid moiety, an amine moiety, an olefinic moiety, a tetrazinyl moiety, a trans-cyclooctenyl moiety, a thiol moiety, a maleimide moiety, a biotin moiety, a streptavidin moiety, a halide moiety, a cyano moiety, an isocyanate moiety, an epoxide moiety, a hydroxylamine moiety, or a sulfonyl fluoride moiety; and / or the second reactive moiety can be an alkyne moiety, an azide moiety, a carboxylic acid moiety, an amine moiety, an olefinic moiety, a tetrazinyl moiety, a trans-cyclooctenyl moiety, a thiol moiety, a maleimide moiety, a biotin moiety, a streptavidin moiety, a halide moiety, a cyano moiety, an isocyanate moiety, an epoxide moiety, a hydroxylamine moiety, or a sulfonyl fluoride moiety.
[0380] 6. A microfluidic device according to any one of embodiments 1 to 5, wherein the first covalent surface modification may comprise a linker, the ...
Claims
1. a microfluidic device comprising a base, a cover, and an enclosure comprising a microfluidic circuit material defining a fluid circuit therein, wherein at least one interior surface of the base, the cover, and the microfluidic circuit material comprises a plurality of first covalent surface modifications, each of the plurality of first covalent surface modifications comprising a first binding group and a first moiety, the first moiety being a first reactive moiety or a first surface contacting moiety, and at least one interior surface of the base, the cover, and the microfluidic circuit material comprises a plurality of second covalent surface modifications, each of the plurality of second covalent surface modifications comprising a second binding group and a second moiety, the second moiety being a second reactive moiety; Formula XII 1 A first surface-modifying reagent having the structure: RP 1 -L 1 - Surface contact part 1 (Formula XII 1 ) A kit comprising: RP 1 is the reactive part and the surface contact part 1 is a moiety configured to support cell growth, survival, mobility, or any combination thereof; L 1 is the linker, L 1 is a bond or 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur, and phosphorus atoms, and may further comprise 0 or 1 linking group, CG; kit.
2. The kit of claim 1 , wherein the first moiety is a first reactive moiety.
3. the first reactive moiety is an alkyne moiety, an azide moiety, a carboxylic acid moiety, an amine moiety, an olefinic moiety, a tetrazinyl moiety, a trans-cyclooctenyl moiety, a thiol moiety, a maleimide moiety, a biotin moiety, a streptavidin moiety, a halide moiety, a cyano moiety, an isocyanate moiety, an epoxide moiety, a hydroxylamine moiety, or a sulfonyl fluoride moiety; and / or the second reactive moiety is an alkyne moiety, an azide moiety, a carboxylic acid moiety, an amine moiety, an olefinic moiety, a tetrazinyl moiety, a trans-cyclooctenyl moiety, a thiol moiety, a maleimide moiety, a biotin moiety, a streptavidin moiety, a halide moiety, a cyano moiety, an isocyanate moiety, an epoxide moiety, a hydroxylamine moiety, or a sulfonyl fluoride moiety; The kit of claim 2.
4. the first reactive moiety has a structure selected from Formula XXX, Formula V, and Formula VII; 【Chemistry 1】 LG -W-Si(OZ) 2 O- or -OP(O) 2 O- and L fm is a linker having 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur, and phosphorus atoms, and which may further comprise 0 or 1 linking group CG; R x is a reactive moiety, W is O, S, or N, Z is a bond to an adjacent silicon atom or a bond to the surface, and n is an integer from 3 to 21; 【Chemistry 2】 The kit of claim 2 , wherein:
5. The kit of claim 2 , wherein the second moiety is a second reactive moiety.
6. the second reactive moiety is an alkyne moiety, an azide moiety, a carboxylic acid moiety, an amine moiety, an olefinic moiety, a tetrazinyl moiety, a trans-cyclooctenyl moiety, a thiol moiety, a maleimide moiety, a biotin moiety, a streptavidin moiety, a halide moiety, a cyano moiety, an isocyanate moiety, an epoxide moiety, a hydroxylamine moiety, or a sulfonyl fluoride moiety; and / or the first reactive moiety is an alkyne moiety, an azide moiety, a carboxylic acid moiety, an amine moiety, an olefinic moiety, a tetrazinyl moiety, a trans-cyclooctenyl moiety, a thiol moiety, a maleimide moiety, a biotin moiety, a streptavidin moiety, a halide moiety, a cyano moiety, an isocyanate moiety, an epoxide moiety, a hydroxylamine moiety, or a sulfonyl fluoride moiety; The kit according to claim 5.
7. the second reactive moiety has a structure selected from Formula XXX', Formula V', and Formula VII'; 【Chemistry 3】 LG' is -W-Si(OZ) 2 O- or -OP(O) 2 O-, and L' fm is a linker having 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur, and phosphorus atoms, and may further include 0 or 1 linking group CG; R' x is a reactive moiety, W' is O, S or N, Z' is a bond to an adjacent silicon atom or a bond to the surface, and n' is an integer from 3 to 21; 【Chemistry 4】 is the surface, The kit according to claim 5.
8. The kit of claim 5 , wherein the first reactive moiety and the second reactive moiety have the same formula.
9. the surface contact part 1 The kit of claim 1 , wherein is a polymer.
10. the surface contact part 1 2. The kit of claim 1, wherein comprises one or more of an alkyl, fluoroalkyl, monosaccharide, polysaccharide, alcohol, polyhydric alcohol, alkylene ether, polyelectrolyte, amino, carboxylic acid, phosphonic acid, sulfonate anion, carboxybetaine, sulfobetaine, sulfamic acid, amino acid moiety, or a cleavable moiety.
11. Formula XII 2 and further comprising a second surface-modifying reagent having the structure RP 2 -L 2 - Surface contact part 2 (Formula XII 2 ) RP 2 is the reactive part and the surface contact part 2 is a moiety configured to support cell growth, survival, mobility, or any combination thereof; L 2 is the linker, L 2 is a bond or 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur, and phosphorus atoms, and may further comprise 0 or 1 linking group CG; the second surface-modifying reagent is different from the first surface-modifying reagent; The kit of claim 1.
12. the surface contact part 2 The kit of claim 11 , wherein is a polymer.
13. the surface contact part 2 12. The kit of claim 11 , wherein comprises one or more of an alkyl, fluoroalkyl, monosaccharide, polysaccharide, alcohol, polyhydric alcohol, alkylene ether, polyelectrolyte, amino, carboxylic acid, phosphonic acid, sulfonate anion, carboxybetaine, sulfobetaine, sulfamic acid, amino acid moiety, or a cleavable moiety.
14. A method of synthesizing a compound of formula IV, comprising: 【Chemistry 5】 reacting a compound having the structure of formula XIII with azide ion; 【Chemistry 6】 thereby producing a compound of formula IV, h is 1 to 19, n is 3 to 21, and R is H or C. 1 ~C 6 is alkyl, method.
15. 15. The method of claim 14, wherein the counterion to the azide ion is sodium.
16. The reaction is carried out in acetonitrile or DMF; the reaction is carried out at ambient temperature; and / or The reaction is carried out under an inert atmosphere. The method of claim 14.
17. A compound having the structure of formula IV: 【Chemistry 7】 n is an integer from 7 to 21, and R is independently H or C. 1 ~C 6 is alkyl, compound.
18. R is Me, Et, or Pr; and / or n is 9 to 21; 18. The compound of claim 17.
19. each R is Me; and / or n is 9, 14, or 16; 18. The compound of claim 17.
20. 18. The compound of claim 17, wherein each R is Me and n is 9.
